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SU~~~~l\RY 
The synthesis of prostaglandins is reviewed and the strategy of 
the more important and interesting approaches is discussed. 
The synthesis of a model prostanoid via a novel three-stage 
approach is described. This involved a Claisen type condensation of 
diethyl azelate to methyl nonyl ketone to form a C20 1,3-diketo -ester. 
Dimethylation of the active methylene at the C-10 position of the 1,3-
diketo-ester, followed by cyclisation across the C-8, C-12 positions, 
afforded the novel ethyl 10,10-dimethyl prost-8(12)-en-9,11-dionoate. 
This synthetic approach was subsequently applied to the preparation of 
the novel ethyl 10,10-dimethyl prost-8(12), 15-dien-9,11-dionoate and 
ethyl 10,10-dimethyl-15-benzy[oxy-prost-8(12)-en-9,11_dionoate. 
Other methods of effecting the C-8, C-12 cyclisation of 8,12-dibromo 
-1 0,1 O-dimethyl eicos-9,11-dionoic esters were investigated. Finally, the 
cyclisation of simpler 1,3-diketone models, 3,7-dibromo-5,5-dimethyl 
nona-4,6-dione and 5, 9-dibromo-7, 7-dimethyl trideca-6, 8-dione was' 
investigated. 
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1. PROSTAGLANDINS 
1.1 Introduction to Prostaglandins 
Prostaglandins are a class of C20-hydroxylated unsaturated fatty 
acids of mammalian origin. They are usually present in minute quantities 
in almost all animal organs. All investigations carried out so far wQuld 
suggest that they are synthesized by an enzyme complex, prostaglandin 
synthetase1 and very rapidly deactivated by other specific enzymes 2• It 
seems likely that in most instances, prostaglandins are not stored as such. 
but are readily formed from precursor unsaturated fatty acids, in response 
to a variety of stimuli3, 4 
Biologically, these substances are unusual because of their 
ubiquity in the human organs, their broad spectrum of physiological activity 
and their very high potency. The problem of their physiological role is 
a complex one and there arc indications that these substances may play a 
5 different role not only in each organ, but possibly in each tissue and cell • 
Generally, they are regarded to be local modulators of cell function or 
tissue hormones. They seem to be involved in the regulation of the 
endocrine, reproductive, nervous, digestive,hemostatic, respiratory, 
6 7 
cardiovascular and renal systems '. Of considerable importance is the 
action of prostaglandins on smooth muscle beds. This has led to the first 
I f t 1 d · t . d h t ·t· 8 clinica use 0 a pros ag an ~n 0 ~n uce uman par ur~ ~on • 
The presence of active factors in the seminal fluid of man was 
first reported by R. Kurzok and C. C. Lieb9 in 1930. This was followed 
10 11 by reports of similar findings by U. S. Von Euler and M. W. Goldblatt • 
However, due to difficulties in purification, the structure of these 
active s~bstances remained unknown for a number of years. Eventually in 
1 U d SI· 12,13 ·f· d d· 1 t d th f· t 957, S. Bergstrum an B. amue sson pur~ ~e an ~so a e e ~rs 
1 
pure crystalline PGF. This was followed by a series of elegant chemical 
elucidation work 14- 18 which culminated in the final proof of the structures 
and the related PGE 1• 
19 20 21 Since then, the crystal structures ' , 
d b 1 t f o to 22 f th d d h b an a so u e con 2gura 20n5 0 ese compoun s an ot er mem ers of the 
family of prostaglandins have been reported. 
The nomenclature of prostaglandins is based on the C20 prostanoic 
acid shown in figure 1.1. The prostaglandins are grouped into six basic 
families which differ from each other in the nature of the cyclopentane 
functionalities. The primary prostaglandins23 are PGF and PGE; the other 
families which may be derived from them are PGA, PGB, PGC and PGD. Within 
each family of prostaglandin are members with different numbers of double 
bonds, such as PGE 1 , PGE2 and PGE 3 • 
In addition to the six basic families of prostaglandins, more new 
families have been discovered. These are the prostaglandin endoperoxides 
25,26(PGG and PGH), the prostacyclin24 (PGX or PGI) and the related 
24 thromboxanes • 
A major difficulty in the biological evaluation and practical 
application of prostaglandin was due to the short supply of the primary 
prostaglandinsfrom natural sources. Early supplies of prostaglandins 
were obtained from extracts of ram seminal ves{icles after lengthy 
purification procedures. However, the problem was partly overcome when 
° 27 28 29 biosynthetic stud2es ' , showed that relatively larger quantities of 
prostaglandins could be prepared by the incubation of certain essential 
polyunsaturated fatty acids with enzyme extracts from sheep seminal 
vescicles. 
For many years,a laboratory scale-up of this biosynthotic route 
was used to obtain gram-quantities of prostaglandins for biological 
1 t o 30 eva ua 20n • More recently, the accidental discovery of a prostaglandin 
2 
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of the A family (15-epi-PGA2 ) in the Carribean coral, Plexaura Homomalla l 
has provided an unexpectedly large quantity of material (1.3 °/0 dry 
weight of PGA). This is presently being used for the synthesis of other 
primary prostaglandins, as well as for the preparation of modified 
t 't' 32,33 en ~ l.es • 
With the anticipation that prostaglandins would become medically 
useful agents, it was necessary to devise efficient methods for their 
synthesis on a large scale. The scale-up of the biosynthetic route was 
not thought to offer the potential for large scale operation,nor the 
flexibility necessary to produce a wide range of different prostaglandins 
and their modified congeners. From the time that the first prostaglandin 
structures were known, chemical total synthesis has been investigated as 
a viable alternative. Only shortly after the final proof of the structure 
of the prim6ry prostaglandins, the first total synthesis of(±)-PGE1 
and {:t)...PGF 1 was reported by Just and Simonovitch34 of McGill University. 
This was followed by a more definitive series of papers on the synthesis 
of(±~PGE1 and{:t)-PGF1~ by E. J. Corey and his co-workers at Harverd 
U · 't 35,36 n1.vers1. y • Subsequently, they demonstrated the first total synthesis 
37 
of PGE1 in its natural enantiomeric form • 
Since then, numerous total and partial syntheses of natural prosta-
gland ins have been reported. This challenge in organic synthesis has 
consequently stimulated new ideas and led to the introduction of many 
novel synthetic methodologies. In the following section, the more general 
strategies of prostaglandin synthesis will be discussed. 
As a result of the intensive research in the prostaglandin field, 
the volume of published literature has increased almost exponentially. 
Several reviews and books with varying emphasis on different aspects of 
prostaglandins are available. To cover some of the more vital literature, 
4 
a selected bibliographi is included in a separate section at the end. 
5 
1.2 Prostaglandin synthesis and the choico of a synthetic target. 
In the ideal total synthesis of prostaglandins, it is desirable to 
prepare all the primary prostaglandins and analogues in their optically 
active forms from a single precursor (synthon). Such a synthon could be 
prepared from chiral starting materials or by chemical resolution or 
stereospecific microbial transformation of achiral precursors at an early 
stage in the synthesis. In practice, the synthon generally bears the 
cyclopentane nucleus in a protected form and provides a degree of 
flexibility for the introduction of a variety of side-chains. 
Generally, the primary synthetic target of most total syntheses is 
a member of the PGE or PGF family. This is due in part to the fact that 
prostaglandins of the A, B,.C and D families can be prepared by further 
conversion of PGE or PGF. The latter pair are also interconvertible 
(see fig. 1.2). 
The 1, 2 and 3 series within each prostaglandin family can generally 
be prepared by the introduction of side chains with different degrees 
of unsaturation. Alternatively, selective hydrogenation of the double 
bonds is possible in limited instances, fig. 1.3. 
The major problems encountered in the total synthesis of 
prostaglandins are those of stereochemical control, lability of the 
prostaglandin molecule (as in the synthesis of PGE) and selective 
manipulation of the functional groups. In PGE 1 for instance, there are 
four asymmetric centres, three of these centres are contiguous on the 
cyclopentane nucleus ~nd mutually trans. This is the more stable arrange-
ment and,therefore,relatively easy to establish. The same is true of 
the trans C-13 double bond. However, stereochemical control of the fourth 
asymmetric centre at C-15 is difficult because of its remote position. 
Furthermore, the general instability of PGE 1 is characterised by 
6 
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the significant dehydration of its 1,3-kBtol system ' at pH values 
outside the 3-9 range. On the other hand, PGF1~ possesses an extra 
asymmetric centre at the C-9 position which complicates the problem of 
synthesis. However, this is more than compensated for by the marked 
increase in the stability of the PGF1~molecule. 
It is evident that the synthesis of PGE and PGF each presents its 
own particular set of problems. It is interesting, therefore, to 
examine in the following section, the various strategies and methodologies 
employed to solve these problems. 
8 
1.3 Strategies in prostaglandin synthesis 
Prostaglandin synthesis can generally be classified into three main 
classes as shown in fig. 1.4. 
i) synthesis from acyclic prEcursors. 
ii) synthesis from cyclopentane or monocyclic precursors. 
iii) synthesis from polycyclic precursors. 
In general, the syntheses of classes (i) and (ii) are beset by 
problems of stereochemical control and the selective protection and 
elaboration of functional groups are often difficult. Syntheses of 
class (iii) generally possess a degree of stereochemical control. Latent 
functionalities held within the rigid framework of these polycyclic systems 
can be used to bring about relative stereochemical control at several 
carbon centres. In addition, the further elaboration of these polycyclic 
precursors can often be achieved in a stereos elective manner by the use 
of bulky reagents. 
(i) Synthesis of pro~taglandin from acyclic precursors 
The construction of the cyclopentane nucleus of the prostaglandin 
skeleton from acyclic precursors may be accomplished in a variety of ways. 
The various possible bond formations shown in fig. 1.5 generally rely on 
acid- or base-catalysed aldol type condensations. Of the five approaches 
shown, only the C-8, C-9 bond formation has not been reported. 
In general the conversion of simple acyclic precursors to alicyclic 
products lack stereochemical control. However, in the synthesis of 
prostaglandins, this problem is reduced by the fact that the required 
relative configuration of the substituents at C-8, C-11 and C-12 of the 
cyclopentane nucleus is the more stable all-trans arrangement. 
---------
9 
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Historically, the approach via the C-11, C-12 bond formation by 
E J C ~ l35-37,55a. ~ . , d h •• orey ~~ 1S aT inter8st,as 1t ~e to t e first total 
synthesis of PGE
1 
in its natural enantiomeric form. A later improved 
version of this synthesis is outlined in fig. 1.6. 
103 
The reaction of 3_nitropropanoldimethylacetal (1) with 
104,105 
9-cyano-2-nonenal (2) in the presence of base gave the Michael adduct (3) 
127,128 
which was converted to the conjugate enone (5) using the Horner-Emmons 
modification of the Wittig reaction. 
Protection of the C-15 carbonyl function gave the bis-dioxolan (6). 
37 
Cyclisation of (6) in the presence of anhydrous stannic chloride almost 
completely and stereoselectively gave the vinylogous aldol product (7), 
with only minor contamination by it 11~-epimer. Reduction of the C-15 
carbonyl group gave a mixture of epimeric diols (8) and (9) which were 
separated by chromatography. The desired nitro-cyclopentane dial (8) was 
subsequently reduced to the amino-derivative (10). Resolution at this 
stage with (-)o(-bromcamphor- 7L -sulphonic acid afforded the required 
enantiomer (13). Sequential N-formylation and protection of the hydroxyl 
groups of (13), followed by base hydrolysis, gave the protected amino-
carboxylic acid (14). Bromination and dehydrobromination of the amino 
106-108 function, followed by carefully controlled acid hydrolysis, afforded 
optically active natural PGE 1• 
As was expected, the stereochemical control of the remote C-15 
centre was difficult. This was exemplified by the sodium borohydride 
reduction of (7) which afforded a mixture of the C-15 epimers (8) and (9). 
However, the undesired 15~epimer (9) could be reconverted to the 
precursor (7) by selective oxidation with DDQ. This recycling procedure 
allowed stereos elective channelling of the synthesis to the desired 
15lX-epimer (8). 
12 
. , 
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Although this approach by E. J. Corey succeeds in the total 
synthesis of nat-PGE1 , several difficulties still remain unresolved. 
For instance, complete stereospecific control of the C-11 centre has not 
been achieved. In addition, the generation of the 1,3-ketol system from 
the 1,3-hydroxylamine precursor (12) or (14) via the procebure described 
106-108 (Ruschig's method) is experimentally difficult. 
58 63 More recently, two biomimetic routes ' have been reported. Of 
63 these, the Roussel-Uclaf approach is conceptually one of the most 
interesting. This approach forges the C-8, C-12 bond and incorporates 
steric control at the C-12, C-13, C-14 and C-15 centres. This is 
achieved by a biogenetic type cyclisation of a conjugated 
epoxide. The synthesis is outlined in fig. 1.1. 
The acetylenic acid (15) was converted to its acyl imidazole 
derivative (17). Reaction of (11) with the magnesium enolate of the 
hemiester of malonic acid, followed by decarboxylation, afforded the 
1,3-diketo-ester (18). Transformation of (18) to its enol ether and sub-
sequent alkylation with 2-chloro-heptanal produced the cirythro-clllorohydrin 
(20) after acid hydrolysis. Partial hydrogenation of (20), followed by 
mild base treatment, afforded the key epoxide (22) which was to act as 
the electrophilic site in the biogenetic type cyclisation. Treatment of 
the pyrrolidine enamine (23) with sodamide in THF, followed by acid 
hydrolysis,provided the cyclopentanone (24) with the correct configuration 
at C-12, C-13, C-14 and C-15. TheDe-side chain at C-8 was introduced 
by alkylation with the bromo-olefin (25) •. Isomerization of the carbethoxy 
group from C-8 to C-10 was effected by a retro-Dieckmann cyclisation. 
Sequential methylation, saponification and decarboxylation of (21) 
afforded an intermediate methyl enol ether which on treatment with bromine 
14 
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in methanol gave the bromo-ketal (28). Dehydrobromination of (2B), 
followed by cleavage of the protecting groups afforded PGA2• 
The Roussel-Uclaf approach is of considerable theoretical interest 
because of the biogenetic type cyclisation of the cis-trans allylic 
epoxide (23) which in a single step introduces the requisite trans double 
bond at C-13, together with relative stereochemical control of the C-B, 
C-12 and C-15 centres. However, in practice, there are difficulties due 
to competing alternate modes of ring-closure. 
(ii) Synthesis of prostaglandin from cyclopentane or monocvclic precursors 
Several in~resting variants of this general approach to 
prostaglandin synthesis have been developed. The strategy of the more 
important syntheses is outlined in fig. 1.B. 
GenerallY,the synthesis commences with a preformed cyclopentane 
nucleus bearing the requisite functionality for the attachment of one or 
both the pendant side-chains. This is exemplified by synthetic approaches 
I, 11 and Ill. Alternatively, stereospecific ring contraction of a 
suitably functionalised cyclohexane precursor provides an entry to the 
cyclopentane template which is subsequently elaborated. 
In the first three approaches, the relative configuration of the 
C-B, C-11 and C-12 centres is predetermined by the regiospecific approach 
of the nucleophilic component Y. For steric reason, the attack by the 
nucleophile Y is generally from the f3 - foe e, this establishes the desired 
mutually all -trans configuration at the C~B, C-11 and C-12 centres of 
the cyclopentane ring. Approach IV, however, employs the cyclohexane 
precursor (33) bearing the correctly disposed substituents and relies on 
stereospecific ring contraction for the formation of the mutually all-trans 
16 
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configuration in the product type (34). 
One of the simplest and shortest route to PGE is by synthetic 
approach 1. 68,69 This was elegantly demonstrated by C. J.Sih et al 
of Wisconsin University. This synthesis is shown in fig. 1.9. 
Condensation of (36) with diethyl oxalate, followed by acid 
hydrolysis and esterification, afforded the trione (37). Stereospecific 
enzymatic reduction by Dipodascus Uninucleatus gave the 11(R)-alcohol (38). 
Reaction of (38) with mesityl sulphonyl chloride and triethylamine gave 
two isomeric enol sUlphonates, (39) and (40). The major isomer (39) 
was reduced with excess sodium bis-(2-methoxyethoxy)-aluminium hydride, 
followed by acid-catalysed rearrangement and elimination to give the 
desired optically active cyclopentanone (41). Protection of the hydroxyl 
function of (41), followed by 1,4-addition of trans-divinyl cuprate (43), 
afforded the protected PGE2 (44). Deprotection by acid hydrolysis and 
enzymatic de-esterification gave PGE 2 • 
The key conjugate addition step was extensively studied by 
C J Sl.·h 66-69 cl th" 71,72,76 • • an 0 er groups The highest yield of 
approximately 65% was reported by Sih 67 for the stereospecific conjugate 
addition of the ~-divinyl cuprate (43) to the protected cyclopentanone 
(45 ). 
LiCu 
(4S) (43) 
18 
.' 
.r 
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An important drawback of this conjugate addition is that only half 
of the precursor rlivinyl cuprate (43) is consumed in the reaction. The 
use of alternative nucleophilescsuch as (X3P)n(R p )CuLi
66
-
69
, 
LiAl( Me) 3R f3 11,12 and (ICuP (n-Bu )3:l.:m~MgBr complex 12 has been reported. 
These alternative methods are less wasteful but unfortunately the yields 
of the conjugate addition are very much lower. 
A logical extension of the 1,4-conjugate addition method is 
approach 11. In theory both the ~ and ~ side-chains can be stereospecifically 
introduced to the cyclopentanone (46) by a sequence of 1, 4-addition of R ~ , 
followed by trapping of the resultant enolate (41) and attachment of the 
R 0(, chain. This sequence of reactions is shown in scheme 1.1. 
Scheme 1~1 
6 
Rd (46) 
-~ 
• Rf3 
RO'" (48) 
I-RO-
~R6 
(49) I 
A major problem in this approach lies in the trapping of the 
kinetic-enolate (41) by a suitable electrophile. The intermediate enolate 
(41), formed by conjugate addition of the Rp side-chain, is in rapid 
equilibrium with the isomeric enolate (48). The latter eliminates RO-
to form the cyclopentanone (49). For instance in the synthesis of PGE 
type, it was found that the alkylation of (47) with reactive allylic 
halides was still sufficiently slow to allow equilibration to the isomeric 
20 
enolate' (48). 
By far the most successful solution to this problem has been 
described by G. Stork et al 77 of Columbia University. Trapping of the 
enolate type (47) was achieved with monomeric formaldehydet which 
subsequently provided the necessary functionality forthe further 
elaboration of the R~ side-chain. In the synthesis of 11-deoxy PGE 2 , 
where the elimination RO- does not occur, successful enolate trapping and 
alkylation with a bromo-allyl side-chain has been reported 76. 
Approach III relies on the nucleophilic displacement of a cyclopentane-
epoxy species (52) or (55), by a nucleophilic R0 group. As shown in 
scheme 1.2, the strategy poses its own problems. 
Scheme 1.2 
0 0 0 
o,'R~ (:rRo( tc~ . ' ( Internal _1~ ) ~~;OH ring-opening 
11 "'0 Rf.! E Rf3 HO 
(51) (52) (53) 
HO HO HO ~JR" b;:: ~ ,..R~ a < ) ~i'1 OH R ~, : R(?> 
Rp f? "0' HO~ R" 
(54) (55) (56) 
Competitive internal ring-opening of the epoxide precursor (52) 
to the hydroxy-cyclopentenone (51) makes this approach inapplicable to 
21 
the direct synthesis of PGE type. As a result, approach III is limited 
to the synthesis of PGF type. However, a more important requirement of 
approach I II is the regiospecific (3 - f ac e attack at C~12 by the 
nucleophile R~. This is probably less likely from steric considerations. 
This problem is well illustrated by the early synthetic work of J. Fried 
et a180 78 
____ and E. J. Corey et al • Both these groups reported the C-11 
alkylation by the nucleophile R~ as the major pathway. 
The problem of the lack of regioselectivity in the ring-opening of 
the epoxide precursor (55) was subsequently overcome by J. Fried and 
C. J. Sih81 • In the total synthesis of PGE and PGF, shown in fig. 1.1U, 
they demonstrated that the presence of a suitably located carbinol 
function elsewhere in the epoxy-precursor (61), capable of forming a 
covalent aluminium-oxygen bond with the nucleophilic alane reagent (65), 
could direct intra-molecular alkynylation at C-12 The observed 
regioselectivity in the opening of the epoxide (61) is believed to be 
due to the preferred transition state complex (66) formed between (61) 
and two molecules of the alane reagent (65), scheme 1.3. 
Scheme 1.3 
H~ OH. 
a-/V (65) ) 
(61) (66) 
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79 Similarly, E. J. Corey ~ al found that the use of divinyl 
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copper lithium which permitted better complexation of the epoxide 
intermediate (71) (reduced steric interaction), compared with the 
alternative complex (70), directed the alkenylation to the C-12 
position, scheme 1.4. 
Scheme 1.4 
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(68) (69) 
Approach IV via the ring contraction of a cyclohexane nucleus has 
83 been effectively employed by both R. B. Woodward et al and E. J. Corey 
84 ~ a1 in the synthesis of primary prostaglandins. The key strategy in 
both the reported syntheses was based on a regiospecific pinacolic 
deamination sequence of a dihydroxy-amino-cyclohexane precursor (72) 
ao shown in scheme 1.5. The resulting synthon (74) bears the requisite 
functionalities in the correct configuration and permits flexibility in 
the introduction of the 0( and (3 side-chains. 
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Scheme 1.5 
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The simpler and more attractiv~ strategy based on the thallium(III) 
82 
catalysed ring contraction of cyclohexene has been successfully applied 
to the synthesis of 11-deoxyprostaglandin85 but not to primary 
prostaglandins. 
(iii) Synthesis of prostaglandin from polycyclic precursors 
Prostaglandin synthesis via polycyclic systems is by far tho most 
thoroughly investigated approach. It relies generally on the relatively 
easier proposition of controlling stereochemistry via rigid cage-like 
structures. Bulky reagents are then effectively employed to attack from 
predetermined directions. The subsequent cleavage of one or more rings 
releases internally protected functionalities which may be further 
elaborated. In theory at least, this strategy potentially allows total 
control over the stereochemical outcome of the cyclopentane substituents 
and even the remote C-15 chiral centre. 
The main polycyclic precursors employed in prostaglandin synthesis 
are shown in fig. 1.11. 
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FIGURE 1,11 
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APP80ACH m 111-113 
The strategy of approach I is based on the stereospecific 
solvolysis of an appropria~ely substituted bicyclo[3.1.0] hexane 
precursor. This results in the formation of an allylic homoallylic 
system at C-11 to C-15 as shown in scheme 1.6. 
(80) 
Scheme 1.6 
ii) Na2C03, MeOH, 
H20 
ACETONE,HP 
) 
) 
This approach was first reported by Just and Simonovitch 34 of McGill 
University and later developed by other research groups 87,115-118. 
It has been reasonably effective in the synthesis of prostaglandin of the 
116-118 E series Unfortunately, however, in spite of the mas~ive effort 
that has gone into approach I, it does not appear to compete favourably 
with Corey's bicyclo [2.2.1] heptane route. (vide infra) 
Approach II via a bicyclo[ 3.2.0] heptane has not been directly 
employed in the synthesis of natural prostaglandin92. However, a number of 
prostaglandin analogues 90,91 have been prepared by this approach. 
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Ey far the most widely acclaimed and versatile prostaglandin 
synthesis is based on approach IIl, via a bicyclo [2.2.1] heptanone 
111 a precursor. This route was devised by E. J. Corey et al and has 
proved to be extremely effective in the synthesis of the entire natural 
prostaglandin family in their optically active forms. Although the 
synthetic route is lengthy, the overall yields for racemic PGF 20<. (27%) . and 
PGE 2 (23%) are reasonably good. It competes favourably with the 
biosynthetic route and in addition it offers much greater flexibility in 
analogue synthesis. Since the early work on this route was reported 
111a,b,c, the synthetic has been varied, extended and developed by other 
research groups and presently adapte~ for pilot plant production in several 
industriallaboratories121 • 
The original synthetic route to PGF2~and PGE2 via the 
bicyclo [2.2.1 ] heptane intermediate is shown in fig. 1.12. 
The sodium salt of cyclopentadiene (82) was alkylated with 
chloromethyl methyl ether (83), to give the intermediate (84), then 
immediately submitted to a Diels-Alder reaction with 2~chloroacrylonitrile. 
The bicyclic derivative (86) was hydrolysed with base to provide the 
unsaturated ketone (87) in high yield. Eaeyer-Villiger oxidation of 
the ketone (87) with .riJ.-chloroperbenzoic acid in the presence of nodium 
bicarbonate gave the lactone (88) in almost quantitative yield. Ease 
hydrolysis of the lactone group furnished the acid (89). Subsequent 
iodolactonization of (89), followed by acetylation, produced the key 
intermediate (90) which possessed the correct stereochemistry, as well as 
functionalities necessary to complete the synthesis. 
Deiodination of (90) with tributyltin hydride, followed by cleavage 
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FIGURE 1.12 
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of the methyl ether group and subsequent Collins oxidatio~~afforded the 
corresponding acetoxy-aldehyde (91). A Horner-Emmons reaction of the 
aldehyde (91) completed the side-chain at C-12 position. Reduction of 
the keto-group of (92) with zinc borohydride, afforded a mixture of 15(R)-
and 15(S)-isomers (93) which were separated by chromatography. 
Deprotection of the C-11 acetoxy-group of (93), followed by 
102 
tetrahydropyranylation and reduction of the lactone group, furnished 
the intermediate hemiacetal (94). 
The Wittig reaction of (94) with the ylid (95) provided PGF 20C 
in the protected form (96). Acid hydrolysis of the ether groups afforded 
PGF 2OC' Alternatively, Jones oxidation of (96), followed by acid 
treatment furnished PGE 2• 
To prepare optically pure PGF 20<. and PGE 2 , it was necessary to 
resolve the methoxy-hydroxy acid (89) using (+)_ephedrine131 • However, 
for the convenience of deprotection by hydrogenolysis, a benzyloxy-
derivative (97a) was later to become the choice precursor in the synthesis. 
132 This was resolved using (+)-amphetamine (see scheme 1.7). 
Scheme 1.7 
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In the early synthetic work, it was found that the 5-substituted 
cyclopentadiene (84) underwent rapid [1,5] sigmatropic shift 122 during 
the subsequent Dials-Alder reaction. To avoid this proble~, other 
research groups employed highly reactive dienophiles such as 
O(-chloroacrylyl chloride 123 (100) apd nitroethylene 124 (101). The 
f 6 f 1 113,125(,- ). . h use 0 a -acetoxy u vene precursor 102 lnstead of t e 
5-substitutedcyclopentadiene provided an alternate solution to the 
problem. 
(oct 
==\ .\ 
Cl N02 
(100) (101) (102) 
The key strategy of the approach by Corey lies in the use of the 
bicyclo[2.2.1 ] heptanone (106) to provide the relative configuration at 
junctions C-8, C-11 and C-12 of the PG cyclopentane nucleus. The crucial 
Diels-Alder addition of the 5-substituted cyclopentadiene (103) to the 
masked ketene (104) provides predominantly the anti-adduct 126 (106) as 
the key intermediate (see scheme 1.8). This step is vital to th~ 
strategy of the synthesis, as it effectively lodges the potential R~ 
side-chain at C-8 trans to the potential R~ side-chain at C-12. By a 
sequence of chemical manipulation, the keto function of (106) is 
ingeniously transformed to provide the two ~- face hydroxyl groups at 
C-9 and C-11 in the form of the iodo-lactone (90). The latter possesses 
all the essential cyclopentane functionalities in the correct configuration. 
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At a later stage in the development of this synthetic route, it 
was found that stereose1ective reduction of. the C-15 keto group could 
be achieved through the combined effect of a large protective group at 
C-11 and the use of certain bulky asymmetric borohydride reducing agents. 
Hence, it was shown that the protection of the C-11 hydroxyl group as 
the p-pheny1 phenyl carbamate effectively stabilized the S-cis enone 
conformer (107) by good ~- ~contact with the R~ side-chain enone moiety. 
In addition, it directed the formation of the desired 15(5) alcohol (109) 
by sevorely shielding the approach of the reducing agent from side B 
(producing the 15(R) alcohol, see scheme 1.9). Using thexy1 1imony1 
129 130 . borohydride (108) as the reducing agent, Corey ~ 61 ' obta1ned 
quantitative yield of the desired a1lylic alcohol in the ratio of 
92:8 (15(5) : 15(R)). 
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Currently, the Corey aldehyde (110) or lactone (111 ) is probably 
the most versatile synthon in the synthesis of natural prostaglandin and 
related analogues. Indeed, the synthesis of either (110) or (111 ) by 
any novel method constitutes a fornlal synthesis of prostaglandin. 
An interesting and versatile variant of the bicyclo [ 2.2.1 ] heptanone 
192 193 
approach has been reported by 5. M. Roberts et ~ , of Salford 
University. The key bicyclo [2.2.1] heptanone intermediate (117) was 
derived from the homoconjugate addition of the dialkyl lithium cuprate 
(116) (bearing the Rf> side chain) to the tricyclic ketone (115), as 
shown in fig. 1.13. Subsequent Baeyer-Villiger oxidation of (117), 
followed by reduction of the resultant lactone (118 »)afforded an intermediate 
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FIGURE 1.13 
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cyclic hemiacetal which was converted to the protected PGF 20<. by a 
Wittig reaction. Acid hydrolysis of.(119) followed by chromatography 
furnished PGF 2 (I(, • 
Approach IV is also based on the bicyclo [ 2.2.1 ] heptane skeleton. 
However, as shown in scheme 1.10, a more simplified strategy is employed. 
(120) 
f RO( R . 
~ 
(121) 
Scheme 1.10 
h9 9h 8 t 8 .. ' ~ R - - -) . Ha -:. R 
" '2' f3 HO"'l,::k (3 Re>< 12 R 
0( 
(122) (123) 
A Diels-Alder cycloaddition of the cyclopentadiene (120) to the 
trans dienophile (121) affords the bicyclo [ 2.2.1 1 heptene adduct (122) 
which possesses the requisite stereochemistry for transformation into the 
prostaglandin cyclopentane nucleus (123). The key strategy lies in the 
use of the trans dienophile (121) to secure the ~ geometry at junctjons 
C-8 and C-12. In addition, the double bond formed from the cycloaddition 
serves as a latent pair of 0( -.face carbonyl functions which are trans-
formed by a C-O inversion sequence to the C-9 and C-11 hydroxyl groups. 
This bicyclo [2.2.1] heptene approach has been effectively employed. by the 
C r 94, 133. th th' f' t 1 d' r •• group ~n e syn es~s 0 pr~mary pros ag an ~ns. 
Approach V is based on the cleavage of the six-membered ring of a bicyclo 
[4.3.0 ]nonane skeleton. This approach has been employed by the Merck 
138 group in the synthesis of PGE 1• However, the route appears too lengthy 
35 
and lacks flexibility. Other report on this approach has been 
limited to the synthesis of a PG anatoguE'136 
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2. PROSTANOIDS 
2.1 Introduction to prostanoid 
112 The term prostanoids was introduced by E. J. Corey to designate 
the family of natural prostaglandins and synthetic prostaglandin-like 
com~ounds. The latter group of substances, better known as prostaglandin 
analogues or prostaglandin congeners, has in recent years gained considerable 
importance over their natural counterparts. 
Due to the vast array of biological activity of the natural 
prostaglandins, it is difficult to use them in a therapeutic manner 
without the occurrence of side-effects. This problem is borne out by the 
fact that in spite of the intensive worldwide efforts of the pharmaceutical 
industry, there is only a single example of the marketing of a natural 
t 1 d · 139 pros ag an ~n • This is PGF2OG , sold as an abortifacient under the 
trade name of Dinoprost by Upjohn & Co •• The second problem associated 
with the use of natural pIostaglandins is their relatively short i!2 vivo 
half lives. This rapid metabolic deactivation of prostaglandin by 
specific enzyme systems considerably reduces their therapeutic efficacy. 
As a result of these difficulties, the present prostaglandin 
research trend has shifted largely to the synthesis and study of modified 
prostaglandins. Already, the initial structure - activity relationship 
studies have brought forth very encouraging results. In addition, they 
hav~ also provided clear-cut evidence that it may be possible to design 
analogues that possess better metabolic stability and higher tissue 
selectivity. 
The prostaglandin (PG) analogues are generally grouped into 
five classes:-
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(i) PGs ItJith modified asymmetric centres. 
(ii) PGs vlith modified RC( side-chain. 
(iii) PGs ItJith modified R~ side-chain. 
(iv) Ring-modified PGs. 
(v) Hybrid analogues. 
Types (i) to (iv) are natural PGs with modifications at specified 
carbon centres or parts of the PG molecule. Type (v), however, incorporates 
simultaneous changes at different parts of the molecule and generally 
combines changes of the type (i) to (iv). 
Generally, the syntheses of these analogues lack flexibility. 
This is due in part to the fact that most of the synthetic routes are 
designed solely to prepare a specific type of analogue. This is a serious 
drawback especially when one considers the few therapeutically useful 
drugs that have been discovered from the thousands that are screened. 
It is, therefore, the object of this project to develop a more general and 
flexible strategy in the construction of novel prostanoids. 
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2.2 A general approach to the synthesis of novel prostanoids 
The general concept of the proposed novel synthetic route to a 
prostanoid i8 schematised in 
The first stage of the synthesis involves a C-C bond formation of 
a general type, where the X group activates the carbon on both the 
side-chains in a complementary manner. The second stage requires the 
protection of the active methylene carbon at C-10. This is followed by 
a second C-C bond formation across the C-8 and C-12 positions. These 
reacting centres are again activated by the X-group. Finally, the removal 
of the protective Y group affords a prostanoid. 
The synthetic scheme is attractively simple and offers a great deal 
of flexibility. In theory at least, a wide range of prostanoids may be 
prepared by varying the choice of the OC- and/or fi -~ide chains. Within 
limits, ring modified congeners .such as those derived by replacement of a 
ring carbon unit by a heteroatom (heteroprostanoids), may be synthesized 
by this approach. 
Following the initial work carried out by Beecham Pharmaceuticals 140 
141 
which was later extended by C. B. Chapman in these laboratories, the 
general concept of the prostanoid synthetic plan took the form of a 
Claisen type condensation between diethyl azelate (C9 carbon unit component) 
and methyl nonyl ketone (C 11 carbon unit component) as its first step. 
This was followed by dimethylation of the active methylene at the C-10 
position. The final stage cyclisation across the C-8 and C-12 positions 
provided an entry to a novel prostanoid. The reaotion sequence is shown 
in figure 2.2. 
Having obtained the first prostanoid (23) by this route, 
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141 C. B. Chapman prepared the C-14 functionalised precursors. However, 
his attempts to cyclise these precursors in a similar fashion failed to 
produce the anticipated prostanoids (see scheme 2.1). 
Scheme 2.1 
x ) 
o o 
x ) 
The present project reinvestigates the synthesis of the model 
prostanoid (23), applies the synthetic route to prepare C-15 functionalised 
prostanoids and studies the final cyclisation step in more detail. 
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3. SYNTHESIS OF THE MODEL PROSTANOID (23) 
3.1 Formation of ethyl eicos-9,11-dionoate and related products 
The first stage of the synthesis utilizes a Claisen type condensation 
to form a C20 1,3-diketo-ester. Hence, the acylation of methyl nonyl 
ketone (2) with diethyl azelate (DEA) gave ethyl eicos-9,1"1-dionoate (3) 
as the model precursor in the proposed synthetic scheme, equation 1. 
(1) 
CO Et 
EtOOC--f\N\! 2 NaH 
~ 
o 
(2) Equation 1. 
) 
(3) R=Et 
(4) R = H 
(5) R = NHPh 
Initial exploratory work on this step was carried out by Beecham 
Pharmaceuticals140 and later used by C. B. Chapman141 in these laboratories. 
A 47% yield was reported for the 1,3-diketo-ester (3). However, subsequent 
work carried out in this project indicated that in practice, the yield 
was much lower and varied from batch to batch. This was suspected to be 
the result of variation in the induction period before the commencement 
of the reaction and the general lack of control over the reaction. It 
was also noted that on work-up in concentrated HC1, the ester (3) was 
partially hydrolysed to the corresponding acid (4). 
In an effort to improve the yield and to introduce more control 
over the reaction, a series of modified Claisen condensation conditions 
were applied. The results of these experiments are given in table 3.1. 
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Table 3.1 
Method Base Solvent Products % Overall %Y 
Ester (3) Acid (4 ) 
1 NaH DEA 22 16 38 
2 NaH DEA in large 18 17 35 
excess. 
3 NaH DEA and DME 20 25 45 
4 NaOEt EtOH 0 0 0 
5 NaH THF ,trace EtOH 28 19 47 
6 NaH DMF 35 9 44 
. 
The best result for the Claisen condensation was obtained when a 
solution of methyl nonyl ketone in THF, with a catalytic trace of 
142 
anhydrous ethanol was added slowly to a stirred slurry of sodium hydride 
in DEA and THF. Scale-up experiments and subsequent trials showed that 
the reaction was more manageable and more reproducible than the early 
method 1. 
In order to avoid the difficulty of having to deal with an end-
product mixture of ester and acid, the portially purified crude product 
from the Claisen condensation was directly hydrolysed in aqueous base 
and purified as the crystalline eicos-9,11-dionoic acid (4), mp 64_650 • 
An overall yield of about 30% of pure acid (4) was generally recorded, 
equation 2. 
(1) CO Et 
Et0 2C-JVW 2 j) NaH 
~ ii)AqNaOH ) 
(2) Equation 2. 
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The overall yield of 32% of (4) is comparable with the result of a 
similar Claisen type condensation reported by Brooke and Smith143. They 
condensed methyl octyl ketone with DEA in sodamide. The resultant crude 
product was purified via a copper (11) chelate to give 35% of crystalline 
ethyl nonadec-9,11-dionoate (7), equation 3. 
(1) 
--NVVC02Et C02Et 
Et0 2C NoNH2 
Yv\f\/\ ) 35
0/0 
0 
(6 ) Equot ion ') (7) Mp. 40° ..J 
Our attempts to purify the semi-solid ethyl eicos-9,11-dionoate (3) 
via its copper (11) chelate were unsuccessful. The latter precipitated 
out of an aqueous methanolic solution of copper (11) acetate as a 
gelatinous bluish-grey waxy semi-solid. 
The spectral data of ethyl eicos-9,11-dionoate (3) were consistent 
with the proposed structure and identical to the data obtained by 
141 C. Chapman • The corresponding crystalline eicos-9 1 11-dionoic acid (4) 
showed spectral data typical of a 1,3-diketo-acid. The IR spectrum of (4) 
-1 
showed bands for the carboxylic acid (3330-3040 and 1688 cm ) and the 
enolizable 1,3-diketo-system (1640(s) cm-1 ). 1 The H-NMR showed characteristic 
peaks at ~ 0.87(t, terminal Me), 1.16-1.93 (m, methylene envelope), 
3.57 (s,<:'1H), 5.49 (5, 1H) and 9.38 - 10.60 (broad 5 ,1H, D20 exchangeable). 
The relative intensities of signals at~3.57 (-CO -CH - CO -) and 
-2 
5.49 (-(HO)C = CH - co -) indicated that the equilibrium mixture of (4) 
consisted mainly of the enol-form (£S 70-80%). Satisfactory accurate 
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mass measurement, ~leffiDAt81 8Aslysis and 13C_NMR (see Appendix) data 
were obtained for the acid (4) 
An important side-reaction of the Claisen condensation was the 
further condensation of ethyl eicos-9,11-dionoate with a second mole 
of methyl nonyl ketone. This afforded a white crystalline C31 - tetrone 
141 (8), equation 4, which was previously characterised by C. B. Chapmsn • 
(2 ) yvvw ~ 
------4) (CH 2)7 . 
NaH WVVV 
(3 ) Equation 4 (8) 
The formation of the tetrone (8) accounted for a loss of about 10-15% Y 
of ethyl eicos-9,11-dionoate. In addition, the side-reaction consumed 
an equal molar amount of the substrate (2), therefore,resulting in a 
overall loss of 20-30%Y of ethyl eicos-9,11-dionoate. One possible 
solution to this problem would be to use the sodium salt of the mono-ester 
of · 1" "d 144,145 aze a2C aC2 • 
An interesting point arose from the investigation of the Claisen 
condensation. This was the absence of any significant quantity of the 
109 
product (10), derived from the condensation of the thermodynamic enolate 
(9) as represented by equation 5. 
(1) 
Et02C~C02Et 
Ywvv ) o 
Na+ 0-
(9) Equation 5, (10) 
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This was inferred from the 1H_NMR spectra of all batches of ' crude ethyl 
eicos-9,11-dionoate. None of the crude products showed any significant 
signal due to the acetyl function of (10). 146 Other reports confirmed 
this general observation that higher methyl alkyl ketones form nearly 
exclusively the methyl derivative and that the ease of acylation of a 
particular ester and base decreased in the order CH 3CO> RCH 2CO > R2CHCO., 
A second point of interest w~s the lack of 1,3-diketo-products in 
the condensaticn of DEA with methyl nonyl ketone using sodium ethoxide 
146 in ethanol. Other reports on the use of this base in the acylation of 
methyl ketones with long chain esters have been quoted as being 
unsatisfactory. The failure of the e~hoxide/ethanol system to produce 
1,3-diketones in these cases is thought to be due to two factors. Firstly, 
the ethoxide base is too weak to generate an adequate concentration of the 
eno!ate (12) to effect condensation, see scheme 3.1. 
Scheme 3.1 
~t02cvn2 EI~ ~R2 EtO- (13) . R2 -EtOH~ " ~ 
)(\Rl ' 'r'R1 " '" " o R1 R1 0 ()- 0 
v 
(11) (12) (14) (15) 
Secondly, the ease of nucleophilic attack of the enolate (12) on the 
ester (13) is influenced by the structure of the latter. This behaviour 
is related directly to the relative rates of alkaline hydrolysis of esters 
in the presence of a particular base. (HC02Et>CH3colt> higher straight-
chain aliphatic esters). Hence, more forcing conditions are required 
46 
for the acylation of methyl nonyl ketone by long chain esters such as 
DEA. 
In the course of this work, it was found that neither the second 
stage ester nor the target prostanoid were crystalline. As a result, 
an attempt was made to prepare other derivatives of eicos-9,11-dionoic 
acid (4) that would confer crystallinity to the final prostanoid. 
Moreover, a highly crystalline product at an early stage and at 
subsequent stages of the synthetic route would considerably reduce the 
difficulties of purification. A crystalline prostanoid derivative 
amenable to X-ray structural examination was also hoped for. 
Attention was focus sed on the preparation of an amide derivative 
of eicos-9,11-dionoic acid (4). Preliminary trials were carried out to 
prepare the corresponding acid chloride (16) in situ, follo\o'/ed by 
reaction with excess aniline, scheme 3.2. 
(4 ) 
(4 ) 
~CI2· 
THF~ 
Scheme 3.2 
(16 ) 
MANCONHPh 
Wvw o 
(S) Mp 79 -800 
Two method~ for the formation of the acid chloride (16) were 
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attempted. The first of these was the reaction of thionyl chloride with 
eicos-9,11-dionoic acid in THF. 
1 The reaction was monitored by H-NMR 
and found to be complete after a 60-BO minutes reflux period. Subsequent 
reaction with aniline afforded the purified anilide (5) in 23%. The 
second method employed triphenylphosphine/carbon tetrachloride147 under 
reflux. This was a much milder procedure and became the preferred method. 
Addition of aniline to the acid chloride (16) formed under these conditions, 
followed by recrystallisation, afforded the anilide (5) as pure crystalline 
needles in 44%. 
The anilide (5) was characterised by its IR spectrum which showed 
-1) ( -1) a distinct N-H (3340 cm and strong carbonyl 1658 and 1637 cm bands. 
The 1H_NMR indicated peaks at '0.88 (t, terminal Me), 1.14-1.94 (m,methylene 
envelope), 2.17-2.63 (-CH2, C-8 and C-12), 3.57 (s,<1H), 5.48 (s,1H) 
and 6.96-7.68 (m, 6H, one D20 exchangeable proton). Accurate mass 
measurement of the molecular ion and elemental analysis were consistent 
with the proposed structure (5). 
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3.2 Dimethylotion of ethyl eicos-9,11-dionoate (3) 
In order to carry out the C-8 to C-12 ring-closure to form the 
cyclopentane nucleus of the prostane structure, it was essential to block 
the active methylene at the C-10 position, so as to avoid complications 
due to reaction at this centre. The ideal blocking group would be one that 
was easy to introduce and subsequently deprotected under neutral conditions; 
such as a 1 ,3-dithiolan moiety introduced via the 1, 3-dithiotosylate 148. 
However, early work by Beecham Pharmaceuticals 140 and C. B. Chapman 141 
indicated that dimethylation of the C-10 position could be conveniently 
carried out to potentially generate a novel class of 10,10-dimethyl 
. 149-153 prostano~ds • These unusual prostanoids would be of interest from 
a biological point of view, since dimethylation of the C-10 position 
\"188 likely to result in enhanced chemical stability of the molecule. 
Deviations in the conformation of these 10,10-dimethyl prostanoids from 
the natural prostaglandins were likely to contribute to altered tissue 
selectivity and/or metabolic stability and consequently provide a better 
insight into the structure-activity relationships of prostaglandins. 
Hence, the dimethylation of ethyl eicos-9,11-dionoate (3) using two moles 
equivalent of sodium hydride in a solution of excess iodomethane in 
DMF/DME, afforded purified ethyl 10,10-dimethyl eicos-9,11-dionoate (17), 
equation 6, in about 70%. Similarly, the dimethylation of eicos-9,11-dion~c 
acid(4} using three moles equivalent of sodium hydride, under the same 
conditions, afforded purified methyl 10,10-dimethyl eicos-9,11-dionoate 
(18), equation 7, in 63%. 
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) 
~C02Et 
'rf\MN 
C0 2E t NaH 1 DME 
Mel/DMF/LJ 
(3 ) Equation 6 (17) 
NaH/DME 
63 0/0 
MeIlDMF/LJ 
(4 ) Equation 7. (18) 
The IR spectra of the 10,10-dimethyl esters (17) and (18) showed 
characteristic bands at 1742 (ester carbonyl), 1720 and 1698 (keto-
-1 1 
carbonyls) cm • The H-NMR spectra of these esters showed common peaks 
at ~ 0.89 (t, terminal Me), 1.10-1.87 (m, methylene envelope), 1.32 
(s, C-10 gem-dimethyl) and 2.18-2.56 (m, -CH2- at C-2, C-8 and C-12). 
In addition, the ethyl ester (17) showed the characteristic triplet 
(1.25£)/quartet (4.13&) pattern, while the methyl ester (18) showed the 
typical singlet (3.67&). The mass spectra gave only weak molecular ions 
for both the esters, however, each showed four strong fragment ions derived 
from the two modes of «-cleavage of the 1,3-diketo moiety. Further 
13 
structural evidence was obtained from the C-NMR spectrum of the ethyl 
ester (17) (see Appendix). 
The crude products of the dimethyl esters (17) and (18) showed a 
distinct lack of O-alkylation products, although the use of DMF in such 
reactions have been reported154 ,155 to favour 0- versus C-alkylation. 
However, there was evidence of ester exchange. This was apparent in the 
1H_NMR spectru~ of the crude ethyl ester (17) which showed a low intensity 
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singlet at 3.67 &, comparable to the carbomethoxy signal of the methyl 
ester (18).· In addition, some batches of purified dimethyl esters showed 
trace contamination of over-methylated products. 1 The H-NMR spectra of 
these batches showed a characteristic doublet at 1.10&(J = 7Hz) assigned to 
An early attempt was made to prepare the dimethyl anilide (19) 
by direct amidation of the corresponding dimethyl ethyl ester (17), 
137.156 
using N-phenylaminomagnesium iodide (prepared in situ) equation 8. 
However, this approach was found to be unsatisfactory and the crude 
PhNHMgI 
) 
EtzO 
(17) Equation 8. (19 ) 
product from equation 8 was found to contain mainly half-chain components 
derived from the cleavage of the 1 ,3-diketo moiety of (17). One of 
these cleavage products was identified by spectral analysis to be the 
anilide of decanoic acid. 
An alternative approach to the anilide (19) was to dimethylate 
N-phenyl eicos-9,11-dionamide (5), using the procedure developed for the 
corresponding esters (17) and (18). An initial trial methylation 
indicated complication due to the formation of an N-methylated product. 
In order to avoid having to deal with a mixture of products, sufficient 
base was used to carry the reaction through to the N-methyl anilide (20). 
Sl 
Hence, the trimethylation of the anilide (5) afforded the· purified N-mBthyl 
anilide (20) in 34%, equation 9. 
CONMePh 
NaH/DME 
) 
MeI I DMF 
o o 
(5) Equation 9. (20) 
Unfortunately, the N-methyl anilide (20) was a viscous yellow 
liquid at room temperature and showed no tendency to crystallise. In 
view of this, further work ~n (20) was abandoned and it was hoped that an 
anilide could be formed at a later stage in the synthetic schem~. This 
appeared promising as it was found that the final stage prostanoid ethyl 
ester (23) (~infra), could be conveniently hydrolysed to the 
corresponding prostanoic acid (24). Furthermore, it was felt that the 
carboxylic acid to acid chloride transformation by the triphenylphosphine/ 
carbon tetrachloride method was sufficiently mild as to be applicable to 
the conversion of prostanoic acid (24) to its acid chloride. The latter 
could then be converted to the corresponding anilide (47). 
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3.3 Formation of ethyl 10,10-dimethyl Qrost-8(12)-en-9,11-dionoate 
and related derivatives 
The final stage of the synthetic scheme involves an intramolecular 
ring-closure across the C-8 and C-12 positions of ethyl 10,10-dimethyl 
eicos-9,11-dionoate (17). Cyclisation of this type should theoretically 
be feasible, as the reaction centres are mutually activated by the adjacent. 
carbonyl groups. In practice, a number of methods for effecting ring-
177-181 . 
closures of this type has been reported (vlde infra). Hmvever, 
a simple and attractive method used in the syhthesis of 1,2-diaroyl 
157,158 
cyclopropanes appeared to be suitable for our purpose. The 
synthesis involved an oxidative intramolecular cyclisation of a 
1,3-diaroyl propane in iodine and methanolic sodiu~ hydroxide, ·equation 10. 
12 ' NaOH 
) 
MeOH ,25-40° 
(21) Equation 10. 
pCOPh 
COPh 
Trons 
(22) 
Direct application of this reaction to the cyclisation of ethyl 
( ) . 141 10,1D-dimethyl eicos-9,11-dionoate 17 was carried out by C. B. Chapman • 
It was found to be unsatisfactory and led to ester-exchange and hydrolysis 
of the starting material (17). However, the use of anhydrous sodium 
ethoxide in ethanol gave satisfactory results and a 40% yield of ethyl 
10,1D-dimethyl prost-8(12)-en~9,11-dionoate (23) was reported 141 , 
equation 11. A more thorough study of the reaction in this project 
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indicated a much lower and more variable yield (14-LI1 0/0) 
NaOEt,EtOH 
) 
o o 
(17 ) Equation 11 (23) 
Purified ethyl 1o,1o-dimethyl prost-8(12)-en-9,11-dionoate (23) 
was isolated as a pale yellow liquid. Its IRspectrum showed 
characteristic bands at 1743 (ester carbonyl), 1698 (keto-carbonyl), 
) -1 -1 1625 (double bond cm and a conspicuous 'doublet' at 1382 and 1360cm 
(gem-dimethyl at C-10). 1 The H-NMR spectrum of (23) showed peaks at 
~0.89 (t, terminal Me), 1.05-1.88 (m, methyl, methylene envelope), 
1.12(s, gem-dimethyl at C-10), 2.16-2.53 (m,-CH2-at C-2, C-7 and C-13) 
and 4.15 (q,2H). The integral of the multiplet at 2.16-2.53 & ~-Jas 
141 first reported by C. B. Chapman as representative of 4 protons. 
The explanation forwarded was that only two of the four methylenic protons 
at C-7 and C-13 were within the deshielding corie of the carbonyl groups 
of the cyclopentene-1,3-dione system. As a result, the signal due to 
these two protons was moved downfield to overlap with the signal due to 
the two C-2 methylenic protons. However, the prostanoid (23) and other 
simple 4,5-dialkyl cyclopent-4-en-1,3-diones synthesized in this project, 
d o 01 1 t 13 dO t d 0 lot t 159-161 dcd an s~m~ ar cyc open ene- . - lanes repor e ~n ~ era ure ,-'-
not appear to show this special magnetic anisotropic effect due to the 
conformational preference of the pendent chains. It was concluded, 
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therefore, that the prostanoid (23) obtained by C. B. Chapman was 
probably impure. 
The mass spectra of the ethyl ester (23) and the corresponding methyl 
ester (25), both showed strong molecular ions at m/e 392 (62%) and 
m/e 378 ( 9%) respectively. This was in contrast to the esters of the 
precursor 10,10-dimethyl eicos-9,11-dionoicacid, where extensive 
0(- cleavage of the 1,3-diketo moiety was observed. 
The UV spectrum of (23) indicated a strong absorption band at il 
max 
t 250nm (t =9,620). Aqueous base hydrolysis of (23), followed by 
preparative TLC, afforded the corresponding 10,10-dimethyl prost-8(12)-
en-9,11-dionoic acid (24). This showed an improved absorption coefficient 
of £ =11,470 at ~ 250nm. Subsequent esterification of (24) in ethereal 
max 
diazomethane, followed by preparative TLC, afforded the prostanoid 
methyl ester (25) as the purest sample obtained so far, with A at 
max 
250nm (g = 12,350), scheme 3.3. 
Scheme 3.3 
°2Et 
_N_o_O_H_, H-::2,-O ~ 
THF,lv1eOH 
o 
(23) (24) 
COi-l 
. CH 2N2 ---~ 
Et20 
The UV absorption obtained for these prostanoids compared 
(25) 
favourably with UV data reported for similar cyciopentene-1,3-diones 
(see table 3.2). 
t ~ ,w ~ be.u-l ~k ~.~ fv (Z3) 
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Table 3.2 
Cyclopent-4-en-1,3-dione A. max Extinction coefficient.£ Reference 
0 C02Me 250nm 12,350 
(EtOH) 
a (25) 
.~ 242nm 12,600 1 62, 1 63 (EtoH) 
(26) 
.~ 246nm 11,400 162 (MeoH) (27) 
0 
·Oc 246nm 14,900 
161 
(MeoH) 
(28) 
0 
9 222nm 14,450 . 188 (EtoH) (29 ) 
>0 219nm 6,030 175 
0 (30) 
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The 4,5-dialkyl-cyclopent-4-en-1,3-dione moiety of examples (26), 
(27) and (28) showed absorption values close to the 250nm abso=ption 
maximum of the prostanoid ester (25). The extinction coefficients of 
these examples were also comparable in relation to the high intensity 
absorption of £ ~12,35o exhibited by (25). In contrast to (25), the 
mentioned examples all possessed a C-2 methylene group in the cyclopent-
4-en-1,3-dione moiety. However, a comparison of examples (29) and (30) 
showed that dimethylation of the C-2 position resulted in only a small 
hypsochromic shift. Similarly, the absorption maxima of the corresponding 
2,2-dimethyl cyclopent-4-en-1, 3-dione chromophores of examples (26), (27) 
and (28) would not be expected to show significant deviation from the 
quoted values. This is consistent with reports that 2-unsubstituted 
cyclopent-4-en-1,3-dione exists wholly in the diketo-form 190,191 and 
that the C-2 methylenic protons are essentially non-acidic. Further 
support for the UV data of (25) was later obtained from 4,5-dialkyl-2,2-
dimethyl-cyclopent-4-en-1,3-diones prepared via a different cyclisation 
procedure (see section V and VI). 
A mechanism for the cyclisation of 1,3-dibenzoyl propane to the 
corresponding 1,2-trans-dibenzoyl cycloprorane was rrorosed by 
I. Colon, G. W. Griffin and E.J. 0'ConneI1158 , scheme 3.4. 
The initial ~tep involves a base-promoted iodination of the diketone 
(21) to form the intermediatec(-iododiketone derivative (32). This is 
followed by a second deprotonation by the base to form the enolate (33). 
Intramolecular cyclisation by an SN2 displacement of iodide affords the 
trans-dibenzoyl cyclopropane (22). 
A similar mechanistic pathway for the cyclisation of ethyl 10,10-
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Scheme 3.4 
C:h
NQ
+ 
I 
CCOPh NaOH 12 t COPh \ ~ + Na1 \ " COPh COPh COPh 
(21) (31 ) (32) 
I 
NaOH ~~:h 4 COPh + ) NaI \ 
~ Na+ PhCO 
(33) (22 ) 
dimethyl eicos-9,11-dionoate (17) in sodium ethoxide/iodine was proposed 
141 by C. B. Chapman • The proposed mechanism is shown in scheme 3.5. 
o -~R1 OEt 
~R2 \ 
0 
(17) 
\XO' -__ + . R1 , OEt \ R2 
o 
(37) 
Scheme 3.5 
0 o . 
-Q) ~~1 ?-JR1 12 ~R2 -OEt '~R2 ~R2' , ) 
-0 
o r 2 
(34) (35) (36) 
-Q::~ ;2 ) \±::_-O_E_t~} «0 :: 
o 0 
(38) (39) (23) 
where R, = (CH2)6C02Et 
R2= (CH 2)7 CH 3 
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The complete reaction sequence shown on scheme 3.5 consumed four 
moles of base and two moles of iodine. Experiments showed that low 
yields were obtained when only two moles of base was used. The 
intermediate 10,10-dimethyl prost-9,11-dionoic ester (37) was never 
detected and it was suggested, therefore, that the reaction proceeded 
through a slow initial cyclisation,followed by a rapid iodination and 
dehydrohalogenation to yield the prostanoid (23). 
The fact that the elusive intermediate (37) was never detected 
also suggested that an alternative pathway may be operative. This could 
involve the initial formation of diiodo-derivatives (40) and (41), 
followed by cyclisation and dehydroiodination. For the present, either 
one or both of these diiodo-species may serve as intermediates in the 
cyclisation process. Further discussion and speculation on this possible 
pathway will be presented at a later stage. 
(40) (41) 
Due to the low and varying yi~ld of the cyclisation reaction, 
equation 11, it was thought that the prostanoid (23) was undergoing 
decomposition on silica gel during preparative TLC. This appeared to be 
supported by the apparent discrepancy between the estimated yield 
('25-S0 o/ o,determined from UV data of crude product) and the isolated yield 
(14-41~o)of the prostanoid (23). The stability of the prostanoid (23) 
was accordingly checked and found to be uncha~ged after 24 hours in a 
slurry of silica gel in chloroform. The apparent loss (approximately 10%) 
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was therefore attributed to separable UV active (absorbing at 250nm 
region) by-products present in the crude product. 
Attantion was also focussed on the cyclisation reaction conditions. 
In an attempt to optimise the yield of (23), the following variables were 
altered accordingly. 
(a) Reagent mole ratios 
For optimum yield, it was found that 4 - 5 moles equivalent of 
base was required. The use of 2 moles equivalent of sodium ethoxide 
resulted in a significantly lower yield of the prostanoid (23). Two 
moles equivalent of iodine was required for the cyclisation reaction. 
However, it was found that excess iodine did not appear to have any 
adverse effect on the yield of the prostanoid(23). Under the optimum 
condition of 4-5 moles equivalent of sodium ethoxide and 2 moles 
equivalent of iodine, it was often found that the yield still varied. 
This suggested that other equally important factors were influencing the 
course of the cyclisation reaction. 
(b) Conditions of reaction 
It became clear from the experiments above that the base contact 
time was an import~nt factor in the cyclisation reaction. The normal 
procedure of the reaction was to add the ethyl 10,10-dimethyl eicos-
9,11-dionoate (17) to a stirred solution of sodium ethoxide in dry 
ethanol, under an atmosphere of nitrogen. Before the addition of an 
ethanolic solution of iodine, a period of about ten minutes was allowed 
for the formation of an equilibrium mixture of (17) and its corresponding 
enolate. It was suspected, and later confirmed that retro-Claisen 
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cleavage of (17) occurred when the latter was left too long in the 
sodium ethoxide solution. Subsequently, it was found that the base 
contact time could be reduced to 45 seconds, without significant loss 
in yield of the prostanoid (23). 
A final point for consideration was the purity of the starting 
material, ethyl 10,10-dimethyl eicos-9,11-dionoate (17). Some 
earlier cyclisation experiments in this project and those of 
"141 C. B. Chapman made use of precursor (17) whose purity was based on 
spectral evidence and homogeneity on TLC. However, a GLC analytical 
system was later developed to further check the purity of (17). A 
re-examination of these earlier batches of (17) was made and they were found 
to be reasonably pure '( > 90% purity, by normalisation). 
From the preceding investigations of the NaOEt/iodine cyclisation, 
the following conditions were found to afford optimum yield of the 
prostanoid (23). 
The optimum mole ratio of base iodine diketo-ester (17) 
was found to be 4 - 5: 2 : 1. 
( .. ) J.J. , The time allowed for the equilibration of the diketo-ester (17) 
in ethanolic sodium et~oxide was about 45 seconds and should not 
exceed 10 minutes. 
(iii) In the absence of experimental data on the effect of the rate of 
addition of iodine on the cyclisation reaction, the addition of 
iodine should be carried out as recommended by Colon, Griffin and 
158 O'Connell ; that is the iodine solution should be added 
"at such a rate that the colour was immediately discharged". 
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This normally took between 2-5 minutes. 
A more fruitful endeavour was the examination of the side-products 
of the cyclisation reaction. It provided some important clues to the 
major side-reaction that was occurring concurrently with the cyclisation 
process. A GLC analysis of the crude product of the cyclisation of (1"7) 
indicated the presence of 'paired' peaks derived from the retro-Claisen 
cleavage of (17). The cleavage of the 1,3-diketo-ester (17) is depicted 
in scheme 3.6. 
Scheme 3.6 
, 
(17) 
EtCH 
~, 
(45) 
o 
~02Et 
Et02CM!VV 
(43) (46) 
A total of eight peaks were normally recorded. Four of these 
were accounted for by the retro-Claisen cleavage of (17), while the 
remaining four were thought to be derived from the cleavage of the 
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corresponding ~ -iododerivatives of (17). One of the by-products was 
positively identified as diethyl azelate and was shown to be present in 
10-15% w/w of the crude product. This figure was translated into a 
17-25% loss of ethyl eicos-9,11-dionoate (17). However, in the retro-
Claisen cleavage of (17), nucleophilic attack at the C-9 and C-11 
carbonyls of the 1 ,3-diketo moiety was probably non-selective. Working 
on this premise, nucleophilic attack at C-11 was equally likely and should 
produce an equivalent amount of ethyl decanoate (46). Hence, the overall 
loss .of starting material (17), via the two modes of retro-Claisen 
cleavage was estimated at 34-50%. Taking the upper limit of this lo~s, 
it was apparent that the maximum yield of the prostanoid (23) in the 
cyclisation reaction could not exceed 50%. This estimation did not 
include losses due to the cleavage of ~-iodo derivatives of (17), in 
which case, the yield of the prostanoid (23) would be even lower. 
Having established that a considerable quantity of the ethyl 10,10-dimethyl 
eicos-9,11-dionoate (17) was lost through retro-Claisen cleavage, attempts 
were made to curb this side-reaction. 
In the course of this work, it became evident that iodine was also 
consumed rapidly by sodium ethoxide. The latter was thought to be 
converted to ethyl hypoiodite according to equation 12. This observation 
164-167 
was supported by similar reports of the conversion of a methanolic 
solution of iodine and sodium methoxide into methyl hypoiodite. 
[EtO -] [I] -====' [EtOI] + [I-] + 2,,-
Equation 12. 
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In this solution, the concentration of molecular iodine is known to be 
164.165 h 
very low ' • By analogy, the et anolic solution of iodine in sodium 
ethoxide was presumed to contain only a low concentration of ethoxide 
base and iodine. Theoretically, this appeared to be the ideal solution 
to carry out the cyclisation reaction. It was thought that the low con-
centration of ethoxide would reduce the extcint of the retro-Claisen 
cleavage and still provide an adequate concentration of the enolate of 
(17) for iodination and cyclisation to proceed. The cyclisation reaction 
under this condition could be envisaged to proceed in a manner similar 
to that shown earlier on scheme 3.5, except that ethyl hypoiodite would 
replace iodine as the iodinating spe~ies. 
This approach was investigated and the results of the experiments 
are shown in table 3.3. 
Table 3.3 
Method ~1ole ratio of reactants Reaction time Result 
1 4 -DEt : 2I2 : 1 ( 17) 15 mins. Mainly retro-Claisen 
'. 
cleavage products with 
trace amounts of ( 17) 
and (23). 
2 4 -DEt 4I2 1 ( 17) 15 mins. Unreacted ( 17) : . . 
4.5 -DEt 4I2 1 (17 ) 2 hrs. Retro-Claisen cleavage 3 : : 
products detected. 
14 hrs. Mainly retro-Claisen 
cleavage products with 
trace amounts of ( 17) 
and (23) 
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Method 1 was carried out using the theoretical molar ratio of reagents 
required for the complete cyclisation of ethyl 10,10-dimethyl eicos-9,11-
dionoate (17) to the prostanoid (23). However, within 15 minutes at 
room temperature, extensive cleavage of (17) occurred. In order to prevent 
this, method (2) was carried out using equimolar quantities of sodium 
ethoxide and iodine. This ethanolic solution, containing mainly ethyl 
hypoiodite and sodium iodide, failed to react with (17). In the final 
method 3, a slight excess of base was introduced and the progress of the 
reaction was monitored by GLC. In the initial two hours, the rate of the 
retro-Claisen cleavage was noticeably slower than that found for method 1. 
However, on standing at room temperature after 14 hours, the crude product 
consisted mainly of retro-Claisen cleavage products. 
The salient results of the investigation were the lack of any 
significant quantity of prostanoid (23) in all the crude products and the 
apparent stability of (17) under the conditions of method 2. From the 
result of the method 2 experiment, it was inferred that the concentration 
of base was probably too low to allow cyclisation to proceed at a reasonable 
rate. However, in method 1 and 3, the presence of excess base did not 
result in the cyclisation of (17), but instead led to extensive retro-
Claisen cleavage. It was' evident, therefore, that ethyl hypoiodite was 
ineffective as an iodinating species and that the competition between 
cyclisation and retro-Claisen cleavage was, at least in part, governed by 
the rate of iodination. 
It became apparent from this investigation that molecular iodine 
played a vital role in the original sodium ethoxide/iodine cyclisation 
of (17) and that the ethyl hypoiodite formed as a side-reaction was 
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essentially unreactive. 
It was clear from the sodium ethoxide/iodine cyclisation and the 
ethyl hypoiodite experiments that the use of nucleophilic base such as 
ethoxide suffered from a number of disadvantages. Firstly, ester -
exchange occurred at the ester side-chain. Secondly, nucleophilic attack 
by the ethoxide at the C-9 and C-11 carbonyls led to extensive retro-
Claisen cleavage of the starting material (17). Finally, 0( -halo 
derivatives of (17) which were suspected to be intermediates in the 
cyclisation were prone to 5N2 substitution by nucleophilic bases. A 
rational solution to these problems was the use of sterically hindered 
bases. 
The first of these bases employed was sodium tert-butoxide. Under 
the same reaction conditions as the original sodium ethoxide/iodine 
method, the reaction of (17) in sodium tert-butoxide/tert-butanol gave no 
UV active products. The GLC analysis of the crude mixture showed the 
presence of volatile cleavage products which were partially obscured by 
the tailing effect of acidic products. On subsequent methylation in 
ethereal diazomethane and GLC analysis, the crude mixture distinctly 
showed four characteristic retro-Claisen cleavage products and no C20 
esters. Further experiment with sodium tert-butoxide was abandoned as 
it was evident that the major course of the reaction was the cleavage 
of (17). 
The use of the sterically hindered lithium diisopropylamide base 
was marginally more successful. The use of 3.5 moles equivalent of the 
o base in a solution of (17) in THF at -78 , followed by the dropwise 
addition of iodine in THF, afforded a crude mixture containing the prostanoid 
(23), equation 13. 
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(17) 
i) LDA.THF.-78° 
------J.)- -
ii) 12 • THF 
Equation 13. 
C0 2Et 
° 
(23) 
Although the loss of (17) through retro-Claisen cleavage was noticeably 
lower than that found for the original sodium ethoxide/iodine cyclisation 
of (17), there appeared to be no improvement in the yield of the 
prostanoid (23) (estimated at 10-15%). The GLC analysis of a purified 
sample of the crude mixture showed the presence of the prostanoid (23), 
along with inseparable starting material (17) and an unknown C20 component. 
The unknown C20 component was initially suspected to be an intermediate 
in the reaction, possibly the elusive ethyl 10,10-dimethyl prost-9,11-
dionoate (37), (see earlier scheme 3.5). However, when a solution of 
the partially purified product mixture was subjected to reflux in DDQ/ 
benzene, the relative proportion of the C20 unknown to the inseparable 
prostanoid (23) and starting material (17) remained unchanged. Retreatment 
of the partially purified product mixture with LDA/THF at _7So, 
followed by addition of iodine/THF, resulted in the loss of starting 
material (17) while the relative proportion of the C20 unknown to the 
prostanoid (23) remained unaltered. It was evident from these experiments 
that the C20 unknown was not the intermediate (37), nor was it an 
intermediate in the cyclisation reaction. 
1 The H-NMR spectrum of the partially purified product mixture of 
the LDA/iodine reaction showed a cluster of peaks at 4.00-4.40 & which 
ap~eared td be a combination of two sets of carbethoxy quartets and a 
triplet. HOvJever, these peaks overlapped too closely to each other to 
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allow the coupling pattern to be unambiguously defined. The group of 
peaks in the 2.15-2.50 ~ region consisted of the characteristic triplet 
at 2.45b(methylenic protons at C-7 and C-13) and an unusually weak 
triplet at 2.27 & (methylenic protons at C-2). The relative integral 
of these peaks indicated four instead of the six expected protons. 
This inconsistency in the proton count suggested that the unknown C20 
component could be derived from the reaction of the C-2 methylene group 
of (17) and! or (23). 
Under the reaction conditions described above, a likely complication 
would be the formation of C-2 iodo-derivatives of (17) or (23). This 
would account for the low intensity of the 2.27 , triplet (methylenic 
protons at C-2) and the appearance of a downfield triplet at 4.27 b 
(-CH2 - C.!iI - C0 2Et). Iodination of the C-2 position of (17) or (23) 
is not unusual, as it is known that ester enolates can be generated in 
. 0 
LDA/THF at -78 , and subsequently elaborated at the O(-position by the 
. 168 169 
addition of suitable electroph11es ' • 
A common feature of all the cyclisation reactions employed so far 
is the low yield of the prostanoid (23) and the contamination of the 
latter by inseparable side-products. As a part of our continued search for 
a pure crystalline derivative of the prostanoid (23)~ we turned our attention 
to the formation of an anilide derivative of 10,1 O-dimethyl prost-8(12)-en-9,"-
dionoic acid (24). Hence, the sequential treatment of the acid (24) 
with triphenylphosphine/carbon tetrachloride and aniline, afforded the 
anilide (47) as a very viscous pale brown liquid, equation 14. 
i) Ph3P, CCI4 ) 
ii} NH2Ph 
(24) Equation 14 (47) 
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The IR spectrum of the anilide (47) showed typical peaks at 3340 
( ) -1 (N - H band), 1734, 1694, 1667 three carbonyl bands, 756 and 692 cm 
{monosubstituted benzene bands}. The 1H - NMR spectrum showed characteristic 
peaks at 6 0.88 (t, terminal methyl), 1.13 (s, gem-dimethyl), 1.20-1.80 
(m, methylene envelope) 2.25-2.60 (m, methylenes at C-2, C-7 and C-13) 
and 7.00-7.68 (m, aromatic and NH protons). The high resolution mass 
spectrum gave the correct mass measurement for the molecular ion of (47), 
m/e 439 (10%). Further structural evidence was obtained from the 
13C _ NMR of (47) (see Appendix). The UV spectrum showed an absorption 
at A max 244nm (£ = 20,630) due to the combined effect of the cyclopent-
4-en-1,3-dione and anilide chromophores of (47). The UV spectrum of the 
anilide of eicos-9,11-dionic acid indicated the anilide chromophore 
absorption at A 243nm (E. = 15,080). In combination "'/i th the cyclopent-
max 
4-en-1 ,3-dione chromophore (\ 250nm, E. = 12,350); the expected UV 
max 
absorption of (47) is at \ 243-250nm (E =27,400). Based on these UV 
max 
figures, the partially purified anilide (47) (l 244nm, t = 20,630) 
. maX 
was estimated at a purity of 75%. This was later substantiated by reversed 
phase HPLC analysis of (47). 
At this point, further work with the anilide derivatives was 
abandoned. Attention was directed at the preparation of C-15 functionalised 
prostanoids. It was thought that with the introduction of a C-15 
functionality, the problems of separation encountered in the model 
prostanoid (23) could be considerably reduced. 
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4. SYNTHESIS OF C-15 FUNCTIONALISED PROSTANOID5 
The synthesis of the model prostanoid (23) in the preceding work 
formed the b~sis for a more geneTsl synthesis of functionalised prostanoids. 
Although the model synthesis was beset by problems of purification and low 
yield, it was nevertheless a viable route to 10,10 dimethyl prost-8(12)-
en-9,11-dionic acid and its derivatives. It was necessary, ther~fore, 
to define the generality of the synthetic route for the preparation of 
other related analogues. Suitable target species would be C-15 
functionalised prostanoids which could be elaborated at a later stage to 
C-15 hydroxylated analogues. A C-15(5) hydroxyl group is of considerable 
importance as it is present in all biologically active natural 
prostaglandins and essential for substantial agonist activity170. 
In the synthesis of C-15 functionalised prostanoids, it is necessary 
to replace the substrate, methyl nonyl ketone (as in the model prostanoid 
route),with suitably functionalised methyl nonyl ketones. For this 
purpose, undec-6-en-2-one (60) and 6-benzyloxy- 2-undecanone ~7)were 
prepared from a common precursor, 5-(1,3-dioxalan)-hexanal (52). These 
functionalised methyl nonyl ketones were subsequently transformed into 
C-15 functionalised prostanoids by the application of the model synthetic 
route, scheme 4.1. 
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Scheme 4.1 
SYNTHESIS OF C-15 FUNCTIONALlSED PROSTANOIDS 
)(:I"CHO 
U 
I 
I 
(52 ) 
I A A A P: 0 2Et 
LEt02C-J V V V } )[vyw" -
° OR 
(67) 
---7 
71 
(63) 
OR 
(74) 
4.1 General route for the preparation of 5-(1 ,3-dioxolan)-hexanal 
The synthetic route for the preparation of the required 
5-(1,3-dioxo1an)-hexanal is depicted in scheme 4.2. 
·\('v\C02H o 
(48) 
\(\!\C02Me 0 
(49) 
(50) 
I 
Scheme 4.2 
) 
Equation 15 
HtjH 
,H -to '~C02Me ) 
PhH,6. 
Equation 16 
U (50) 
LAH,THF,6 
) 
Equation 17 
i}'CHO 
Equation 18 (52) 
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141 The above synthetic route was first established by C. B. Chapman 
in the preparation of the lower homologue, 4-(1,3-dioxolan)-pentanal. 
This was followed by successful attempts at preparing the 5-(1,3-dioxolan)-
hexanal. The yields shown in scheme 4.2, have been fully optimised in 
this project. 
Commercially available 4-acetylbutyric acid (48) was methylated 
using ethereal diazomethane (generated from Diazald) at room temperature. 
The purified methyl 4-acetylbutyrate (49) was obtained in nearly 
quantitative yield. Protection of the keto function as a 1,3-dioxolan 
was readily carried out by heating methyl 4-acetylbutyrate (49), 
ethane-1,2-diol and a trace amount o~ E-toluene sulphonic acid in benzene, 
with azeotropic removal of water. The purified methyl 5-(1,3-dioxolan)-
hexanoate (50) was subsequently reduced to the corresponding alcohol (51) 
with lithium aluminium hydride in refluxing THF. Oxidation of the alcohol 
(51) in a solution of chromium trioxide/pyridine complex in dry 
dichloromethane at room temperature, afforded the key precursor 
5-(1,3-dioxolan)-hexanal (52). 
The overall yield of 5-(1,3-dioxolan)-hexanal (52) from 
4-acetylbutyric acid was about 50%. With the exception of the final 
, 
stage Collins oxidation, the reactions were readily reproducible, The 
, 
Collins oxidation of the alcohol (51) was found to be very sensitive to 
moisture. Yields ranging from 40-14% were obtained. In addition, the 
purified 5-(1,3-dioxolan)-hexanal (52) was found to be unstable when left 
for long periods at room temperature. It was, therefore,used immediately 
in subsequent chain extension reactions. 
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4.2 Route to undec-6-en-2-one and subseauent formation of ethyl 
10,10-dimethyl prost-8(12), 15-dien-9,11-dionoate 
The prime objective \-,as to prepare a C-15 functionalised prostanoid 
by the use of a suitably functionalised methyl nonyl ketone in the 
established model prostanoid synthetic route. Undec-6-en-2-one(60) was 
selected for this purpose. The application of this functionalised methyl 
nonyl ketone to the model prostanoid synthetic scheme, would by analogy, 
furnish ethyl 10,10-dimethyl prost-8(12),15-dien-9,11-dionoate (63). 
The introduction of the C-15 double bond formed part of a plan that 
would permit further elaboration of the ft-alkyl side-chain. Epoxidation 
of this double bond, followed by reductive epoxide ring-opening was envisaged 
to provide e C-15 or C-16 hydroxyl group. It was thought that ~teric 
crowding by the cyclopentene-1,3-dione nucleus at one end of the ~ -alkyl 
side-chain would lead to stereos elective epoxide ring-opening in favour 
of the desired C-15 hydroxyl prostanoid. 
Undec-6-en-2-one (60) was prepared according to scheme 4.3 
Scheme 4.3 
NV 
Br 
Ph 3P I Xylene 16 
) 
35 0/0 
(53) Equation 19 
'>(:ACHO 
U 
(52) 
Ph3~IEt20 
) 
51 0/0 
Equation 20 (55) 
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r 
H+.MEK \(V'NV ) 
0 
(55) Equation 21 (60) 
n-pentyltriphenyl phosphonium bromide was prepared by heating 
n-pentylbromide with an equimolar amount of triphenyl phosphine in dry 
171 
xylene • Early attempts using this procedure invariably resulted in 
the formation of a brown viscous semi-solid product which was difficult to 
recrystallise. The problem was eventually resolved by heating a rnore 
dilute solution of triphenyl phosphine with ~-pentyl bromide in dry xylene, 
under a gentle stream of nitrogen. On cooling to room temperature, pure 
white crystalline phosphonium salt (54) was obtained in 35%. 
In the subsequent Wittig olefination, the n-pentyl triphenyl 
phosphonium ylid, formed iD situ by the addition of n-BuLi at,- 20o ,was 
allowed to react with freshly prepared 5-(1 ,3~dioxolan)-hexanal (52), 
to afford a crude mixture of olefins (55). Successive chromatographic 
purification of the crude, afforded a mixture of cis/trans isomers (55) 
in 51%. 
Acid hydrolysis of (55) afforded the crude isomeric undec-6-en-2-one 
(60) in quantitative yield (purity of 95% by GLC). 
The IR spectrum of undec-6-en-2-one (60) showed typical bands at 
-1 . 3010 and 969 cm for the disubstituted double bond and a strong carbonyl 
-1 band at 1720 cm 1 The H-NMR spectrum of (60) showed characteristic 
signals at~0.89 (t, terminal methyl), 1.18-1.50 (m,-C!!2-Ctl,2-)' 1.50-1.86 
(m,-CH -), 1.86-2.20(m,-CH -CH=CH-CH -), 2.13(s,C!:i3-CO-), 2. 33(t,-C!:!2-CO-) 
-2 -2-2 
and 5.13-5.58 (m,-~!:!=C!:!-). The accurate mass measurement gave the required 
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",:", 
molecular ion of (60) at m/e 16B (14%, measured 168.1518, calculated 
168.1514). 
Undec-6-en-2-one was subsequently subjected to the three-stage 
prostanoid synthetic route shown in scheme 4.4. 
Scheme 4.4. 
NaH 
11 010 
(60) Equation 22 (61) 
NaH,DME 
C0 2Et 
> .3,10 
MeI,DMF VVV (~'hg '11>'%) 
(61 ) Equation 23 (62) 
NaOEt 
(62) Equation 24 (63) 
The Claisen condensation of undec-2-en-6-one to diethyl azelate" 
gave the crude 1,3-diketo-ester (61) as expected. Careful column 
chromatography and preparative TLC separation of the crude product, afforded 
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purified ethyl eicos-15-en-9,11-dionoate (61) as a viscous yellow oil 
in 1'%. 
The IR spectrum of (61) showed characteristic bands at 1610 and 1739cm-1 , 
assigned respectively to the enolizable 1,3-diketo and ester functions. 
1 The H-NMR spectrum showed typical signals at' 0.88 (t, terminal methyl), 
1.10-1.87(m, methyl methylene envelope), 1.87-2.19 (m,-CH 2-CH=CH-CH Z-)' 
2.19-2.62 (m, methylenes at C-2, C-8 and C-12), 3.54 (s,-CO-CHZ-CO-), 
• 
4.14 (q, -0-C!22CH3)' 5.29-5.46 (m,-C~=C~-) and 5.49 (s,-CO-CH=C(OH)-). 
The low resolution mass spectrum of (61) showed the presence of the required 
molecular ion at m/e 366 (highest ion) and a fragment ion at m/e 321, 
+ [M- OEt] • 
Dimethylation of the 1,3-diketo-ester (61), followed by preparative 
3'f 
TLC, afforded ~% yield of purified ethyl 10,10-dimethyl eicos-15-en-9,11 
-dionoate (62) as a viscous yellowish oil. The GLC analysis of the purified 
sample indicated a purity of about 70% (by normalisation). 
The IR spectrum of (62) showed characteristic carbonyl bands at 
1738, 1720 and 1700 cm-1• The 1H_NMR spectrum showed typical peaks at 6 
0.88 (t, terminal methyl), 1.08-1.80 (m, methylene, methyl envelope), 
1.33 (s,gem-dimethyl), 1.80-2.18 (m, -C~-CH=CH-Cli2-)' 2.18-2.54 
(m, methylenes at C-2, C-8 and C-12), 4.12 (q, -0-Cli2CH3) and 5.22-5.51 
(m, -Cl!=Cli-) • 
The C-8, C-12 cyclisation of (62) was achieved using the sodium 
ethoxide/iodine procedure. Purification of the crude product by 
preparative TLC, afforded 16% of ethyl 10,10-dimethyl prost-8(12), 
15-dien-9,11-dionoate (63) as a yellowish oil. 
The IR spectrum of the prostanoid (63) showed strong carbonyl 
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bands at 1737 and 1698 -1 cm However, the expected conjugated double 
bond Btretch of the dimethyl cyclopentene -i,3-dione moiety was too weak 
to be assigned with certainty, The same was true of the C-15 double 
bond stretch at 969 The 1H_NMR spectrum of (63) showed characteristic 
signals atSo.9o (t,terminal methyl), 1.01-1.87 (m,methylene, methyl 
envelope), 1.87-2.16 (m, -C~2-CH=CH-C~2-)' 2.16-2.65 (m, methylenes at 
C-2, C-7and C-13), 4.15 (q, -0-Cll2-CH3 ) and 5.25-5.56 (m,-Cll=Cll-). 
A sharp singlet at 1.13 ~in the methylene envelope provided strong evidence 
for the presence of the C-15 functionalised prostanoid (63). This 
characteristic signal was assigned to the magnetically equivalent C-10 
gem-dimethyl of (63). The unusually intense carbethoxy triplet (1.265) 
and quartet (4.15 6) and an isopropyl doublet (1.07 b, C.!:!3-P-I-Cli3) 
suggested the presence of diethyl azelate and co-products of the retro-
Claisen cleavage of the precursor (62). The GLC analysis of (63) 
indicated a mixture of diethyl azelate (20%), half-chain components (50%) 
and the prostanoid (63) (30%). The UV spectrum of (63) showed a broad 
absorption band at ~ 
max 
242nm, c.= 3,640. The low resolution mass 
spectrum of (63) showed the intense molecular ion (M]t at m/e 390 (30%) 
and the corresponding [M - oEt ]+ (15%) fragment ion. 
The purity of prostanoid (63) sample as determined by GLC (30%), 
compared favourably with the figure estimated from the UV absorption 
(28%, based on the UV absorption of the model prostanoid,~ 250nm, 
max 
t= 12,350). It was evident from these purity figures and the spectral 
data of (63) that the cyclisation of (62), using the sodium ethoxide/ 
iodine procedure, produced only a low yield of the C-15 functionalised 
prostanoid (63), together with other inseparable retro-Claisen cleavage 
products. 
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4.3 Route to 6-benzyloxy-2-undecanone and subsequent formation of ethyl 
.1.Q..J..9-dimethvl-15-benzyloxy - prost-B (12 )-en-9 ,11-dionoate 
The sucsessful applicetion of the three-stage prostanoid synthetic 
route to the preparation of the model prostanoid (23) and the 15 ~ - prostanoid 
(63), encouraged uS to concentrate our effort on the direct preparation of 
a C-15 hydroxyl prostanoid. This could be achieved by the use of an 
appropriately hydroxylated methyl nonyl ketone substrate in the prostanoid 
synthetic route. The required 6 -hydroxyl methyl nonyl ketone was 
prepared from 5-(1,3-dioxolan) hexanal according to scheme 4.5. 
Scheme 4.5 
BrM/'N 
't;/VW ) Et20. 6, OH 77 % 
(52) Equation 25 (65) 
BzBr,NaH ~ ) DME 71 °/0 
(65) Equation 26 (66) 
+ H,MEK yvyvv ) 
° OBz Quantitative 
(66) Equation 27 (67) 
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The Grignard reaction of .!},-pentyJrnagnesium bromide ~Jith the protected 
aldehyde (52), followed by column chromatographic separation of the crude 
product, afforded 2-(1,3-dioxolan)-undecan-6-ol (65) as a thick colourless 
oil. The IR spectrum of (65) showed absorption bands due to hydroxyl 
-1 -1 1 (3450 cm ) and ketal (1064 cm ) groups. The H-NMR spectrum shol'/ed 
typical signals at 50.84 (t, terminal methyl), 1.05-1.78 (m, methylene, 
methyl envelope), 1.91 (s,-OH, D20 exchangeable), 3.60 (m, -C!i-OH) and 
3.92 (5, -O-CH -CH -0-). 
-2 -2 
141 Earlier work by C. B. Chapman indicated that the prot~ction of 
the hydroxyl group of the ketal alcohol (65) or the keto-alcohol (69) 
was difficult, scheme 4.6. For instance, the hydroxyl function of the 
keto-alcohol (69) could not be protected as the tetrahydropyranyl ether. 
~ ) 
(65) 
Scheme 4.6 
~ 
(68) 
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This was presumed to be due to the favourable formation of the six-membered 
cyclic hemi-ketal (70). It was also found that the ketal alcohol (65) 
failed to form the benzyl ether under a variety of alkylation conditions; 
such as BzCl/KOH in toluene, BzBr/NaH in DMF and A9 20 in methyl iodide. 
In this project, some of the earlier methods of benzylation were 
reinvestigated and a number of different methods were attempted. The 
results are summarised in table 4.1. 
i) 
ii) 
Reagents 
NaH/DMF172 
BzBr/17h/R.T. 
N2• 
NaH/DMS0 173 
BzBr/17h/R.T. 
N2• 
Table 4.1 
Results of GLC analysis 
60% starting material (65), 
20-40% benzylated product (66) and 
large amount of dibenzyl ether. 
Mainly starting material (65), 
trace amount of benzylated product (66) and 
20% dibenzyl ether. 
iii) NaH/THF Mainly starting material (65) and 
iv) 
BzO-~(NMe2)3 PF 6+ less than 10% benzylated product (66). 
13h/~/N2 
NaH/DME 
BzBr/46h/R.T. 
N2 • 
Trace amount of starting material (65), 
70% benzylated product (66) and 
small amount of dibenzyl ether. 
The use of NaH/DMF/BzBr afforded a variable 20-40% of the ketal 
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benzyl ether (66), together with large amounts of starting material (65) 
and dibenzyl ether. The latter was separated from the product (66j with 
difficulty. The lack of reactivity of the ketal alcohol (65) was thought 
to be due to the low solubility of sodium hydride in DMF. This led to 
the use of sodium hydride in DMSO/BzBr •. The soluble dimsyl base was 
173 initially formed and to it was added the ketal alcohol (65), followed 
by benzyl bromide. However, on work-up, this produced mainly dibenzyl 
ether and only a trace amount of product (66). 
The tris-(N~-dimethyl)-benzyloxy phosphonium salt (reagents iii) , 
developed in these laboratories174 as an alkylating agent, was employed 
in an attempt to effect benzylation without the inherent difficulties 
associated with the use of benzyl bromide. This was, however, equally 
unsuccessful. 
Eventually, an attempt was made using a mixture of NaH/DME/BzBr. 
+ DME was selected for its ability to partially solvate Na. It was hoped 
that this would reduce the problem of heterogeneity. The initial 
experiment was monitored by GLe. The benzylated product (66) to starting 
material (65) ratio measured after 21 and 45 hours were (70:30) and 
(95:5) respectively. After numerous attempts, the benzylation was 
optimized to produce 71% of purified ketal benzyl ether (66) as a thick 
colourless oil. 
The selective deprotection of the ketal benzyl ether (66) by acid 
hydrolysis, afforded quantitative yield of the keto-benzyl ether (67). 
However, in subsequent work, it was found that the crude ketal benzyl 
ether (66) could be directly hydrolysed in acid and purified as the 
keto-benzyl ether (67) in an overall yield of 69%. 
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The IR spectrum of the 6- benzyloxy-2- undecanone (67) showed 
characteristic bands for- the caru(Hlyl (1715 cm -1) and the benzyl groups 
-1 1 (3030, 733 and 696 cm ). The H-NMR spectrum of (67) showed typical 
signals at6'0.89 (t, terminal methyl) 1.16-1.90 (m, methylene envelope), 
2.10 (5, ClilO-), 2.43 (t, -C!i2-CO-), 3.39 (broad rn, -Cli-OBz), 
4.49 (5, -0-Cli2-Ph) and 7.16-7.48 (m, aromatic protons). The accurate 
mass measurement of the molecular ion [M]t (measured 276.2091, calculated 
276.2089) established the correct formula of (67). 
The next stage was to subject the 6-benzyloxy-2-undecanone (67) 
to the prostanoid synthetic route as shown in scheme 4.7. 
Scheme 4.7 
/rvyvv 
o OBz 
(67) Equation 28 
NaH,DME 
MeI. DMF 
(72) Equation 29 
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) 
> 
08z 
(72) 
(73) 
16 % 
,,?\ /\ /\ /\ /C0 2E t 
,;---' v v v NaOEt,EtOH Ayvyw ---1
2
---4) 
OBz OBz 
(73) Equation 30 (74) 
The first stage Claisen condensation of 6-benzyloxy-2~undecanone(67) 
with diethyl azelate,using sodium hydride,gave a crude mixture containing 
the 1,3-diketo-ester (72). The light-ends in the crude mixture was 
removed by passing the latter down a uniformly heated vigreux column 
(200-2100 /0.5 torr). The partially purified heavy-ends was successively 
separated by column chromatography and preparative TLC, to afford 16% of 
ethyl 15-benzyloxy eicos-9,11-dionoate (72) as a viscous yellow oil. 
-1 The IR spectrum of (72) showed the typical ester (1739 cm ), 
-1 -1 
enolizable 1,3-diketone (1607 cm ) and benzyl (3030, 732 and 696 cm ) 
bands. 1 The H-NMR spectrum showed characteristic signals at 5o.B9 
(t, terminal methyl), 1.15-1.90 (m, methyl, methylene envelope), 2.15-2.70 
(m, methylenes at C-2, C-B and C-12), 3.40 (broad m, -CH-oBz), 3.50 
(S,-Co-~H2-Co-), 4.4B (s,-0-CH2Ph), 5.45 (s,-CO-CH=CoH) and 7.32 (m, 
aromatic protons). 
Treatment of the 1,3-diketo-ester (72) with NaH/MeI in DME/DMF 
at reflux temperature, followed by preparative TLC, afforded purified 
ethyl 15-benzyloxy-1O.10-dimethyl eicos -9,11-dionoate (73) in B5% yield. 
The IR spectrum of the dimethyl 1,3-diketo-ester (73) showed 
( -1) ( -1 ) characteristic bands for the ester 1736 cm , the keto- 1719, 1696 cm 
( 6 -1) . 1 and the benzyl 3045, 734 and 97 cm groups. The H-NMR spectrum 
showed typical peaks at So.BB (t, terminal methyl), 1.13-1.B5 (m, methyl, 
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methylene envelope), 2.17-2.54 (m, methylenes at C-2, C-8 and C-12), 
3.21-3.53 (broad m, -CH-OBz), 4.13 (q, -O-CH2CH3 ), 4.49 (5, -0-CH2-Ph) 
and 7.32 (m, aromatic protons). The presence of a weak singlet signal 
at 3.67 & indicated contamination by a trace amount of the methyl ester 
of (73), formed by an ester-exchange side-reaction. The accurate mass 
measurement of (73) indicated no [M]t ion. Extensive fragmentation 
across the C-9, C-10 and the C-10, C-11 bonds of (73), however, 
characteristically produced the corresponding C12 and C9 long chain 
ethyl esters ions at m/e 242 (7%) and m/e 199 (18%) respectively. 
The final stage C-8, C-12 cyclisation of (73) was carried out by 
the sodium ethoxide/iodine method. The crude product was purified 
by preparative TLC to afford 14% ethyl 15-benzyloxy -10 .10-dimethyl 
prost-8(12)-en-9,11-dionoate (74) as a viscous yellow oil. 
The IR spectrum of the prostanoid (74) showed typical bands for the 
-1 -1) benzyl (3040, 735 and 697 cm ), the ester carbonyl (1739 cm ,and the 
-1 1 
cyclopentene-1,3-dione (1694 and 1629 cm ) groups. The .H-NMR spectrum 
shmJed characteristic signals atbO.88 (t, terminal methyl), 1.03-1.90 
(m, methyl, methylene envelope), 1.12 (5, gem-dimethyl at C-10), 
2.17-2.59 (m, methylenes at C-2, C-7 and C-13), 3.26-3.62 (broad m, 
aromatic protons). The UV spectrum of the purified prostanoid (74) 
showed a typical absorption band at A. 248nm (E. = 5,790) for the 
max 
dimethyl cyclopentene-1,3-dione chromophore. The accurate mass 
measurement of the molecular ion [M]t (measured 498.3338, calculated 
498.3345) established the correct formula of the prostanoid (74). 
The UV measurement of (74) (A 248nm, E= 5,790) indicated 
max 
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an estimated purity of 45-50%. 1 In addition, the H-NMR of (74) showed 
two singlet signals (at 4.54 and 4.5U &) instead of a single peak for 
the -O-CH Ph group. This indicated the presence of other benzyl ether 
-2 
contaminants in the sample. The mass spectrum of (74) also showed 
strong fragment ions at m/e 199 (40%) and m/e 242 (10%) which suggested 
that the dimethyl 1,3-keto-ester precursor (73) was present as a 
contaminant. 
In an attempt to remove the contaminants, (74) was hydrolysed in 
aqueous sodium hydroxide to the corresponding crude prostanoic acid (75), 
equation 31. Separation of the crude product by preparative TLC, 
afforded purified 15-benzyloxy-10,10-dimethyl prost-B (12)-en-9,11-dionoic 
acid (75). 
aq NaOH 
) 
MeOH,THF 
08z 
(74 ) Equation 31 (75) 
The IR spectrum of the prostanoic acid (75) showed characteristic 
-1 bands for the benzyl (3045, 736 and 697 cm ),the carboxylic acid 
-1 . (broad shoulder at 3000-3500, 1714 cm ) and the dimethyl cyclopentene 
-1 1 
-1,3-dione (1741, 1698 and 1629 cm ) groups. The H-NMR spectrum showed 
typical signals at 50.90 (t, terminal methyl), 1.11 (s,gem-dimethyl at 
C-10), 1.1B~1.B9 (m, methylene envelope), 2.18-2.70 (m, methylenes at 
C-2, C-7 and C-13), 3.25-3.63 (m, -Ctl-OBz), 4.54 (5, -0-Ctl2Ph) and 
86 
7.35 (m, aromatic protons). By comparison with the corresponding prostanoid 
ester (74), the prostanoic acid (75) showed a relatively weaker signal 
at 4.50~. This indication of a slight improvement in purity was 
reflected in the UV data of (75) (~ 250nm, E= 5,820). The accurate 
max 
mass measurement of (75) gave a distinct molecular ion, [M] t at m/e 470 
(measured 470.3037, calculated 470.3032). 
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5. »rSCUSSION OF THE PROSTANOID SYNTHESES 
The success of the synthesis of the model prostanoid (23) and the 
two C-15 functionalised prostanoids (63) ~nd (74), described in the preceding 
sections, established the generality of the prostanoid synthetic scheme. 
The overall results of these individual syntheses are shown in 
table 5.1. 
Table 5.1 
Claisen condensation Dimethylation at C-10 C-B,C-12 cyclisation 
(23) 1Li-410f0 
(61) 110f0 (62) 210f0 (63) 16 % 
I-_______ ~.-__ ~ ___ .!_-------------f-----------l 
(72 ) 20% (73) (74) 14% 
The first stage Claisen condensation of the ~-functionalised 
2-undecanones with diethyt azelate appeared to be general. However, the 
yields of (61) and (72) were lower than that obtairied for (3). This was 
.1"";', . 
.. .... 
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probably due to the much lower scale at which the Claisen condensations 
of the &-functionalised 2-undecanones were carried out. The low yields 
were expected to improve on scale-up and optimisation and not thought to 
be a serious limitation to the overall synthetic route. 
The second stage dimethylation reactions also appeared to be 
general and did not present difficulties. ,Again, the low yield of (62) 
was not thought to be typical and was likely to improve on scale-up and 
optimisation. 
The final stage C-8, C-12 cyclisation was found to be general for the 
C-15 functionalised dimethyl-1,3-diketo-esters (62) and (73). However, 
as expected the yields of the corresponding C-15 functionalised prostanoids 
(63) and (74) were low. As a result of the large variation in the yield 
of the cyclisation leading to the model prostanoid (23), we were uncertain 
if the low yields of the prostanoids (63)and(74) were a direct effect of the 
added constraint of the C-15 functionality in the ~alkyl side-chain. 
An additional problem occurred with the benzyloxy prostanoid series. 
Neither the dimethyl benzytoxy -1,3-diketo-ester (73), nor the corresponding 
benzyloxy prostanoid (74), could be analysed by GLC. As a result, the 
purity of this series was based solely on TLC homogeneity and the consistency 
of spectroscopic data. However, these were later augmented by HPLC 
analysis. 
Early attempts at purifying the model prostanoid (23) by normal-
phase HPLC (silica gel) provided evidence of decomposition. Consequently, 
this method of purification was abandoned. However, investigations into 
the use of reversed-phase HPLC was resumed when it was found that 
preparative TLC separation, although satisfactory for the model prostanoid 
89 
(23), \l'JaS sholtJn to be less effective for the benzyloxy prostanoid (74). 
It was found that (74) could be partially purified by reversed-phase 
HPLC (C 18 bonded porasil AI UV254 detection) with methanol as the mobile 
phase. For example, a single passage of the benzyloxy prostanoid (74) 
()\max 248nm, £ = 5,350) through a semi-preparative reversed-phase 
column, afforded a partially purified sample of the prostanoid (\ 248nm, 
max 
C = 5,940). Although the analysis on a finer grade analytical column 
indicated the purified sample to be still impure, the poorer resolution of 
the semi-preparative column limited improvement. 
As mentioned in section 4, the base hydrolysis of the benzyloxy 
prostanoid (74), followed by preparai;ive TLC of the benzyloxy prostanoic 
acid (75), resulted in a slight improvement in purity. Purification of 
the crude benzytoxy prostanoic acid (75) by reversed-phase HPLC showed 
some promise. An alternate approach via controlled hydrogenation of the 
benzylo~y prostanoid (74) to the C-15 hydroxyl prostanoid (76) was also 
briefly investigated, equation 32. However, for reasons discussed at 
the beginning of section 6, both these approaches have not been fully 
exploited. 
) 
OH 
(74) Equation 32 (76) 
As it was extremely difficult to purify the' C-15 functionalised 
prostanoids, we focussed our attention on the spectroscopic evidence for 
90 
the presence of these species in their respective purified samples. 
Table 5.2 summarises the common and recognisable spectroscopic data 
related to the dimethyl cyclopentene-1,3-dione nucleus in each of the 
prostanoids prepured so far. Corresponding spectroscopic data reported 
for similar cyclopentene-1,3-dione systems are also included. 
Typically, the prostanoids showed IR absorption bands for the 
{ -1 ester carbonyl 1730-1743 cm } and the cyclopentene-1,3-dione group 
-1 (1694-1698 and 1625-1630cm ). In examples (77), (78) and (79), the 
corresponding cyclopentene-1,3-dione groups showed absorption bands at 
-1 1750{w), 1710(s) and 1620-1650(w) cm • In these examples, the 
cyclopentene-1,3-dione carbonyl bands appeared as two peaks at 1750{wj 
and 1710{s}. In the case of the prostanoids, however, the weak band at 
1750cm-1 was presumably obscured by the strong ester carbonyl band at 
-1 1730-1743cm • This supposition was later confirmed by the IR spectra of 
similar 4,5-dialkyl-2,2-dimethyl cyclopent-4-en-1,3-diones (143) and 
(147) {vide infra} which showed typical carbonyl bands at 1740{w}, 
1693{s) and 1625-1630(w) -1 cm 
1 The H-NMR spectra of the prostanoids were characterised by two 
important sets of peaks; the C-10 gem-dimethyl protons at 1.12~ (s,6H) 
and the C-7 and C-13 methylenic protons (adjacent to the cyclopentene 
-1 ,3-dione nucleus) at 2.45 & {t,4H}. The triplet at 2.45 b generally 
overlapped with C-2 methylenic protons at 2.31b (t,2H) to form a characteristic 
pair of triplets, see figure 5.1. 
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Table 5.2 
, 
IR(cm-1) NtvlR ( 6 ) UV (nm) MS 
~02Et 1739,1699 1.12(s,6H) A. 250 [M]t (62°/0) max 
1631 . + .. 2.30(t,2H) E. =9,620 [M -OEt]· ( 25°/0) 
o (23) 2.46 (t,4H) (EtOH) 
~02Me 1743,1698 1.12(s,6H) ). 250 [M]T (9%) max 1625 2.32 (t,2H) c.=12,350 [M-OMe]t (5%) 
o (25) 2.45 (t,4H) (EtOH) 
~02Et 1730,1698 1 • 1 3 ( 5 , 6H) A 242 [Mt (30%) max 
1630 2.31(t,2H) ~ = 3,640 (M-OEt]t (15%) 
o (63) 2.45(t,4H) (EtOH) 
lj:f0zE! 
1738,1694 1.12(s,6H) A 249 [M]t (3%) 
max 
1629 2.30(t,2H) c= 5,950 [M-OEt] t (4%) 
Bz (74) 2.46(t,4H) (EtOH) 
1750,1710 A. 246 ~1~ max 
. 163 1650 2.40(t,2H) £=11,400 (77) 
0 (MeOH) 
~78)161 1750,1710 A 246 max 
1640 E.= 14,900 
I (MeOH) 
*,79)175 1750,1710 
1.10(s,6H) 
1620 
Q(BO)175 
1750,1710 1.12(s,6H) \ 219 
max 
e. ::6,030 
Qy176 1740,1702 1.20(s,6H) A. 284 max 
1610 E::10,470 
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Correspondingly similar gem-dimethyl signals, as seen in examples 
(79) and (BD), appeared at comparable chemical shift values of 1.1o-1.12b 
(s,6H). While in example (77), the methylene adjacent to a similar 
cyclopentene-1,3-dione group also appeared at a comparable chemical 
shift value of 2.406'"(t,2H). 
The UV data reported for examples (77) and (7B) compared favourably 
with our best UV data for (25),A. 250nm, £'=12,350, (also see table 3.2). 
max 
This figure has been used as a reference standard ('assuming 1 00% purity) 
to determine the purity of the other prostanoids. 
In addition to these spectroscopic data, we obtained the 
13 C-NMR spectra of the model prostanoid (25) and its corresponding anilide 
(47). These data further confirmed the presence of the 2,2-dimethyl 
cyclopent-4-en-1,3-dione moiety (see Appendix). 
From the overall results of the application of the prostanoid 
93 
synthetic plan and the examination of the spectral data of the 
resultant prostanoids (23), (25), (63) and (74), we were able to establish 
that:-
· '.' ' 
i) the prostanoid synthetic route was general, as shown by the 
synthesis of the three main prostanoids (23), (63) and (74). 
ii) the C-15 functionalised prostanoids (63) and (74) could only be 
partially purified by tedious and repetitive chromatographic 
separation procedures. 
iii) the yield of the final stage C-8, C-12 cyclisation was low and, 
therefore,seriously limiting the effectiveness of the overall 
synthetic route. 
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6. THE SYNTHESIS OF THE MODEL PROSTANOID VIA A DIBROMO PRECURSOR 
An overall assessment of the results of the prostanoid synthesis 
in the last section left us with two options. 
i) To develop and extend the work on the C-15 functionalised prostanoids. 
ii) To examine alternative C-8, C-12 cyclisation procedures with the 
object of improving the yield of this crucial step. 
We were satisfied that the prostanoid synthetic route was general 
and applicable to the synthesis of C-15 functionalised prostanoids. At 
that point in time, it was felt that development work on the C-15 
functionalised prostanoids was not of immediate importance. We opted 
to investigate alternative methods of effecting the C-8, C-12 
cyclisation of the 10,1D-dimethyl eicos-9,11-dionoic ester. It was 
clear that the low yield of the cyclisation step was the key problem 
limiting the potential of the prostanoid synthetic plan. Furthermore, 
it was argued that if the yield of the cyclisation reaction could be 
significantly improved, the problems of purification may become less 
severe. 
In essence, the sodium ethoxide/iodine cyclisation of 1D,10-dimethyl 
eicos-9,11-dionoic ester can be envisaged as proceeding viaaniodo-species 
(35) or a diiodo-species (40) as discussed in section 3. The postUlated 
mechanistic pathway is shown in scheme 6.1. 
It is interesting to note that pathway 2 offers an alternative 
approach to the C-8, C-12 cyclisation of (17). In a generalised form, 
this approach is envisaged as a two-stage synthetic process, scheme 6.2. 
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(17 ) 
(17) 
Scheme 6.1 
, ~R1 -HI X ~ ) 
(40) 
- HI 
1<, = -(CH2)6C02Et 
R2 = - (CH 2)7CH3 
Scheme 6.2 
(82) 
96 
'. ':,." 
(39) (23) 
(23) 
Figure 6.1 
~COPh 
T COPh 
Br 
(83) 
Br 
~02Et 
C0 2Et Br . 
(85) 
c; C02Me C02Me 
Br 
(87) 
~ Br 
(89) 
~8r 
Br 
° (91) 
NaI, Acetone 
Zn 
Equation 33 
NaCN ,EtOH 
6. 
Equation 34 
NaH. DMF 
0° 
Equation 35 
Li Br, li 2C03 
DMF.95° 
Equation 36 
Et 3N.MeCN 
40° 
Equa tion 37 
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) 42 % 177 
(84) 
q,,'C02Et 
> 88
oJ78 
'C02Et CN 
(86) 
«.C02Me 
) 69 0/0179 
C02Me 
(88) 
} 25% 176 
(90) 
) >9 39%153 
(92) 
This step-wise synthetic approach to the prostanoid (23) is potentially 
more versatile in that the cyclisation step can be carried out by a 
variety of methods. Precedents for similar intramolecular cyclisation of 
aliphatic dihalogeno-diketo derivatives have been established as 
indicated in figure 6.1. The example in equation (37) is particularly 
interesting in the context of our work. 
We, therefore, were encouraged to embark on the proposed scheme 6.2 
and prepared the required dihalogeno precursor (93) as indicated in 
equation 38. 
Br 2,cat.~lCl3 
) 
V EtOAc,CHCl3 
(17 ) Equation 38 (93) 
Controlled bromination of (17) with two moles equivalent of bromine 
and a catalytic amount of aluminium trichlorid~? followed by chromato-
graphic separation, afforded 80% of the dihalogeno derivative (93). 
However, it was found at a later stage that the bromination could be 
carried out more conveniently using the crystalline trimethylphenyl 
134 
ammonium perbromide in dry THF, equation 39. 
THF 
(18 ) Equation 39 (94) 
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810J0 
·: .:. 
The purified 8,12-dibromo-10,10-dimethyl eicos-9,11-dionoic esters 
(93) and (94) were obtained as lachrymatory and viscous colourless liquids. 
They appeared to be diastereomeric mixtures which were only partially 
separated after careful preparative TLC (see below). 
The IR spectrum of (93) showed characteristic ester carbonyl 
-1 (1740cm ) and keto-carbonyl (1730(s), 1700(m» bands. The relative 
intensity of the two peaks in the latter band contrasted considerably 
with the keto-carbonyl band (1720(m), 1698(s» of the precursor (17). 
1 The H-NMR spectrum showed characteristic peaks atSO.88 (t, terminal 
methyl), 1.10-1.50 (m, methyl, methylene envelope), 1.50-1.75 (4 X s, gem-
dimethyl at C-10), 1.75-2.15 (m, methylenes at C-7 and C-13), 2.29 
The low resolution mass spectra of both the methyl ester (94) and the 
ethyl ester (93) did not show their respective molecular ions. However, 
they both gave characteristic [M - Br]+io~81as a 'doublet' and 
[M - OR]+ ion (where R = Et or Me) as a 'triplet'. The [M - OR]+ 'triplet' 
appeared in the correct m/e region of 500-510, but unfortunately the 
actual m/e value could not be determined with accuracy. 
Careful preparative TLC of the diastereomeric mixture afforded two 
bands containing the partially purified diastereomers (95) and (96), 
table 6.1. 1 From the H-NMR spectra of these individual bands, we 
established that the signals at 1.59, 1.6t and 4.54 & were associated 
with the low Rf band, while the corresponding signals at 1.56, 1.69 and 
4.57 6 were related to the higher Rf band. 
The TLC analysis of the crude diastereomeric product (93) showed 
the low Rf band to be in slight excess of the high Rf band. The relative 
. intensity of the -CHEr-triplets at 4.54 and 4.57Sin the 1H_NMR 
99 
suggested that the ratio was~. 60: 40 (LmoJ Rf : High Rf bands). Sub-
sequent preparative TLC of this mixture, followed by isolation and 
analysis of the low Rf band material indicated an improved (70:30) 
diastereomeric composition. A second successive purification of this low 
Rf band material, however, did not result in any further improvement in 
purity. This suggested that the low Rf band material was undergoing 
isomerization at the second successive stage of purification and 
reverting to the limiting diastereomeric composition of (70:30). 
Further attempts at separating these diastereomers was therefore 
abandoned. 
A tentative assignment of the 1H_NMR spectra of the diastereomers of 
(93) was made on the basis of the molecular symmetry of these species, 
table 6.1. 
Diastereomers 
~-isomer 
40°/0 of mixture 
Br 
(+,-) - isomer 
60°/0 of mixture 
Table 6.1 
Gem-dimethyl at C-10 
&1.56 (s,3H) 
b 1 .69 (5, 3H) 
$ 1.59 (s,3H) 
&'1.61 (s,3H) 
100 
Bromomethine 
&,4.57 (t,2H) 
&4.54 (t,2H) 
TLC 
High Rf 
band 
LO,,"J Rf 
band 
1 The H-NMR spectra of the pure crystalline cis and trans 
176 diastereomers (97) and (98) have recently been reported • 
C is-diastereomer Trans-dias tereomer 
(97) (98) 
It was found that the more symmetric trans-diastereomer (98) showed only 
two singlets at 1.25 and 1.55 6 for the pair of gem-dimethyl groups. 
On the other hand, the more complex cis-diastereomer (97) showed a 
different chemical shift for each of the four methyl groups. 
In the case of the alicyclic dibromo-diketo diastereomers (97) and 
(98), where the respective conformations are relatively well-defined, 
a more reliable 1H_NMR assignment of these diastereomers can be made. 
However, the same is not true of the acyclic dibromo-diketo 
diastereomers (95) and (96),where the respective conformational 
preference resulting from the overall effect of dipole-dipole and 
steric interactions is unknown. From the observation of molecular 
models, it is suggested that the preferred conformations of (95) and 
(96) are likely to resemble those shown in scheme 6.3. 
H 
Br,\ 
(99) 
(+I-)-isomer 
Scheme 6.3 
(100) 
meso - isomer 
101 
In both these conformations, the carbonyl group is thought to be 
anti-periplanar to the adjacent bromo-substituent by virtual of their 
mutual dipole-dipole interaction. In each case, further relief of the 
dipole-dipole interaction of the 1,3-dicarbonyl system can be brought 
about by the slight tilting of each carbonyl group away from each 
other. These resultant conformations, (99) and (100), also appear to 
suffer relatively less steric crowding as compared with other possible 
conformations. It must be stressed that these preferred conformations, 
1 (99) and (100), are only qualitative models, and therefore, the H-NMR 
assignment of (95) and (96) based on these conformations must remain 
conj ectural. 
For our purpose, the diastereomeric mixtures of (93) and (94) 
were thought to be less important from the point of view of the proposed 
C-B, C-12 cyclisation. We, therefore, proceeded to investigate the 
cyclisation reactions of these compounds. 
The treatment of the dibromo-ester (93) with sodium hydride in DMF 
at room temperature, afforded a trace amount of the model prostanoid 
(23). Several later attempts at optimising the yield of the reaction 
failed to bring about any significant improvement. The highest 
estimated yield of the model prostanoid (23) was found to be 12%, 
equation 40. 
NaH,DME 
) 
25 0 Estimated 
(93) Equation 40 (23) 
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179 Follm-Jing the conditions employed by R. N. McDonald et & , 
equation 35, the dibromo-ester (93) was treated with sodium hydride in 
DMF at 00, equation 41. This reaction afforded an estimated 13% yield 
of the model prostanoid (23). The same reaction carried out at room 
temperature for 18 hours gave a complex mixture of UV active products. 
COzEt 
NaH,DMF 
) 13 % 
Estimated 
(93) Eq ua tion L.1 (23) 
A reductive coupling reaction of the dibromo-ester (93) was 
carried out in a mixture of zinc dust and sodium iodide in acetone, 
177 according to the conditions reported by J. B. Conant et al 
equation 33. However, instead of the expected intramolecular C-8, C~12 
coupling reaction, the dibromo-ester (93) was cleanly reduced to the 
dimethyl ester (17) in very high yield, equation 42. 
COzEt 
Zn,Nat 
) 91 0/0 
Acetone 
Br 
(93) Equation 42 (17 ) 
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These less successful results led us to examine the prospect of 
effecting the C-B, C-12 cyclisation by the use of suitable alkoxide 
bases on the dibromo-esters (93) and (94). It was thought that the 
increased steric crowding by the ~ -bromo substituents on the 
1,3-diketo moiety would reduce the extent of the competitive retro-
Claisen cleavage which was predominant in the reaction of the diketo-
ester (17) with sodium ethoxide/iodine. However, this was not the case 
and both the reactions according to oquations 43 and 44 resulted in 
extensive retro-Claisen cleavage. Only a trace quantity of the 
respective prostanoids (23) and (25) was obtained in each case. 
NaOEt,EtOH 
-----) 
(93) Equation 43 (23) 
NaOMe,MeOH 
------> 
(94) Equation 44 ( 25) 
As before, we proceeded to solve the problem of the retro-Claisen 
cleavage in these reactions by replacing the alkoxide bases with a 
1 B2 less nucleophilic nitrogeneous base. Work by R. Breslow ~ al 
indicated that a modified Farvoskii type cyclisation could be brought 
about using a weaker base such as triethylamine, equation 45. 
104 
Br 
< 
, A Et3N, CHCl 3 ~ ) 12 % [j 
Br 
(101 ) Equation 45 (102) 
In an early attempt, the dibromo-ester (93) was treated with neat 
triethylamine at room temperature, equation 46. The resultant crude 
mixture indicated the presence of UV active products absorbing in the 
240-250nm region. Subsequent GLC analysis of the crude indicated an 
estimated 14% yield of the model prostanoid (23). 
) 
(93 ) Equa tion L.6 
153 
(23) 
'4 0 / 0 
Estimated 
More recently, E. McDonald et al reported the cyclisation of 
1, 5-dibromo-3, 3-dimethyl 2.4-pentanedione (91) in triethylamine /~1eCN, 
equation 37. Encouraged by this report and by our earlier findings, 
we followed up this work and employed a triethylamine/MeCN solvent 
mixture. Hence, the treatment of the dibromo-ester (94) under the 
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reaction conditions reported by E. McDonald et a1 153 , afforded 
an estimated 10% yield of the model prostanoid (25), along with a 
considerable amount of unreacted starting material (94), equation 47. 
) 10 % 
Estima.ted 
(94 ) Equation 47 (25) 
Subsequently, the reaction conditions were improved to afford an 
estimated 19% yield of the model prostanoid (25) and a major non-UV 
activ8 product (103), equation 48. 
C0 2Me 
. Et 3N,MeCN ) + Unknown 
(94) Equa tion 48 
19% 
Estimated 
(25) 
The unknown product (103) was isolated from the crude product 
mixture as a viscous, colourless oil. The IR spectrum showed 
( -1 characteristic carbonyl bands 1723, 1740 and 1765cm ) and a broad 
(103) 
-1 1 hydroxyl band (3440cm ). The H-NMR spectrum of (103) showed signals 
at f., 0.89 (t, terminal methyl), 1.02, 1.04, 1.17, 1 .18 (4 X S., 6H), 
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1.25-1.90 (m, methylene envelope),.2.32 (t, -CH2C0 2Me), 2.60-2.93 
(m, 2H), 3.67 (5, 0-C!:!3 ) and 4.10-4.39 (m, 1H). The presence of the 
hydroxyl proton was not obvious and could not be located by D20 exchange. 
The accurate mass measurement showed important ions at m/e 271 (6%), 
241 (36%),239 (36%). 171 (35%), 153 (24%),141 (52%) and 57 (100%). 
The GLC analysis of (103) was unsatisfactory and although it appeared 
to be homogeneous on TLC, the spectral data indicated it to be a complex 
mixture of isomeric cyclic hemi-ketals. These were tentatively assigned 
the general structures (104) and (105). 
HO 
X~C02Me 
(104) (105) 
where X = =0 (a) 
= -H,-OH Cb) 
= -H,-Br (c) 
Although the mass spectrum of the unknown (103) did not show the 
molecular ion for (104) or (105), the fragment ions provided strong 
evidence in favour of these proposed structures. The accurate mass 
measurement of the highest ion at m/e 271 (C14H2305) and the next 
highest ion at m/e .241 (C14H2S03) suggested the fragmentation 
(104)~(106) and (105)~(107) respectively, scheme 6.4 
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Schp.me 6.4 
It ~\ I\j\jVOl/j e \\ /\ 1\ /\ /C0 2Me ?9 v v v > X' ; mle 239(36°10) y -MeOI-! 
H0;;J 
~VVV HO+ mle 271(6°10) 
(104) (106) 
It ~V\ ) 
H HO+ 
m/e 241 (5°10) 
(105) (107) 
More specifically, the weight of the spectral data of the unknown 
(103) waG in favour of the cyclic hemi-ketal (104a) and (105a). The 
mass spectrum of the unknown (103) showed strong fragment ions at 
m/e 141 and 171 which suggested the o<-cleavage of a ketonic side-chain 
component as shown in scheme 6.5. The carbonyl bands in the IR 
spectrum of (103) could now be assigned to the aliphatic ~-hydroxyl 
-1 ) keto-group (1723cm ,the -1 ester group (1740cm ) and the substituted 
f 2 mOl·ety 184,185 (1765cm-1 ). Th . 1 . d uran- -one e prevlous y UnaGSlgne 
1 
signals in the H-NMR spectrum of (103) could be accounted for by the 
cyclic hemi-ketals (104a) and (105a). The four singlet signals at 
~ 1.02, 1.04, 1.17 and 1.18 were assigned to the C-10-gem-dimethyl 
108 
protons of (104a) and (105a). The remaining multiplets at ~ 2.60-2.92 
(m,2H) and 4.30-4.39 (m,1H) were assigned respectively to the 
-CO-CH - and -CO-CH(0)-CH2-groups of (104a) and (105a). 
-2 
Scheme 6.5 
+ ) O==\./Vv\ 
H 
(1040) (108 ) 
) 
(109) 
Although the mass spectrum of (103) lacked convincing evidence for 
species (104b), (104c), (105b) and (105c), we could not on the basis 
of the spectral data accummulated so far, rule out the presence of these 
species in the unknown mixture. These species were proposed from a 
mechanistic consideration of the cyclisation reaction (see section 8). 
The cyclisation of the dibromo-ester (94) was briefly investigated 
to determine other possible combinations of base and solvent. A number 
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Table 6.2 
. ~VC02Me _____ , X ~ . ,. Bose,solvent 7 
'\ """'VVVV 60°. 15h lfs'r 
(94 ) (25) 
Base Solvent Result 
Et3N MeCN Model prostanoid (25) 
Control (100%) 
Pyridine MeCN No GLC product. 
2,6-lutidine r'1eCN Model prostanoid (25) absent 
Starting material present 
Aniline MeCN Model prostanoid (25) absent 
Unknown (unidentified) 
Piperidine ~1eCN Model prostanoid (25) present 60% 
relative. 
Et3N DMF Model prostanoid (25) present, 
30% relative. 
Et3N DMSO f>-lodel prostanoid (25) present, 
20% rolative. 
Et3N THF/HMPA Model prostanoid (25) present, 
10% relative. 
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of comparative experiments were carried out. The results are shown in 
table 6.2. These reactions were monitored by GLC and the yield of the 
model prostanoid (25) in each case was estimated against a control 
reaction. 
As shown in table 6.2, all other combinations of base and solvent 
were found to be inferior to the triethylamine/MeCN mixture (the control). 
Only the use of piperidine/MeCN gave the model prostanoid (25) in 
relatively significant quantity. Combinations of MeCN with pyridine, 
2,6-lutidine and aniline gave no trace of the model prostanoid (25). 
However, in the case of the aniline/MeCN combination, the reaction 
afforded a major unidentified product. In addition, it was also 
found that the use of triethylamine in different solvents appeared to 
offer no improvement over the triethylamine/MeCN combination. 
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7. INVESTIGATION OF" THE CYCLISATION OF SIMPLE 1,5-DIALKYL-1,5-
DIHALOGENO -3,3-DIMETHYL-PENTA-2,4-DIONES 
In the preceding section, it was shown that the C-8, C-12 
cyclisation of methyl 8,12-dibromo-10,10-dimethyl eicos~9,11-dionoate 
(94) in triethylamine/MeCN, afforded the model prostanoid (25) and a 
co-product which was tentatively identified as a mixture of cyclic 
hemiketals (104a) and (105a). In a related study in this section, we 
extended this work and examined the triethylamine/MeCN cyclisation 
reaction in more detail. In order to simplify the investigation, two 
simple 1,5-dialkyl-1,5-dibromo penta-2,4-diones (131) and (132) were 
employed as models. 
The object of the study was to 
i) investigate the effect of the side-chain length on the 
triethylamine/MeCN cyclisation of these dibromo-diketones. 
ii) positively identify the co-product formed in the triethylamine 
/MeCN cyclisation of these dibromo-diketones. 
iii) obtain UV data on the pure 4,5-dialkyl-2,2-dimethyl 
cyclopent-4-en-1,3-diones (143) and (147) for comparison 
with those of the prostanoids. 
iv) investigate the cyclisation of the corresponding diiodo-diketones 
(137) and (138) in sodium ethoxide/EtOH and triethylamine 
/MeCN. 
The proposed plan was carried out according to the general 
scheme 7.1. 
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Scheme 7.1 
(110) 
Et02C~R 
(111 ) 
where 
= n-Bu 
(115 ) 
The Claisen condensation of 2-pentanone (117) and 2-heptanone (120) 
with the .' respective esters (118) and (121), with sodium hydride/THF, 
in each case afforded the 1,3-diketones (119) and (122), equations 49 
and 50. These 1,3-diketones were isolated and purified as their greyish 
blue crystalline Cu(II) complexes. The acidification of these complexes, 
followed by extraction into ether and distillation under reduced pressure, 
in each case, afforded the free 1,3-diketones (119) and (122) as 
viscous colourless liquids. 
(117) 
J--A NaH I THF ~ isolated as the ) Et02C~ cat.EtOH C u (II) complex, 54 0/0 
(118 ) Equation 49 ( 119) 
113 
(120) 
}-JV\ NaH,THF 
-----7 
Et02c--\N cat. E tOH 
(121 ) Equation 50 (122) 
Isolated as the 
Cu(II) complex, 72 Ofo 
The IR spectra of the enolizable 1,3-diketones (119) and (122) 
-1 
showed the typically broad and strong carbonyl bands at 1610cm • 
1 The H-NMR spectrum of the 1,3-diketone (119) showed typical signals at 
S 0.98 (t, terminal mathyls), 1.43-1.94 (sextet, 4H), 2.30, 2.53 
(2 x t, methylenes at C-3 and C-7), 3.58 (s, -CO-C~2-CO-) and 
5.51 (5, Co-C~=C(OH)-). 1 The H-NMR spectrum of (122) displayed a 
pattern similar to that of (119 ) with typical signals at { 0.89 
(t, terminal methyls), 1.13-1.84 (m, methylene envelope), 2.28, 2.51 
(2 x t, methylenes at C-5 and C-9), 3.56 (5, -Co-C~2-CO-) and 5.48 
(5, Co-C~ =C(oH)-). In each case, the ratio of the enol-to keto-
tautomers as determined from the relative intensity of the peaks at 
about ~ 5.50 and 3.60 was found to be (8:1) for (119) and (6:1) for 
(122); thereby indicating a slightly higher enoliccontent for the 
short side-chain 1,3-diketone (119). 
The low resolution mass spectra of (119) and (122) showed the 
respective molecular ions at m/e 156 (21%) and m/e 212 (13%). 
In each case, extensive <X-cleavage of the 1 ,3-diketone,with loss of an 
alkyl radical ('R), gave a resonance stabilized fragment ion of the 
114 
type (124) as the base peak, scheme 7.2. 
(123) 
Scheme 7.2 
+ 
-·R H9 + HO ) ~-:P (-) 11 _ ~ 
f( n~ 
where n = n-propyt 
= n-pentyl 
(125 ) 
This fragmentation pattern-has been found to be typical of tautomeric 
183 1,3-diketones with high enolic content • Further structural evidence 
for (119) and (122) was obtained from their 13C_NMR spectra 
(see Appendix). 
In each case, the dimethylation of the 1,3-diketones (119) and 
(122) afforded good yields of the respective crude dimethyl 1,3-diketones 
(126) and (127), equations 50 and 51. Further purification of the 
respective crude products by distillation under reduced pressure 
afforded> 80% of pure dimet~yl 1,3-diketone~ (126) and (127). 
~ NaH,DME ) 88 % MeI,DMF 
(119 ) Equa tion 51 (126) 
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NoH,DME 
) 83 0/0 
MeI,DMF 
(122 ) Equation 52 (127) . 
The IR spectra of these dimethyl 1,3-diketones (126) and (127) 
-1 
showed distinct carbonyl bands at 169B(s) and 171B(m) cm • The 
1H_NMR spectrum of (126) showed characteristic peaks at 6 0.90 
(t, terminal methyls), 1.35 (s, gem-dimethyl at C-5), ~.4o-1.B5 
(sextet, methylenes at C-2 and C-B) and 2.41 (t, methylenes atC-3 
and C-7). 1 The H-NMR spectrum of (127) showed signals at & 0.90 
(t, terminal methyls), 1.o3-1.Bo (m, methylene envelope), 1.35 
(s, gem-dimethyl at C-7) and 2.41 (t, methylenes at C-5 and C-9). 
The high resolution mass spectra of the dimethyl 1,3-diketones (126) 
and (127) did not s~ow their respective molecular ions. However, 
a major fragment ion of the type (129), derived in each case from the 
McLafferty rearrangement of the molecular ion with the expuloion of 
a neutral ketene species (130) was observed, scheme 7.3. This mode of 
fragmentation of (126) and (127) produced the respective daughter 
ions at m/a 114 (90%) and m/e 142 (100%). 
In each case, the bromination of the dimethyl 1,3-diketones (126) 
and (127) with phenyltrimethylammonium perbromide in THF, afforded 
the respective crude dibromo~1,3-diketones (131) and (132), 
equations 53 and 54. Purification of the crude products by column 
chromatography gave high yield of (131) and (132) as viscous 
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lachrymatory pale yellow oils. 
Scheme 7.3 
+ .
o y ~ . HO !RCnl+ nCH2 V'\ ~O ---R-')CH~ 
(128) (129) (130) 
where R:: Et 
= n-Bu 
PTAB,THF 
) Quantitative 
(126) Equation 53 . (131) 
PTAB,THF 
) 91 0/0 
(127) Equation 5~ (132 ) 
The IR spectra of (131) and (132) showed characteristic carbonyl 
-1 bands at 1728(s) and 1699(s) cm Examination of the 1H_NMR spectra 
of (131) and (132) revealed, in each case, the presence of diastereomers. 
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1 . 
The H-NMR spectrum of (131) showed distinct signals at &1.00, 1.03 
(2xt, terminal methyls), 1.56, 1.61 and 1.69 (3xs, gem-dimethyls at 
C-5), 2.02 ( quintet, methylenes at C-2 and C-B), 4.50 and 4.54 
(2xt, -CH -CHBr-CO-). 2 -
1 The H-NMR spectrum of (132) was less distinct 
and showed peaks at &0.92 (t, terminal methyls), 1.06-1.52 (m, methylene 
envelope), 1.56, 1.61,1.69 (3xs, gem-dimethyl at C-7), 1.79-2.25 
(m, methylenes at C-4 and C-10), 4.55 and 4.5B (2xt, -CH2-C~Br-CD-). 
1 A tentative assignment of the H-NMR spectra, with respect to the 
diastereomers, was made on the basis of the relative intensity of the 
'paired' peaks and on molecular symmetry argument referred to in 
section 6. Table 7.1 shows the 1H_NMR assignment of the diastereomers 
of (131) and (132) in comparison with those of ethyl B,12-dibromo-
10,1D-dimethyl eicos-9,11-dionoate (93). 
As shown on table 7.1, the gem-dimethyl signal for the (+, -) 
diastereomers (135) and (136) appeared as a sharp singlet at 1.61 3 . 
However, the corresponding gem-dimethyl signal of the (+,._) 
diastereomer (96) appeared as two equal intensity singlets at 1.59 
and 1.61~. This slight separation of the C-10 gem-dimethyl signal 
was attributed to the unsymmetric nature of the side-chains attached 
to the C-8 and C-12 positions of (96). In the case of the ~-
diastereomers (133),(134), and (95), all the gem-dimethyl signals 
appeared as two equal intensity singlets at identical chemical shift 
values of 1.~6 and 1.69 t. The bromo-methine signals of the (+, -) 
diastereomers (136) and (96) appeared at 4.54 £ (triplet), however, the 
shorter side-chain congener (135) showed an upfield shift of this 
signal to 4.50 £(triplet). In addition, the two terminal methyl grcups 
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Table 7.1 1 H-NMR assignment of Pertinent Signals ( ~) 
DIAstEnEOME[{S 
~ 
~ Br 
(meso) 
(133 ) 
(meso) 
(13L. ) 
(-,+) 
(135 ) 
~(-'T)  (136) 
Br 
)-SMN-02Me 
(-,+) 
(96) 
Terminal Me 
1.03(t} 
0.92(t) 
O.88(t) 
1.0o(t} 
O.92(t} 
O.88(t) 
119 
(CH ) C 3 2 CHBr-Cli2 -CliBr 
1.56(s) 
2.o3(quin) 4.54(t} 
1.69(s} 
1.56(s) 
1.79-2.25(m) 4.57(t) 
1 .69 (s ) 
1.56(s) 
1.8o-2.15(m) 4.57(t) 
1 .69 (s) 
1.61(s} 2.30 (quin.) 4.50(t} 
1.61(s) 1.79-2.25(m} 4.54(t) 
1.59(s) 
1.80-2.15(m) 4.54(t) 
1.61(s) 
of the short side-chain dibromo-diketone (131) appeared as two triplets 
at 1.00 and 1.03 S, these were assigned respectively to the (+, -) 
and ~-diastereomers (135) and (133). 
In addition, the relative intensities of the diastereomeric 
pairs of triplets assigned to the bromo-methine and terminal methyl 
groups of (131) indicated a (50:50) mixture of the (+, -) and ~­
diastereomers. However, in the case of (132), the relative intensities 
of the diastereomeric pair of triplets assigned to the bromo-methine 
groups suggested a (60:40) mixture of the (+, -) and ~-diastereomers. 
This diastereomeric composition compared more favourably with the 
diastereomeric ratio (60:40, (+, -): ~) found for ethyl 8,12-dibromo 
-10,10-dimethyl eicos-9,11-dionoate (93). 
As expected, the low resolution mass spectra of (131) and (132) 
did not show the respective molecular ions. However, in each case, the 
highest fragment ion was characterised by an equal intensity doublet due 
to the isotopic [M-Br]+ (16-18%) species. 
Treatment of the dibromo-1,3-diketones (131) and (132) with sodium 
iodide in dry aceton~~5in each case, afforded the respective diiodo-1, 
3-diketones (137) and (138), equations 55 and 56. These diiodo-1,3-
diketoneswere thermally unstable and darkened from a pale yellow to a 
reddish brown viscous liquid when left at room temperature for extended 
periods. In view of this, (137) and (138) were only prepared from the 
more stable dibromo-diketone precursors when required and used immediately 
in subsequent reactions. 
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~ Na I ,ace tone )- 91 0/0 Br 
(131 ) Equation 55 (137) 
NaI,acetone 
) Quantitative 
(132) Equation 56 (138) 
The IR spectra of (137) and (138) showed characteristic carbonyl 
-1 bands at 1688 and 1T19cm • In the case of (138), an additional weak 
band at 1620 cm-1 indicated the presence of dehydroiodination 
contaminants. The 1 H-NMR spectrum of (137) showed typical peaks at £ 
0.98, 1.01 (2xt, terminal methyls), 1.67, 1.73, 1.80 (3xs, gem-dimethyl 
at C-5), 1.73-2.30 (quintet, methylenes at C-2 and C-8), 4.65 and 4.70 
(2xt, -CH -CH.I-CO-). 2 -
1 The H-NMR spectrum of (138) showed comparable 
signals at ~0.93 (t, terminal methyls), 1.09-1.60 (m, methylene 
envelope), 1.67, 1.72, 1.80 (3xs, gem-dimethyl at C-7), 1.74-2.14 
. (m, methylenes at C-4 and C-10), 4.71 and 4.76 (2xt, -CH2-C!:!.I-CO-). 
1 Table 7.2 shows the tentative assjgnment of the H-NMR spectra of 
the diastereomeric mixtures (137) and (138). 
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Table 7.2 
1H_NMR ( ~ ) assignment of (meso) and (+,-) diastercomers of (137) and (138) 
-
Diastereomer Terminal methyls (C1i3 )2C -CH -CHI--2 -C.!:!r-CH~t 
~ (mesa) 1. 01 1. 67 1.73-2.20 4.70 -. b (139 ) 1. BD I 
e (~) a (140) 0.93 1. 67 1.74-2.14) 4.76 o I 1.80 
.-
~ (-, +) (141 ) 0.98 1,73 1.73-2.20 4.65 /" if I 
J 
-
- (-,+ ) 
fNV (142) 
r 0.93 1. 72 1.74-2.14,4.71 
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In comparison with their respective dibromo-1 ,3-diketone precursors 
(131) and (132), the diiodo-1,3-diketones (137) and (138) showed a 
relative doltmfield shift of the C!iI (~. 0.15-0.17ppm) and the gem-
dimethyl (~. 0.11-0.21 ppm) signals, ItJhile the rest of the signals 
showed a slight upfield shift (0.02-0.04ppm). In both cases, the (+,-)/ 
(meso) diastereomeric ratio of (137) and (138) as determined from 
the relative intensities of the two (-C!iI-CO-) triplets was found to be 
(70:30). 
As with the dibromo-1,3-diketones,(137) and (138) lacked the 
respective molecular ions. The highest fragment ion detected in each 
was the [M-I]+ species. 
With the dibromo-diketones (131), (132) and the diiodo-derivativ8s 
(137) , (138) in hand, we proceeded with the planned investigation of the 
cyclisation of these compounds in triethylamine/MeCN. 
Hence the cyclisation of the diastereomeric mixture of (131) in 
triethylamine/MeCN at 65°, followed by preparative TLC, afforded the 
expected 4,5-diethyl-2,2-dimethyl cyclopent-4-en-1,3-dione (143) and 
the corresponding unknown co-product (144)r equation 57. 
YiA 
W 
(131 ) 
Equation 57 
) + 
(143) 
Co-product 
(144) 
28 % w/w of 
crude product 
The IR spectrum of (143) showed characteristic carbonyl bands 
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(1741 (m), 1693(s),'630(m)cm')attributod to the cyclopentene-1,3-dione 
moiety~ 1 The H-NMR spectrum of (143) showed typical peaks at £1.14, 
1.14 (s and t, 12H) and 2.52 (t, 4H). Tho overlapping singlet and 
triplet at 1 .14 & \-Jere ass igned to the gem-dimethyl (singlet at 1.14 & ) 
and the terminal methyl (triplet at 1.14 ~) protons. The UV spectrum 
of (143) indicated an absorption band at ~ 245nm, E, =8,670 and 
max 
accurate mass measurement gave the molecular ion [M]t (4%) (measured 
180.1141, calculated 180.1132). Further confirmation of the structure 
of (143) was obtained from its simplo 13C_NMR spectrum which showed 
six peaks; two of which were in the lowfield sp2 carbon region while 
the remaining four were in the highfield sp3 carbon region (see 
Appendix) • 
The co-product (144) w~s isolated as a viscous colourless oil. 
It was homogeneous on TLC and GLC, and appeared to be non-UV active on 
silica gel, HF 254 • The IR spectrum of (144) showed typical hydroxyl 
-1 -1 . band (3450cm ), carbonyl bands (1764 and 1726 cm ) and c-o bands 
-1 1 (1098 and 1045 cm ). The H-NMR spectrum of (144) showed complex 
sets of multiplet at ~ 0.93-1.28 (m, terminal methyls and gem-dimf.lthyl), 
1.58-2.12 (m, 4H), 2.62-3.07 (m, 2H) and 3.90-4.52 (m~ 2H~ one D_O 
c. 
exchangeable proton). The accurate mass spectrum of (144) indicated 
the absence of bromine and important fragment ions appeared at m/e 
157, C8H1303 (51%), 115, C5H703 (46%), 112, C7H120 (25%), 87, C4H702 (691~)' 
71, C4H7
0(24%), 70, C4H60 (62%), 69, C4H50(100%), and 57,C3H50 (38%). 
These spectral data seemed to support the earlier supposition 
that the unknown was a complex isomeric mixture of the cyclic hemiketal 
(145). However, in this instance, the bromo species (145c) was ruled 
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out by the mass spectral evidence (no Br+ or HBrt species detected). 
where X= ==0 (a) 
= -H,-OH (b) 
= -H,-Br (c) 
(145) 
In a separate experiment, an attempt was made to prepare the cyclic 
isopropylidene derivative of (145b), by treatment of the co-product 
180 (145) with dry acetone and a. catalytic amount of p-TsOH ,equation 58. 
This was unsuccessful. Although all of the co-product (144) was consumed 
1 in the reaction, it was evident from the TLC, H-NMR and IR spectra 
that the crude product was a complex mixture of~,fo-unsaturated keton~s, 
hydroxy-ketones and contained only an insignificant amount of the 
anticipated cyclic isopropylidene derivative (146). 
Dry acetone 
------~ 
p_ TsOH, PhH. 50 0 
(145 b) Equation 58 (146) 
1 Due to the complex nature of the H-NMR spectrum of the co-product 
(144), a more detail structure elucidation was left to a later stage 
when the homologous co-product (148) from the triethylamine/MeCN 
cyclisation of (132) was obtained. 
The cyclisation of the dibromo-1,3-diketone (132) in triethylamine/ 
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Me/CN at 65 0 , followed by preparative TLC, afforded 4,S-dibutyl-2,2-
dimethyl cyclopent-2-en-1,3-dione (147) and the co-product (148), 
equation 59. 
-----~. 
(132 ) Equation 59 (147) 
29 Ofo 
+ Co-produc t 
(148) 
23% wrw of crude 
product 
The IR spectrum of (147) showeq characteristic carbonyl bands 
-1 (1741(w), 1697(s) and 1627(w) cm ) attributed to the cyclopentene-1,3-
dione moiety. 1 The H-NMR spectrum of (147) showed typical peaks at 
~ 0.94 (t, terminal methyls), 1.12 (s,gem-dimethyl), 1.21-1.72 
(m, methylene envelope) and 2.47 (t, 4H)~ An extensively. purified 
sample of (147) indicated an intense UV absorption band at A 249nm, 
max 
£=11,260. The high resolution mass spectrum of (147) indicated the 
presence of the molecular ion [M]t (9%) (measured 236.1776, calculated 
236.1776). Further confirmation of the structure of (147) was obtained 
13 from the C-NMR spectrum which showed eight peaks; two of which were 
2 in the lowfield sp carbon region while the remaining six were in the 
3 highfield sp carbon region (see Appendix). 
The IR spectrum of the co-product (148) showed characteristic 
-1 -1 hydroxyl band (3430 cm ), carbonyl bands (1762 and 1720 cm ) and 
c-o bands (1101 and 1045 cm-1 ). 1 The H-NMR spectrum of (148) showod 
typical peaks at b O. 94 (t, terminal methyls), 1.01, 1 .18 (2xs, gem-
126 
dimethyl), 1.26-2.00 (m, methylene envelope), 2.61-2.94 (m, 2H), 
3.49-4.05 (broad s, D20 exchangeable proton)and 4.10-4.45 (m, 1H). 
At higher resolution; the multiplet at 2.61-2.94 and 4.10-4.45& 
appeared, in each case, as a pair of overlapping triplets (J = 8Hz). 
These triplets were broad and their coupling pattern was not well-
defined. The high resolution mass spectrum of (148) showed the 
[ ] + 13 presence of isotopic bromo-species (149c)-OH at m/e 320 (C 14 C,H2602 
in low relative abundance. High intensity fragment ions appeared at 
m/e 185(97%),167(39%),115(63%),97(100%),87(76%), and 85(58%). 
The spectral data for (148) appeared to be consistent with the 
proposed general structure (149). However, in this case, the-
co-product (148) appeared to be diastereomeric mixture of (149a) 
contaminated with (149c). 
where X = =0 (a) 
= -OH,-H (b) 
= -Br ,-H (c) 
(149) 
The presence of (149c) was inferred from the accurate mass measurement 
of the four isotopic ions from the t (149c) -OH]+ species and the 
fragment ion [(149c) -HBr]+ at m/e 254 (11%). Although the molecular 
ion for the proposed species (147a) was not detected, the appearance 
of strong daughter ions at m/e 185(97%) and 85(58%) was consistent 
with the anticipated breakdown of (149a), scheme 7.4. 
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Scheme 7.4 
lt~ (150) 
(151) 
(1490) 
The O<-cleavage of (149a) results in two daughter ions (150) and (151), 
with charge retention predominantly on the latter resonance stabilized 
species. 
The 1H_NMR spectrum of (148) supported the supposition that the 
co-product consisted mainly of (149a) and the multiplets at ~ 2.61-2.94 
(2xt,2H) and 4.10-4.45 (2xt,1H) were tentatively assigned to (-CH2-C~2-
CO-C(O)-O-) and (-CH2-C~(CO)-0-) respectively. The minor contamination 
by the bromo-species (149c) would not be apparent as the (-CH2-C~(Br)-C-) 
triplet would be obscured within the multiplet at t4.10-4.45. The 
IR spectrum of (148) was also consistent with the proposed structure 
( 47 ) h h 1 · h t· d f 2 184,185 t b 1 b cl 1 a; wit tea lp a lC an uran- -one ype car ony an s 
-1 
at 1720 and 1764cm respectively. 
Further proof of the proposed cyclic hemiketal structure (149a) 
came from the formation of the cyclic methyl ketal (152a) when the 
co-product (148) was treated with anhydrous MeOH and a catalytic 
amount of HC1, equation 60. 
12B 
J--fv' MeOH,AcCl ~ X==O (a) ~ = -oH,-H (b) = -Br,-H (c) 
(149 ) Equo tion 60 (152 ) 
The IR spectrum of (152a) showed the disappearance of the precursor 
hydroxyl band and the presence of sharp bands due to the carbonyl 
-1 -1 (1766 and 1725 cm ) and C-0(1116, -1074 and 1032cm ) groups. The 1H_NMR 
spectrum of (152a) showed characteristic peaks at&'0.94, 0.94 (s and t, 9H), 
1.19 (s,3H), 1.10-2.05 (m, methylene envelope), 2.67 (t,-CH2-CO-), 
3.22(s,CH3-O-), 3.95 (broad t,1H) and 4.10-4.45 (broad m, <1H). The 
broad multiplet at ~4.10-4.45 was suspected to be due to the presence of 
the bromo-cyclic methyl ketal contaminant. (152c). The low resolution 
mass spectrum of (152) showed important fragment ions at mle 279, 
[(152c)-Br]+ (9%), 253 [(152a)-OMe]+ (7%), 199 (92%), 97 (82%) and 
85 (89%). The strong fragment ions at m/e 199 and 85 were presumably 
derived from the eX -cleavage of (152a), scheme 7.5. 
5cheme 7.5 
------~ 
(1520 ) (154) m/e 253(7°/0) 
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Acetylation of (149) in acetic anhydride/triethylamine and a catalytic 
amount of 4-(diethylamino)-pyridiJ9~ equation 61, afforded a crude 
mixture of acetates. By careful repetitive preparative TLC, the mixture 
was separated into two components. A lower Rf band acetate was isolated 
as a viscous colourless liquid and identified as the acetate (155a). 
A marginally higher Rf band afforded a similar quantity of a semi-
crystalline unidentified acetate (156). 
(149) 
) 
Equation 61 (155) 
where X = =.0 (a) 
= -OH,-H (b) 
= -Br,-H Cc) 
+ Unknown acetate 
(156 ) 
-1 As expected, the IR spectrum of (155a) in the 1700-1800 cm region 
remained virtually unchanged. The carbonyl bands appeared at 1760 and 
-1 -1 1729 cm and other strong C-O bands (1239, 1109, 1028 and 999 cm ) 
were apparent. The 1H_NMR spectrum of (155a) showed characteristic 
peaks at bO.94 (t, terminal methyls), 1.00, 1.23 (2xs, gem-dimethyl), 
1.30-1.40 (m, methylene envelope), 2.04 (s, ClilO-),2.39, 2.60(dof t,1H, 
J gem = 19Hz, J. = 7.5Hz), 3.13,3.33 (d of t, 1H, J = 19Hz, J . v~c gem v~c 
= 7.5Hz), and 4.12 (t, -CH2-Cli(CO)-0-). The two sets of doublet of 
triplets were assigned to O(-methylene protons (-CH2-Cli2-CO-). The 
. large chemical shift difference (0.74 ppm) betwBen these gaminal 
protons was attributed to the anisotropy of the neighbouring acetoxy-
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substituent. Each of these methylenic protons showed a very large 
geminal coupling constant, J = 19Hz which was further splitted into gem 
triplets by a typical vicinal coupling constant, J. = 1.5Hz. The vJ.c 
high resolution mass spectrum of (155a) did not give the required 
molecular ion but showed relevent fragment ions at m/e 269, 
and 85 (85%) which were rationalised in terms of the proposed 
struc~ure (155a). It is noteworthy that the mass spectra of (152a) 
~nd (155a) provide strong evidence of the ketonic side-chain in the form 
of the common fragment ion m/e 253 (also see scheme 1.5). 
The unknown acetate (156) was shown by spectral evid~nce (see 
experimental) to be a mono-acetate with the alkyl side-chains intact. 
1 The H-NMR spectrum displayed two unusual overlapping doublets at 
G 4.14 (J=8Hz) and 4.23(J=8Hz). Decoupling experiment showed that the 
two doublets were ,",oi;; eouJ31eel i;;o oaeh oi;;ho3?j b~ individually coupled 
to signals at h1.60 and 1.15, within the methylene envelope, This 
could not be rationalised in terms of possible structures related to 
the ketal acetate (155). Furthermore, its semi-crystalline nature led 
us to suspect that it was prohably still impure. 
The presence of the cyclic hemiketal (149a) in the triethylamine/ 
MeCN cyclisation of the dibromo-1,3-diketone (132) was unusual in that 
one of the carbon bearing the bromo-substituents was over-oxidised in 
the reaction. Accordingly, the presence of an oxidant or oxidants in 
the reaction mixture was suspected. 
A possible candidate was triethylamine N-oxide which could be a 
contaminant in triethylamine. The former was prepared by the 
186 
oxidation of triethylamine ~d th .!!l--chloroperbenzoic acid 
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A molar 
equivalent of triethylamine N-oxide was added to the (132) and the 
triothylamine/MeCN cyclisation reaction was carried out undex the 
usual conditions, equation 62. 
Et3 N,MeCN 
> + Co-produc t 
o 
Et3N-D, 70 -75 
+ -
(132 ) Equation 62 (147) (148) 
A GLC comparison of the crude product of equation 62 with the crude 
product of the normal triethylamine/MoCN cyclisation of (132)~indicated 
no significant change in the ratio of the co-product (148) to the 
dimethylcyclopentene-1,3-dione product (147). 
Another possible explanation for the presence of the over-oxidised 
product (149a) was the contamination of the dibromo-1,3-diketone 
precursor (132) bya tribromo-1,3-diketone species of the type (159), 
scheme 7.6. 
Schem~ ~~ 1 mole PTAB (158 ) ~: ~ ~:r (159) 3 moles PTAB 
Br 
In some early work on the bromination of methyl 10,10-dimethyl eicos 
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-9,11-dionoate (17) with phenyltrimethylammonium perbromide, we 
succoeded in preparing the monobromo-species type (158). However, 
several attempts to prepare the tribromo-spocies type (159) by using 
three moles equivalent of phenyltrimethylammonium perbromide 
consistently failed. 1 This observation,along with correct H-NMR 
integration obtained for the dibromo-1,3-dikotone (132) were 
incompatible with the significant amount of the cyclic hemiketal 
(149a) being derived from the tribromo-species (159). 
The presence of other oxidants such as oxygen, bromine, or an active 
source of bromonium species were also anticipated. The latter two 
oxidants could plausibly be derived from the disproportionation of the 
dibromo-1,3-diketone (132). 
Although the oxidant responsible for the production of the cyclic 
hemiketal (149a) was not determined, it was subsequently found that the 
relative amount of (149a) could be reduced considerably by carrying 
out the reaction under nitrogen, using freshly prepared dibromo-1,3-
diketone (132) and anhydrous freshly distilled triethylamine and MeCN. 
Under these conditions, the cyclisation was eventually optimised and 
vastly improved, to produce the dimethyl cyclopentene-1,3-dione (147) 
in 56% and the cyclic hemiketal (149a) in about 9% yield, equation 63. 
) 
(132 ) Equation 63 (147) (1490) 
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To complete this series of investigation, we studied the 
triethylamine/MeCN and sodium ethoxide/EtoH cyclisations of the diiodo-
derivativF.s (1~7) nnd (138). The results of this investigation are 
shown in table 7.3. 
diiodo ketone 
~ 
(137) 
I 
I 
(138) 
Table 7.3 
_B_QS_e_-') >9( 
Base 'toy Result 
Et3N/MeCN 15 Four other products, wi th tar ge 
amount of ()( , ~ unsaturated 
ketones. 
2Eto-/EtoH 16 Retro-Claisen products 
present 
30 Co-product present, suspected 
to be the cyclic hemiketal (149a) 
2Eto-/EtoH 24 Two retro-Claisen products 
present. 
As evident from the investigation, the use of the diiodo-1,3-
diketones (137) and (138) in the triethylamine/MeCN cyclisation did not 
result in any vast improvement in the yield of the 4,5-dialkyl 
2,2-dimethyl cyclopent-4-en-1,3-dione. It was found that the short 
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side-chain diiodo-1,3-diketone (137) underwent dehydroiodination to form 
~,~ -unsaturated ketones. 1 This was evident from the H-NMR spectrum 
of the crude product which showed strong doublets at about S1.B5 (J=BHz) 
assigned to (C.li3-CH=C-) and multiplets in the b 5.90-7.40 region 
(vinylic protons of et, (J -unsaturated ketone). In contrast, the crude 
product of the triethylamine/MeCN cyclisation of the longer side-chain 
diiodo-1,3-diketone (13B) showed a distinct lack Of~,~-unsaturated· 
ketones and the presence of a co-product (17% w/w of crude product) 
suspected to be the cyclic hemiketal (149a). 
The sodium ethoxide/EtOH cyclisation of the diiodo-1,3-diketones 
(137) and (138) afforded a comparatively lower yield of the respective 
4,5-dialkyl-2,2-dimethyl cyclopent-4-en-1,3-dione. The cyclisation of 
(137) was a poor reaction. Six by-products were detected by GLC and 
four of these were presumed to be retro-Claisen cleavage products. It 
was also apparent f~om the 1H_NMR spectrum of the crude product mixture 
that tX-ethoxy ketones/esters were present. However, no 0( , ~ -unsaturated 
ketones/esters were detected. The cyclisation of (13B) was a much 
cleaner reaction. Two major retro-Claisen cleavage products and two 
minor by-products were evident from the GLC analysis of the crude 
product mixture. 1 The H-NMR spectrum of the crude product mixture also 
showed the presence of ethyl ester and ~-ethoxy ketones/esters but lacked 
evidence of ~ ,(3 -unsaturated ketones/esters. 
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B GENERAL DISCUSSION 
The general concept of the proposed prostanoid synthetic scheme 
Itlas sholtlTl to be viable thruugilLile SYfi thesis of the model prostanoid. 
In the subsequent stages, the scheme was applied to C-15 functionalised 
prostanoids with partial success. At that point, it became evident 
that the overall effectiveness of the three-stage synthesis was seriously 
reduced by the poor yield of the C-B, C-12 cyclisation and difficulties 
encountered in the purification of the prostanoids. As a result, efforts 
were directed at investigating other methrids of effecting the same ring-
closure. 
In the course of this extended investigation, it was found that the 
Claisen condensation of 2-heptanone with ethyl hexanoate afforded 12% 
yield (isolated as the Cu{II) complex) of the trideca-6,B-dione (122). 
This supported earlier speculation that the Claisen condensation of 
methyl nonyl ketone with DEA{ 32% yield at best) could be vastly improved 
and that the loss of the product, ethyl eicos-9,11-dionoate (3), via 
further condensation of the latter with a second molecule of methyl 
nonyl ketone was the reason for the low yield. 
The eventual synthesis of the symmetrical 4, 5-dialkyl-2,2-dilnethyl 
cyclopent-4-en-1,3-diones (143) and (147) provided similar models with 
which the prostanoids could be compared. A comparison of the pertinent 
spectral data of these compounds is given in table B.1. This 
comparison as a whole provides more substantial evidence in support of 
the proposed prostanoid structure. 
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Table 8.1 
Cyclopentene-1,3-diones UV(EtOH)nm IR(film)cm -1 1H-NMR(CDCl3)S 
>Ye 245 1630(m) ,1693(5) 1.12(s,6H) c= 8,670 1741 (w) 2.52(q,4H) 
(143 ) 
249 1627(w),1697(s) 1.12(s,6H) 
E. =11 ,260 1741(w) 2.47(t,4H) 
(147) 
250 1625(w),1698(s) 1.12(s,6H) 
£=12,350 1743(s) 2.45(t,4H) 
(25 ) 
The sodium ethoxide/EtOH cyclisation of the diiodo-1,3-diketones 
(137) and (138) provided insight into the mechanism of the sodium 
ethoxide/iodine cyclisation of the esters of 1D,1D-dimethyl eicos 
-9,11-dionoate. The relatively high yields of the dimethyl cyclopentene 
-1,3-diones (143) and (147) obtained from the sodium ethoxide/EtOH 
reaction of the respective diiodo-1,3-diketones (137) and (138) strongly 
suggest that the analogous B,12-diiodo-1D,1D-dimethyl eicos-9,11-dionoic 
ester (163) could be an important intermediate in the sodium ethoxlde/ 
iodine cyclisation reaction. Hence, the stepwise cyclisation of ethyl 
10,10-dimethyl eicos-9,11-dionoate (via an intermediate dimethyl cyclopenta-
1,3-dione) proposed by C~ B. 141 Chapman is probably a minor mechanistic 
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pathway. A more plausible mechanistic pathway is included in scheme 8.1. 
Scheme 8.1 
Mechanistic pathways of the sodium ethoxide/iodine cvclisation 
(160) 
Minor Pathway 
(162 ) 
Eto-~ 
> 
(165 ) 
(161) 
EtO-,I \ 2~ Preferred 
I 
Pathway 
It is significant that the sodium ethoxide/EtOH cyclisation of the 
esters of 8,12-dibromo-10,10-dimethyl eicos-9,11-dionoic acid gave 
10% or less of the expected model prostanoids (23) and (25). This low 
yield of dimethyl cyclopentene-1,3-dione product is in contrast with the 
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relatively high yield obtained from the cyclisation of the diiodo 
-1,3-diketones (137) and (138). This discrepancy in the results may be 
rationalised in terms of the poorer leaving group ability of the bromide 
versus the iodide ion. However, this rationale and the proposed 
'preferred pathway' must remain tentative in view of the lack of 
information on the sodium ethoxide/EtOH cyclisation of the esters of 
8,12-diiodo-10,10-dimethyl eicos-9,11-dionoic acid. 
Our investigation into other. methods of cyclisation led us to the 
general triethylamine/MeCN cyclisation of 1,5-dibromo-2,4-diketones 
of the type (166), scheme B.2. 
Scheme 8.2 
~nl Et3N >Qlnl 111 en 2) > 
n2 MeCN 
. n 
2 
Br 
(166) . (167) (168) 
Dibromo-1,3-diketone % yield % yield 
R1 = R2 = H 39
194 ? 
R1 = R2 = Et 40-45 18-22 
R, = R2 = .!!-Bu 30-35 22-28 
R1 = -(CH2)6C02Me 15-20 27 
R2 = -(CH2 )7CH 3 
Scheme 8.2 indicate~ conservative estimated yields of the various 
dimethyl cyclopentene-1,3-dione derivatives under similar reaction 
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. ',""; . 
conditions. The figures suggest a progressive reduction in yield of 
(167) with the increase in the length of the side-chains. This trend 
is compatible with the simple steric and entropy argument that the 
formation of the prostanoid (23) would be relatively more demanding 
than the formation of the short side-chain cyclopentene-1,3-dione (143). 
On the other hand, the yields of the cyclic hemiketal (168) show a 
reverse trend. However,' the reason for this trend is still unclear. 
It must be emphasized that the estimated yields of the dimethyl 
cyclopentene-1,3-dione derivatives (167) and the cyclic hemiketal (168) 
were unoptimised. Furthermore, the cyclisation reaction behaved 
somewhat unpredictably194. In fact more recently,it was found that the 
most consistent and favourable reaction conditions afforded 56% of 
dimethyl cyclopentene-1,3-dione (147) and very little of the cyclic 
hemiketal (149a). 
An interesting and unusual feature of the triethylamine/MeCN 
ring-closure of the dibromo-1,3-diketone (132) is the high yield of 
the dimethyl cyclopentene-1,3-dione derivative (147) (56%Y). In 
. 196-198 
contrast to this, J. E. Baldwln et al and more recently 
H. O. House et a1199 have shown that five-membered ring-closure of 
the general type shown in scheme 8.3, classified as a 5-endo-tTigonal 
process is disfavoured. The preferred pathway is via the 5-~-trigonal 
process. This general rule was exemplified by the ring-closure of the 
«-bromoketone (173), scheme 8.4 
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X 
(169) 
I 
Scheme 8.3 
5-endo-trigonal 
~l b 
(171 ) 
Scheme 8.4 
~~ X 
(170) . 
I 
5-exo-trigonal 
. 1 
er 
(172) 
>(:J < 3 '/, 5-endo-trigonol 
tSuOH 
/ 6' product 
yB~ (175) yYsr + -K QBut ~ 
(173 ) 
+ K (174) 
141 
(176 ) 
70 % 5-~-trigonal 
product 
The remarkable difference between these two cyclisations is thought 
to result from the stereochemical control of the alkylation of the 
ambident nucleophilic anion. The C-alkylation requires the electrophile 
to approach perpendicular to the plane of the enolate anion and with 
the C-Br orbital colinear to the~-carbon of the enolate in an internal 
SN
2 
type geometry. Study of molecular models indicates that this 
transition state can only be attained with substantial distortion of 
normal carbon bond angle. The alternative O-alkylation requires 
approach of the non-bonded electron pair on the oxygen atom in-plane 
with the C-Br bond. This is sterically less strained and favours the 
formation of the enol ether product (176). 
The same stereoelectronic argu ment when applied to the 
5-membered ring-closure of the dibromo-1,3-diketone (132) should 
predominantly afford the 5-~-trigonal product (119). On subsequent 
acid work-up, (179) would hydrolyse to afford the cyclic hemiketal 
(149c), scheme 8.5. However, in contradication of this argument 
the ring-closure of (177) afforded the 5-endo-trigonal product (147) 
(56%) as the major pathvJay • The alternate 5-~-trigonal 
ring-closure was thought to result in the formation of the co-products 
(149a), (149b) and (149c) and deemed to be a minor pathway. 
The formation of the cyclic hemiketal (149a) (9%) is thought to be 
derived by further oxidation of the 5-~-trigonal intermediate (179) 
by an unknown species, scheme 8.6. 
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" ~ . " 
." .... 
Scheme 8.5 
Et3N 
) 
l (178 ) (147) 5-endo-trigonal 
/ 
Et3N 
B( 
') (177) 
+ 
(132 ) 
- HNEt3 
\. I 5-exo-tr I gona 
~ -l-
H30 
> 
(179) (149c) 
Scheme 8.6 
2H 2O ~ ~ ) t'H 
(179) (180) ( 181) 
-l. 
\ 
j -HX 
(149a) (182) 
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The abnormal 5-endo-trigonal ring-closure observed in this case 
may be due to structural differences between J. E. Baldwin's model 
(173) and our model (132). The first of these differences is the change 
in the state of hybridization of the carbon adjacent to the leaving 
group (-Br). In (132) the carbon in question is sp2 whereas the analogous 
carbon in (173) is sp3. Study of molecular models indicates that the 
o 3 0 2 
change in bond angle of ~. 110 (sp) to 120 (sp ,carbonyl) does not 
appear to facilitate the requisite steric alignment of the reaction 
centres of (177) so as to favour the ~-trigonal approach. In order 
to examine this molecular model prediction, it was necessary to 
transform one of the carbonyls of (132) into an sp3 centre. Unfortunately, 
attempts to prepare either the mono-dioxolGn or the mono-dithiolan 
derivative of methyl 8,12-dibromo-10,10-dimethyl eicos-9,11-dionoate 
(94) failed and we were unable to test our supposition. 
Another important difference between (132) and (173) is the 
presence of the extra bulky bromine atom and the long side-chains in 
the former. Molecular models indicate that the transition states 
(184) and (185) leading to the 5-~-trigonal product (179) suffer 
serious steric compression arising from the interaction between the 
geminal dimethyl group and the bulky bromo-substituent or alternately 
the alkyl side-chain of the enolate. This steric congestion is virtually 
absent in the bromoketone enolate (187), scheme 8.7. 
A comparison of the transition states (183) and (186) leading to the 
respe,ctive ~-trigonal products (178) and (175) did not reveal a 
large difference in steric demand. It is, therefore, likely that 
unfavourable steric interaction leading to transition states (184) and 
(185) has resulted in a change in the predicted ratio of the ~:endo-
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>9 
(175 ) 
5-endo 
-< 
trigonal 
Scheme 
XI} 
~ 
(186 ) 
--:::::. 
..... 
8.7 
sp3 
...... 
sp2 
I 
I 
-
~ 'QJ 5-exo ) 
trigonal 
(187) 
(183) (184) (185) 
I I 
5-endo-trigonal 5-exo-trigonal 
1 J, 
{f: R 
(178) (179) 
,)45 
>9 
(176) 
trigonal products. 
A further consideration may be made regarding the enolate ion-pair 
in each case. In the case of the bromoketone (173), scheme 8.4, the 
deprotonation by potassium tert-butoxide results in the K+ enolate 
intermediate. On the other hand, the deprotonation of the dibromo-
1,3-diketone (132), scheme 8.5, by triethylamine leads to the 
+ Et3NH enolate intermediate. It is known the 0- versus C-alkylation 
of these ambident enolate anions is often very sensitive to the 
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choice of solvent and counter-ions amongst other factors This 
apparent difference between the triethylamine/MeCN and the potassium 
~-butoxide/tBuOH cyclisations has not been investigated and, 
therefore,a direct comparison of their results must be viewed with 
caution. This is further emphasized by the fact that cyclisation of 
the dibromo-1,3-diketone (132) in triethylamine/DME and triethylamine 
/benzene do not produce any significant quantity of the dimethyl 
cyclopentene-1,3-dione product (147), therefore, indicating that 
solvent effects are also of paramount importance. 
11 ~ ~ ~ eeue. r e.~ 
~tk~'i(J;ll~~ 
tN"di A.e.... -1-0 ~ ~ ~ ~ 
~ ~'I1u-~r~F~ 'I 
" L/~ Jt~ .. I (1'1~2) 
T. g. ~ (,Ht -",~). 
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9. EXPERH1ENT8.b. 
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All solvents were routinely distilled before use and aprotic 
solvents were stored over sodium wire. Dimethyl sulphoxide, 
N,N-dimethylformamide and triethylamine were dried using calcium 
hydride. Tetrahydrofuran was distilled from lithium aluminium hydride 
as required and tertiary butanol was dried by distillation from 
potassium tertiary butoxide. Acetonitrile, chloroform and dichloromethane 
were distilled over phosphorus pentoxide. Unless otherwise stated, all 
solutions of product in organic solvents were evaporated on a rotary 
evaporator, under water-pump pressure. 
Analytical thin layer chromatography (T.L.C.) was carried out on 
silica gel (Merck HF 254 ) with 0.8mm thickness. Preparative T.L.C. was 
carried out in a similar manner but with larger plates. Analytical 
gas-liquid chromatography was run using Pye 104 series with a hydrogen 
flame ionisation detector (FID) and temperature programme facility. 
The five foot columns used were:-
(i) 3% DV 11 on 80-100 Gas chromosorb Q 
(ii) 3% SE 30 on 80-100 Gas chromosorb Q 
1H_NMR spectra were recorded from 20% w/v solutions in deutero-
chloroform, using tetramethylsilane as internal standard, at 90 MHz 
using Perkin Elmer R32·spectrometer. Infra-red (IR) spectra were determined 
for thin films (for liquids) and potassium bromide (KBr) disc (for solids) 
using a Perkin Elmer 177. Ultra-violet (UV) spectra were recorded using 
a Pye Unicom SP800 spectrophotometer. Mass spectra (MS) were recorded 
on an A.E.I. MS12 spectrometer. High resolution mass spectrometry was 
carried out on a A.E.I. MS9 at P.C.M.U. 
Melting points were determined on a Kofler hot-stage apparatus 
and are uncorrected. 
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1. Preparation of eicos-9,11-dionoic acid (4) 
A solution of 2-undecanone (8.5g, 0.05 mole) in dry distilled THF 
(25ml/EtOH(0.5ml) was added dropwise (over a period 0.5h) to a stirred 
~uspension of diethyl azelate (24.4g, 0.1 mole) in sodium hydride (5g of 
a 60% dispersion in oil; washed with dry benzene) and THF (50ml), under 
nitrogen blanket. After the complete addition of the ketone, the 
resultant yellowish brown slurry was stirred for an hour at room temperature 
o 
and a further one hour at 60. The reaction mixture was finally left 
stirring at room temperature for 15 hours. 
The resultant mixture was acidified with glacial acetic acid 
(20 ml) and evaporated under reduced pressure. The yellowish white 
precipitate was taken up in ether (3ooml) and washed with water (4 x 50ml). 
The organic phase was separated, dried with anhydrous magn8sium sulphate, 
filtered and evaporated under reduced pressure to afford a crude product. 
The crude product was taken up in dry xylene (25 ml) and paised 
down a vigreux column at 2200 /0.5 torr to afford crude ethyl eicos-9,11-
dionoate (18.91g) as the heavy-end. The crude ester was taken up in 
pet. ether 60-80 and recrystallised to remove the C31 tetrone as a white 
crystalline solid. The mother liquor w~s spun down to afford partially 
purified ethyl oicos-9,11-dionoate (3) (16.52g, 89%). 
A portion of the partially purified ester (1og, 0.021 mole) was 
magnetically stirred in an aqueous solution of sodium hydroxide (1og) in MeOH: 
THF : H20 (350ml:150ml:10oml) for 4 hours at room temperature. 
The resultant mixture was evaporated under reduced pressure, taken 
up in ether (250ml), cooled in an ice-bath and cautiously acidified with 
concentrated HCl (30ml). The organic phase was separated, washed with 
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water (4 x 4oml), dried over anhydrous magnesium sUlphate and evaporated 
under reduced pressure, to afford crude eicos-9,11-dionoic acid (9.31g). 
Purification of the crude acid by column chromatography (silica 
o 
gel 4oog, CHC13 : Pot. ether 60-80, 1:1) afforded purified acid (5.17g), 
Two successive recrystallisation of the purified acid furnished pure 
eicos-9,11-dionoic acid (4) (3.94g, 43%; estimated yield based on the 
total amount of partially purified ester is 32% ), mp 64 -65 0 
IR(KBr disc) -1 cm 
1 H-NMR (CDCI3 ) ~ 
MS 
Elementat analysis 
3440,3140, 171"9, 1689, 1641, 1463, 1441, 1423, 
1238, 905, 785 and 725. 
0.88 (t,3H), 1.12-1.85 (m, methylene envelope 24H), 
2.17-2.62 (m,6H), 3.57 (s,.( 1H), 5.48 (s,1H) 
and 9.80 (s broad, 2H, D20 exchangeable protons). 
[M]t measured 340.2618, calculated 340.2614, C20H3604 
Others [M-H20]+, mle 171 (82%), 155 (60%) and 
100 (100%). 
Found C = 69.8 H=10.5 
Theory C=70.54 H=1O.66 
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2.Preparation of the anilide of eicos-9,11-dionoic acid 
A solution of dry triphenylphosphine (589mg, 2.25 m moles) and eicos 
-9,11-dionoic acid (17omg 1 0.5m moles) in dry carbon tetrachloride/benzene 
(1 oml: 5ml) "Jas magnetically stirred and refluxed in an oil bath (El!. 85 0 ) 
for 4 hours, with the exclusion of moisture. 
A \-Jhite suspension of the phosphine ox ide ItJas formed. The 
resultant suspension was allowed to cool to room temperature. A solution of 
dry aniline (28omg, 3m moles) in carbon tetrachloride (1 ml) was added 
and the suspension was left stirring overnight. 
The resultant mixture was evaporated under reduced pressure and 
taken up in ether (150ml). It was thoroughly washed with 2N HCl (3x25ml), 
water (4x25ml) and dried over anhydrous magnesium sUlphate. On evaporationm 
the solvent, the crude anilide (0.703g, 100%Y) was obtained as a gluey 
solid containing excess triphenylphosphine. 
The crude product was purified by preparative TLC (Silica gel, 
o 
Pet. ether 60-8o/CHCI ,3:5) and recrystallised from Pet-ether 60..:.80/EtOH to afford 
pure N~phenyl eicos-9,l1-.dionamide(5) (91mg.44°/o) as a white crystalline solid. 
o 
m.p. 78.5-79.5, 
Elemental analysis: 
white micro-crystalline solid. 
Found C = 75.5 H 10.1 N = 3.5 
Theory C = 75.13 H .- 9.94 N = 3.37 
) -1 IR(KBr cm : 3340, 1658, 1637, 1601, 1549, 1443,901,781,761 and 731. 
1H-NMR(CDCl3) ~ 0.88 (t,3H), 1.04-1.98 (m, methylene envelope), 2.16-2.64 
(m,6H), 3.56 (s,"::::1H), 5.48 (s,1H), 6.92-7.66 (m,6H, 
one D20 exchangeable proton). 
MS [M]t measured 415.3090 (25%),calculated 415.3086 C26H41 N,03 
Others m/e 246 (59%), 204 (100%), 135 (93%) and 94 (73%) 
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lDimethylation of ethvl eicos-9.11-dionoate (3) 
A solution of ethyl eicos-9,11-dionoate (4.56g, 12.5m moles) in 
dry DME (40ml) was added dropwise to prewashed sodium hydride (0.76g, 
32m moles), under a gentle stream of nitrogen. The resultant slurry was 
stirred for 0.5h, followed by the addition of a solution of iodomethane 
(5.72g, 40m moles) in dry DMF (1ooml). The resultant suspension was 
stirred for a further 0.5h and then maintained at reflux temperature for 
6h. 
The resultant mixture was evaporated under reduced pressure and 
water (50ml) was cautiously added. The mixture was extracted with ether 
(2x1ooml). The ethereal layer was separated, washed with more water 
(4x2oml) and dried over anhydrous magnesium sulphate. Evaporation of the 
ether1 afforded crude ethyl 1o,1D-dimethyl eicos-9,11-dionoate (4.77g,96%Y) 
as a viscous pale brown oil. 
Purification of the crude product by column chromatography (silica 
gel. Pet. ether 6o-Bo/ether, 9 :1 ) afforded pure ethyl 1o,1o-dimethyl 
eicos-9,11-dionoate (17) (3. 43g, 69%Y) as a pale yellow oil. 
-1 IR(film)cm 
1H_NMR (CDC13 ) & 
MS 
1740,1720,1700, 1471, 1369, 11Bo, 1033 and 722. 
0.B7 (t,3H), 1.1o-1.87(m,methyl,methylene envelope-33H), 
2.31 (t,-C!:!2-Colt), 2.38 (t, C-8, C-12 methylenos-4H), 
4.13 (QI-oCtl2-CH3) 
[rvJ-OEt] + 351 (44%) 
Others m/e 19B (100%) and 155 (100%). 
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4.Preparation of methyl 10,1 o-dimethvl eicos-9.11-dionoate (18) 
A solution of eicos-9,11-dionoic (0.68g, 2m moles) in dry DME (14ml) 
was added dropwis8 to prewashed sodium hydride (336mg/6o% dispersion in 
oil, B.4m moles), under a gentle stream of nitrogen. Brisk effervescence 
followed and the suspension was magnetically stirred at room temperature 
for 20 • .J.. mlnu "es. A solution of iodomethane (1.136g, 8m moles) in dry DMF 
(33ml) was then added and the reaction mixture stirred for a further 
30 minutes. The temperature \"JaS gradually raised to reflux point (.£2,.120-
1300 ), maintained for 6 hours and left stirring overnight at room 
temperature. 
The resultant mixture was evaporated under reduced pressure and 
taken up in ether (150ml) and water (25ml). The organic phase was 
separated, thoroughly washed with water (3x20ml) and dried over anhydrous 
magnesium sulphate. Evaporation of the solvent under reduced pressure 
afforded the crude product (74omg, 97%Y). 
Purification of the crude product by preparative TLC (silica gel, 
Pet. ether 60-BO/ether, 3:2) afforded methyl 1o,1o-dimethyl eicos-9,11-
dionoate (1B) (47Bmg, 63%Y) as a colourless viscous oil. 
( ) -1· IR film cm 
1 H-NMR (CDC13 ) & 
MS 
1742, 1720, 1698, 1367, 1199, 1172, 1165 and 722 
0.89 (t,3H), 1.18-1.82 (m, methylene envelope), 
1.34 (s,6H), 2.31, 2.39 (2t,6H) and 3.67(s,3H). 
[M]t measured 382.3088 (0.5%), calculated 382.3083 C23H420L, 
Others m/e 351 (1%), 228 (69%), 198 (86%), 185 (38%) 
155 (62%), B2 (100%) and 71 (58%)". 
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~Bromination of ethvl 1o;1o-dimethyl eicos-9.11-dionoate (17) using bromine 
A solution of bromine (48omg, 3m moles) in chloroform/ethyl acetate 
(2.5ml:2.5ml) was added in one portion to a magnetically stirred solution 
of ethyl 1o,10-dimethyl eicos-9,11-dionoate (396mg, 1m mole) in the same 
solvent mixture (15ml). A catalytic amount of anhydrous aluminium trichloride 
was added and the solution was stirred at room temperature for.18 hours. 
The resultant mixture was evaporated under reduced pressure and 
taken u~ in ether (1DOml). The solution was washed with saturated aqueous 
sodium bicarbonate (10ml), water (3x20ml) and dried over anhydrous magnesium 
sUlphate. Evaporation of the solvent gave the crude dibromo-ester (93) 
(583mg) 
Purification of the crude product by preparative TLC (silica gel, 
Pet. ether/ether, 19:1) afforded ethyl 8 , 12-dibromo-10;1o-dimethyl eieos 
-9,11-dionoate (93) as two close bands containing the different isomers; 
a high Rf band (198mg, 36%Y) and a IOvJ Rf band (243mg, 44%). 
-1 IR(film)em 
MS 
High Rf band 
1 H-NMR (CDC1
3
) & 
Low Rf band 
1 H-NMR (CDC13 ) 6 
1740, 1730, 1700, 1465, 1371, 1180 and 1035 
·[M-oEt]+ 507,509,510, triplet 1:2:1, (!;:1!. 5%) 
Others m/ e, [r""l-Br] + 227 (15%) and 279 (15%) 
0.90 (t,3H), 1.10-1.50 (m, methyl,methylene envelope), 
1.57, 1.70 (2s,6H), 1.85-2.19 (m,4H), 2.30 (t,2H), 
4 • 1 5 (q, 2 H) and 4. 59 (t , 2 H ) 
0.90 (t,3H), 1.10-1.50 (m, methyl,methylene envelope), 
1.60, 1.62 (2s,6H), 1.85-2.19 (m,4H), 2.30 (t,2H), 
4.15 (q,2H) and 4.56 (t,2H). 
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6.Dibromination of methyl 1o,10-dimethvl eicos-9,11-dionoate (1B) 
A solution of methyl 1o,1o-dimethyl eicos-9,11-dionoate (227mg, 
0.6m mole) in dry THF (3ml) was added in one portion to a magnetically 
stirred solution of trimethylphenylammonium perbromide (459mg, 1.22m moles) 
in the same solvent (2ml). The resultant clear orange solution developed 
into a clear white suspension after 6 hours at room temperature. 
The resultant mixture was evaporated under reduced pressure and 
taken up in ether (150ml) and water (20ml). The organic phase was separated, 
thoroughly washed with water (3x20ml) and dried over anhydrous magnesium 
sUlphate. Evaporation of the solvent afforded the crude product 
(407mg) 
Purification of the crude product by preparative TLC (silica gel, 
Pet. ether 60-80/ether, 9:1, 3 passes) afforded two bands of partially 
separated isomeric methyl 8,12-dibromo-10,10-dimethyl eicos-9,11-dionoate 
(94) as viscous lachrymatory oils. (High Rf. band 93mg, 29%Y and low Rf ban.d 
12Bmg, 4o%Y : total 69%Y). If the separation of the diastereomers is not 
required, the dibromo-ester can be isolated as a single band by preparative 
TLC (silica gel, Pet. ether 60-80/ether, 7:1) in 81%Y. 
Methyl B,12-dibromo-iO,10-dimethyl eicos-9,11-dionate (94) epimers 
-1 IR(film)cm 
1 H-Nr.m (CDCI ) S 
3 
~15 
.. 
1735, 1723, 1700, 1370, 1255, 1200 and 1120 
0.88 (t,3H), 1.10-1.50 (m, methylene envelope), 
1.56,1.59,1.62,1.69 (4s,6H), 1.85-2.15 (m,4H), 
2.32 (t,2H), 3.67 (s,3H), 4.55 and 4.58 (2t,2H). 
[M~MeOH]+ 506, 508, 510 (1:2:1), (.£9.. 5%) 
Others in/e [r~-Er] + 461 (25%), 459 (25%) and 265 (6%), 
263 (6%). 
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~Preparation of ethyl 10,10-dimethvl prost-8(12)-en-9,11-dionoate (23) 
via the sodium ethoxide/iodine cyclisation procedure 
A solution of ethyl eicos-9~11-dionoate (99mg, O.25m moles) in dry 
EtOH (10ml) was added in one portion to a magnetically stirred solution of 
sodium ethoxide (from 29mg, 1.25m moles of sodium) in EtOH (10ml), under 
a nitrogen blanket. The yellow solution was stirred for 45 seconds and 
a solution of iodine (443mg, 1 .25m moles) in EtOH (15ml) was added dropwise 
over a period of 18 minutes. During the addition, the colour of iodine 
was continuously and instantly discharged. The final reaction mixture was 
stirred for a further 2 minutes at room temperature and evaporated under 
reduced pressure to afford a berge solid. The latter was taken up in 
ether (70ml) and water (20ml). Excess iodine was removed by shaking the 
mixture with sodium metabisulphite. The organic layer was ~eparated, 
washed with water (2x20ml), dried over anhydrous magnesium sulphate, 
filtered and evaporated under reduced pressure to afford the crude prostanoid 
(115mg, UV:~ 250nm, £ = 4,110). 
max 
Purification of the crude pIoduct by preparative TLC, afforded 
ethyl 10,1o-dimethyl prost-B(12)-en-9,11-dionoate (23) (45mg, 46%,~ 
max 
250nm E = 7,15m as a pAle yellow nil. 
-1 IR(film)cm 
1H-NMR(CDC13) ~ 
MS 
1739, 1699 and 1631 
o.BB (t,3H), 1.12(s,6H), 1.10-1.B5(m, methylene, 
·methyl envelope), 2.15-2.60 (m,6H) and 4.13 (q,2H). 
[M)t mle 392 (62%) and [M-OEt]+ m/e 347 (25%) 
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a.Hydrolysis of ethyl 10,10-dimethyl prost-8(12)-en-9,11-dionoate (23) 
and re-esterification of the pro8tsnoic acid (24) 
A solution of ethyl 10,10-dimethyl prost-8(12)-en-9,11-dionoate 
(230mg, 0.59m mole) in THF/MeOH/H20 (10ml:1.5ml:10ml) and sodium hydroxide 
(400mg) was magnetically stirred at room temperature for 16 hours. 
The resultant solution was cooled in an ice-bath and acidified with 
conc. HCl to pH1. The solution was saturated with sodium chloride and 
extracted with ether (2x25ml). The organic layer was separated, washed 
with water (2x25ml) and dried over anhydrous magnesium SUlphate. 
Evaporation of the ether under reduced pressure, afforded the crude acid 
(250mg). 
Purification of the crude acid by preparative TLC (silica gel, 
ether), afforded ethyl 10,10-dimethyl prost-8(12)-en-9,11-dionoic acid 
(24) (60mg, 28%) as Cl pale yellow liquid. 
-1 IR(film)cm 
1 H-NMR (CDC13) 6 
UV(EtDH) 
3500-3000, 1742, 1713, 1705 and 1629 
0.B9 (t,3H), 1.12(s,6H), 1.18-1.B7(m, methylene 
. envelope), 2.25-2.63 (m,6H) and 8.61-9.69 (broad 5 
1H,D20 exchangeable). 
~ 250nm, t =11,470. 
max 
The prostanoic acid (24) (45mg, 0.12m mole) was re-methylated with 
ethereal diazomethane at room temperature to afford the crude methyl ester 
(25) (41mg). Purification of the crude ester by preparative TLC (silica 
o gel, Pet. ether 60-BO/ether,5:3), afforded methyl 10,10-dimethyl prost 
-8(12)-en-9,11-dionoate (25) (21mg, 45%). 
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~1S 
UV(EtOH) 
1743,1698,1625,1382 and 1360. 
0.89 (t,3H), 1.12 (s,6H), 1.20-1.85 (m, methylene 
envelope), 2.32, 2.45 (2t,6H) al'd 3.67(s,3H) 
[M] t( 9%) measured 378.2774, calculated 378.2770 
[M-OMet( 5%) and [M-MeOH] (6 %) 
A 250nm, C =12,350. 
max 
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9.Prp-paration of methyl 10,1 o-dimethyl prost-B (12 )-en-9, 11-dionoate ( ill 
via the cvclisation of methyl 8,12-dibromo-1o,10-dimethyl eicos-9,11-
dionoate (94) in trip-thylamine/MeCN 
A solution of the dibromo-ester (94) (222mg, 0.4m mole) in 
triethylamine/MeCN (2ml:3ml) was magnetically stirred and maintained at 
600 for 14 hours (with exclusion of moisture). 
The resultant brown suspension was evaporated under reduced pressure 
and taken up in ether (150ml) and water (25ml). The suspension was 
washed with dilute HCl (5ml). The organic phase was separated, washed 
with water (3x25ml) and dried over anhydrous magnesium sulphate. 
Evaporation of the ether, afforded the prostanoid ester (25) (10omg, 65%, 
UV : A 250nm, C =3660). 
max 
Purification of the crude product by preparative TLC (silica gel, 
o 
Pet. ether 60-Bo/ether, 9:1, 3 passes), afforded methyl 10,10-dimethyl 
prost-B(12)-en-9,11-dionoate (25) (22mg, 14~, UV A 250nm, £..=B,44o). 
max 
The prostanoid methyl ester (25) prepared via the sodium ethoxide/iodin8 
cyclisation of methyl 1 0, 1 O-dimethyl eicos-9, 11-dionoate (17) was identical 
to the prostanoid methyl ester (25) prepared here. 
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1~M3thylation of 4-acetyl-butyric acid (4B) 
An ethereal solution of diazomethane generated from N-methyl-
N t 1 1 . . d 200 dd d d . -nitroso-p- 0 uene su pnonam~ e was a e ropw~se to a magnetically 
stirred solution of 4-acetyl-butyric acid (25.6g, 197m moles) in ether 
(50ml). Methylation was presumed to be completed when a persistent 
yellow coloration appeared and no further efierverscence 'tlas apparent on the 
addition of more diazomethane solution. 
The resultant solution was stirred at room temperature for 
30 minutes and then evaporated under reduced pressure to afford crude 
methyl ester (26.o8g, 92%Y) as a yellow oil. 
Purification by column chromatography (silica gel, Pet. ether 
o 
6o-Bo/ether, 2:3) afforded pure methyl 4-acetyl-butyrate (49) (25.48g, 
90%Y) as a pale yellow oil. 
-1 IR(film)cm 
1H-NMR{CDCl3) & 
1739, 1715, 143B, 1366, 1158 and 1071. 
1.75-2.06 (m,2H), 2.14 (s,3H), 2.39{t,2H), 2.55 (t,2H) 
and 3.69 (s,3H) 
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l1.Preparation of methyl 5-(1 ,3-dioxolan)-hexanoate (Sot 
A solution of dry ethane-1,2-diol (14.10g, 0.23m mole), methyl 
4-acetyl butyrate (21.87g, 0.15 mole) and a few crystals of p-toluene-
sulphonic acid in dry benzene (250ml) was magnetically stirred and 
refluxed in a Dean and Stark trap for 24 hours. 
The resultant solution vias cooled to room terrperature, washed vlith 
water and dried over anhydrous magnesium sUlphate. Removal of benzene 
under reduced pressure afforded the crude ketal ester (26.52g, 93%Y). 
Purification of the crude product by column chromatography 
(silica gel, Pet. ether 60-80/'ether, 2:3) afforded pure methyl 
5-(1,3-dioxolan)-hexanoate (50) (24.84g, 87%Y) as a colourless thick oil. 
-1 IR(film)cm 
1 H-N~1R (CDC13 ) {; 
1739, 1436, 1377, 1257, 1198,1172,1063,947 and 844. 
1.32 (s,3H), 1.62-1.88 (m, 4H), 2.25-2.50 (m, 2H), 
3.69 (s,3H) and 3.96 (s,4H). 
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12.Preparation of 5-(1 ,3-dioxolan) hexanol (51) 
A solution of methyl 2-(1 ,3-dioxolan)-hexanoate (11.2g, 0.06 mole) 
in dry THF (125ml) was added dx-opwise tu a IlIdgrle-tically stirred slurry 
of lithium aluminium hydride (49,0.105 mole) in dry THF (125ml), under a 
gentle stream of nitrogen. A mild exothermic reaction ensued. After this 
initial reaction had subsided, the suspension was kept under reflux for 
12 hours. 
The resultant mixture was cooled in an ice-bath to below 50. 
Water (5ml) was added cautiously in small portions, followed by 15% 
aqueous sodium hydroxide (12ml) and more water (5ml). The resulting white 
suspension was stirred for 15 minutes and filtered off. The filtrate 
was dried over anhydrous magnesium sulphate. Subsequent removal of THF, 
afforded the crude ketal alcohol (8.9g, 93%Y). 
Purification by column chromatography (silica gel, ether)afforded pure 
5-(1,3-dioxolan)-hexanol (51) (15.14g, 86%Y) as a colourless thick oil. 
-1 IR(film)cm 
1H-NMR(CDC13) b 
3430,1461,1377,1222,1069,948 and 855 
1.31 (s,3H), 1.41-1.81 (m,6H), 2.72 (s,1H,D20 
exchangeable) 3.63 (t,2H) and 3.96 (s,4H). 
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13.Preparat!on of 5-(1 ,3-dioxolan)-hexanal (52) 
Dry chromium trioxide 201 (24g, 240m moles) was added in portions 
to an ice-cooled, magnetically stirred solution of dry pyridine (38g,480m 
mole) in dry dichloromethane (600ml), under a slow stream of nitrogen. 
The dark red solution was allowed to warm up to room temperature gradually 
(approximately 1.5 hours). A solution of 5-(1,3-dioxolan)hexanol (6.4g, 
40m moles) in dry dichloromethane (40ml) was added in one portion to the 
oxidant.' The reaction mixture was stirred thoroughly for 20 minutes and 
then filtered through Hi-flo Supercel. The gluey residue left over was 
washed with dichloromethane (4x100ml). All washings and filtrate were 
combined and evaporated under reduced pressure. Excess pyridine was 
removed by azeotropic distillation with dry benzene,under reduced pressure. 
The partially purified crude product was then taken up in ether (3x100ml), 
filtered through glass wool and evaporated under reduced pressure to 
afford reasonably pure aldehyde (6.26g, 99%Y). 
Further purification by column chromatography (silica gel, 
chloroform) afforded pure 5-(1,3-dioxolan} hexanal (52) (5.56g, 88%Y). 
-1 IR(film}cm 2730, 1725, 1378, 1253, 1223, 1148, 1072, 948, 
855 and 75-,. 
1.34 (s,3H), 1.59-1.91 (m,4H), 2.30-2.64 (m,2H) 
3.96 (s,4H) and 9.70-9.85 (m,1H). 
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14.Preparation of 2-(1,3-dioxolan)-undec-6-ene (55) 
A solution of n-butyl lithium (10.2ml, 3.7M, 38m moles) was added 
dropwise to a magnetically stirred suspension of n-pentyl phosphonium 
bromide (15.7g, 38m moles) in dry ether (220ml) at _200 , under a gentle 
stream of nitrogen. The suspension was stirred for an hour and then 
o 
allowed to reach O. 5-(1,3-dioxolan) hexanal (4g, 25m moles) in dry 
ether (50 ml) was added to the orangey brown suspension of the phosphonium 
ylid in a dropwise manner. A thick yellow precipitate was thrown out of 
solution. More ether (1ooml) was added to keep the slurry thin. The 
reaction mixture was allowed to warm to room temperature and stirred for 
a further 10 minutes. 
The resultant suspension was quenched with water (10ml). ,The 
organic phase was separated, washed with more water (3x50ml), dried over 
anhydrous magnesium sulphate and evaporated under reduced pressure to 
afford the crude product (7.87g) 
The crude product was purified by column chromatography (TLC silica 
gel, chloroform/benzene, 3: 17, under pressure, 1 opsi) to afford 2-( 1,3-
dioxolan)-undec-6-ene (55) (2.73g, 51%Y) as a pale yello~J oil. 
-1 IR(filrn)crn 
1H-NMR(CoCI3) & 
MS 
3010, 1462, 1378, 1252, 1217, 111tJ, 1064, 968, 945 
and 870. 
0.90 (t,3H), 1.27-1.84 (m, methylene envelope), 
1.32 (s,3H), 1.90-2.23 (m,4H), 3.94{s,4H), 
5.28-5.52 (m,2H). 
[M]t measured 212.1778 (weak), calculated 212.1776 
Others m/e [M-CH3 ]+ 197 (8%) and 87 (100%). 
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15.Hydrolvsis of 2-(1 ,3-diDxolan)-undec-6-ene (55) 
A 607~ aqueous perchloric acid solution (0. 5rnl) was added dropwise to a 
magnetically stirred solution of 2-(1 ,3-dioxolan)-undec-6-ene (144mg, 
0.67m mole) in methyl ethyl ketone (10ml). The solution was stirred at 
room temperature for 2.5 hours. 
Powdered sodium bicarbonate was added until brisk efferverscence 
ceased. The suspension was taken up in ether (50ml), washed thoroughly 
with water (2x10ml) and dried over anhydrous magnesium sulphate. 
Evaporation of the ether afforded the crude product (196mg) 
Purification by preparative TLC (silica gel, benzene/chloroform 1:1) 
afforded undec-6-en-2-one (60) (87mg, 77%Y) as a pale yellow oil. 
-1 IR(film)cm 
1 H-NMR (COC13 ) £ 
MS 
3010, 1720, 1455, 1367, 1159 and 969 
0.89 (t,3H) 1.18-1.50 (m,4H), 1.50-1.86(m,2H), 
1.86-2.20(m,4H), 2.13(s,3H), 2.33(t,2H) and 
5.13-5.58(m,2H). 
[M]t measured 168.;513 (14%), calculated 168.1514 
Others m/e 125(14%) and 110(59%) 
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16.Preparation of 2-(1 ,3-dioxolan)-6-lIndecanol (65) 
A solution of n-pentyl bromide (8.73g, 58m moles) in dry ether 
(2oml) was added dropwise to a magnetically stirred suspension of 
magnesium turnings (1.30g, 54m moles) and a few crystals of iodine in dry 
ether (100ml), under a gentle stream of nitrogen. When the exothermic 
reaction ceased, the suspension was refluxed for 15 minutes and then allovled 
to cool to room temperature. 
A solution of 5-(1,3-dioxolan) hexanal (5.50g, 35m moles) in dry 
ether (30ml) was added dropwise to the Grignard reagent. When the initial 
exothermic reaction had ceased, the mixture was refluxed for 30 minutes and 
allowed to cool to room temperature. 
The resultant mixture was taken up in ether (50ml), quenched with 
saturated ammonium chJ.oride and filtered. The residue was washed with more 
ether (2x20ml). The filtrate and washings were combined and dried over 
anhydrous magnesium SUlphate. Evaporation of the ether afforded the crude 
ketal alcohol (7.95g, 99%Y). 
Purification by. column chromatography (silica gel, ether) afforded 
pure 2-(1,3-dioxolan)-6-undecanol (65) (6.17g, 77%Y). 
-1 IR(film)cm 
1H-NMR(CDC13) b 
3450, 1460, 1378, 1223, 1146, 1064, 947 and 863. 
0.84 (t,3H), 1.05-1.78(m, 17H), 1.91 (broad s,1H,D2o 
exchangeable), 3.60 (broad m, 1H) and 3.92 (s,4H). 
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1~Preparation of 2-(1 ,3-dioxolan)-6-benzyloxy -undecane (66) 
A solution of 2-(1 ,3-dioxolan)-6-undecanol (460mg, 2m moles) in 
dry DME (Sml) was added dropwise to a slurry of prewashed sodium hydride 
(300mg, 80% dispersion in oil, 10m moles) in dry DME (25ml). The 
suspension was magnetically stirred under a gentle stream of nitrogen for 
2 hours. A dry solution of benzyl bromide (83Smg, Sm moles) in DME, (Sml) 
was added dropwise to the reaction mixture and stirred at room temperature 
for 48 hours. 
Methanol (10ml) was added to the resultant mixture, stirred for an 
hour anq evaporated under reduced pressure. The semi-solid obtained was 
taken up in ether (100ml), washed with water (4x2Sml) and dried over 
anhydrous magnesium sulphate. Removal of ether under reduced pressure 
afforded the crude ketal benzyloxy-ether (63Smg, 99%Y). 
Purification by column chromatography (silica gel, benzene/chloro-
form, 7: 3) afforded pure 2-{ 1, 3-dioxolan )-6~benzyloxy ~ undecane (66) 
(4S3mg, 71%Y) as a pale yellow oil. 
-1 IR(film)cm 
1 H-NMR (CDC1 3 ) b 
MS 
3035, 14S3, 1374, 1204, 1094, 1063, 946, 863, 732 
and 696. 
0.89 (t,3H), 1.21(s,3H), 1.2S-1.70(m, methylene 
envelope~'4H), 3.32 (broad rn, 1H), 3.84 
(s,4H), 4.4S (s,2H) and 7.10-7.40 (m,SH). 
[M]t measured 30S.2116 (S%), calculat~d 30S.2117. 
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la.Hydrolysis of 2-( 1 ,3-dioxolan )-6-benzyloxy -undecane (66) 
A 60% aqueous solution of perchloric acid (2.5ml) was added 
dropltJise to a stirred solution of 2-( 1 ,3-dioxolan )-6-benzyl oxy -undecane 
. (1.22g, 3.Bm moles) in methyl ethyl ketone (50ml). The solution was 
stirred at room temperature for 2.5 hours. 
Powdered sodium bicarbonate was added in portions until brisk 
efferverscence ceased. Ether (100ml) was added and the organic phase was 
separated, washed with water (4x25ml) and dried over anhydrous magnesium 
sulphate. Removal of ether under reduced pressure afforded the crude 
product in quantitative yield. 
If necessary, the crude may be pur.ified by column chromatography 
. . 
(silica gel, Pet. ether 60-BO/ether, 4:1). In most cases, the crude 
2-(1,3-dioxolan)-6-benzyloxy.-undecane obtained by benzylation of the 
precursor alcohol ItJas directly hydrolysed without prior purification. The 
major impurity, dibenzyl ether, is easily removed by column chromatography 
(as above). The yield of the 6-benzyloxy -2-undecanone (67) based on the 
ketal alcohol is about 69%Y. 
) -1 IR(film cm 3030, 1715, 1495, 1453, 1356, 1160, 1090, 1065, 
733 and 696. 
0.B9 (t,3H), 1.16-1.90 (m, methylene envelope) , 
2.10 (s, 3H ) , 2.43 (t,2H), 3.39 (broad t, H), 
4.49 (s, 2H) and 7.1~-7.4B (m, 5H). 
MS [M]t measured 276.2091 (weak), calculated 276.2069 
Others m/e 170 (33%) and 91 ( 1 00%) • 
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19.Preparation of ethyl eicos-15-en-9,11-dionoate (61) 
A solution of undec-6-en-2-one (1.2g, 7m moles) in dry diethyl 
azel~te (0.5g, 2m moles) was added to a magnetic~lly stirred slurry of 
prewashed sodium hydride (0.92g, 50% dispersion in oil, 19m moles) in 
diethyl azelate, (2.9g, 12m moles), under a gentle stream of nitrogen~ The 
temperature was then gradually brought to 600 and maintained for an hour. 
The reaction mixture was subsequently left to cool to room temperature 
and stirred overnight. 
D~y ethanol (10ml) was added to the resultant mixture to destroy 
excess sodium hydride. It was then taken up in ether (100ml) and acidified 
with cone. HCl"to pH 1. The organic phase was separated, thoroughly 
washed with water (3x2oml) and dried over anhydrous magnesium sulphate. 
Evaporation of the ether afforded the crude product (4.65g). 
Purification by column chromatography (silica gel, Pet. ether 
" 60-8o/ether, 90:1) afforded ethyl eicos-15-en-9,11-dionoate (61) 
(463mg, 13%Y) as a yellow viscous oil. 
-1 IR(film)cm 
1 H-NMR (CDC13 ) & 
'1739, 1610, 1460, 1371, 1180, 1034, 969 and 774. 
0.88 (t,3H), 1.10-1.87 (m, methyl methylene envelope), 
1.87-2.19 (m, 4H), 2.30 (t, 6H), 3.54 (s,.:(fH), 
4.14 (q, 2H), 5.29-5.46 (m, 2H) and 5.46 (s, 1H). 
[M]t 366 (13%), [M-oEt) + 321 (32%) 
Others m/e 256 (53%), 199 (74%) and 153 (32%) 
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2~Preparation of ethyl 1o,1o-dimethyl eicos-15-en-9,11-dionoate (62) 
A solution of ethyl eicos-15-en-9,11-dionoate (377mg, 1.o3m moles) 
in dry DME (10ml) was added to prewashed sodium hydride (108mg, 60% 
dispersion in oil, 2.7m moles),under a gentle stream of nitrogen. Brisk 
efferverscence followed and the suspension was magnetically stirred at 
room temperature for 15 minutes. A solution of iodomethane (47omg, 3.3m moles) 
in dry DMF (15ml) was added and the reaction mixture stirred for a further 
30 minutes. ·00 It was brought to reflux temperature (100 -110 ) and 
maintained for 6 hours. Finally, it was allowed to cool to room 
temperature and left stirring overnight. 
The resultant mixture was evaporated under reduced pressure ~nd 
taken up in ether (100ml) and water (50ml). The organic phase was 
separated, wa~hed with more water (3x2oml) and dried over magnesium sulphate. 
Evaporation of the ether afforded the crude product (351mg, 86%Y). 
Purification of the crude product by preparative TLC (silica gel, 
benzene/chloroform, 1:1) afforded ethyl 1o,1o-dimethyl eicos-15-en-9,11-
dionoate (62) (150mg, 37%Y) as a viscous pale yellow oil. 
-1 IR(film)cm 
1H-NMR(CDC13) & 
1738, 1720, 1700, 1468, 1369, 1179, 1110 and 1032. 
0.88 (t, 3H), 1.08-1.80 (m, methyl, methylene 
envelope), 1.33 (s,6H), 1.80-2.18 (m, 4H), 2.18-2.54 
(m, 6H), 4.12 (q,2H) and 5.22-5.51 (m, 2H). 
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21.Preparation of ethyl 10,1 O-dimethyl prost-B( 12) ,15-dien-9, 11-diononte (63) 
A solution of ethyl 10,10-dimethyl eicos-15-en-9,11-dionoate 
(100mg, 0.25m mole) in dry ethenol (5ml) Hes added to a solution of sodium 
ethoxide (prepared from Na, 35mg, 1.52m mole) in dry ethanol (5ml), under 
a slow stream of nitrogen. The yellowish solution so formed was magnetically 
stirred for 2 minutes. A solution of iodine (130mg, 0.51m mole) in dry 
ethanol (5ml) was added dropwise over a period of a minute. After the 
completion of iodine addition, the solution was stirred at room temperature 
for a further 45 minutes. 
The resultant mixture was evaporated under reduced pressure to give 
a yellowish white residue. This was taken up in ether (50ml) and water (10ml). 
Sodium metabisulphite was added and the suspension was thoroughly shaken. 
The organic phase was separated, washed with water (4x10ml) and dried over 
anhydrous magnesium sulphate. Evaporation of the ether afforded the crude 
product (73mg, 74%Y). 
Purification of the crude product by preparative TLC (silica gel, 
chloroform/benzene, 1:1) afforded ethyl 10,10-dimethyl prost-B(12), 
15-dien-9,11-dionoate (63) (16mg, 16%Y) as a yellow oil. 
) -1 IR(film cm 1738, 1698, 1630(w), 1466, 1373, 117B, 110B and 1034 
1 H-NMR (CDC13 ) b 0.90 (t,3H), 1.01-1.B7 (m, methyl, methylene envelope) 
. 
1.13 (s, <6H), 1.B7-2.16 (m,<4H), 2.31, 2.45 (2t,)6H), 
MS 
UV(EtOH) 
GC 
4.15 (q,2H) and 5.25-5.56 (m broad, 1H). 
[M]t 390 (30%) and [M-OEt]+ 345 (15%) 
: A 242, t = 3,640 
max 
: Purity approximately 30% (by normalisation) 
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22.Preparation of ethyl 15-benzyloxy -eicos-9 .11-dionoate (72) 
A solution of 6- benzyloxy -2-undecanono (1. 38g, 5m moles) in dry 
ether (5ml) was added dropwise (over a period of an hour) to a magnetically 
stirred slurry of diethyl azelate (2.44g, 10m moles) and prewashed 
sodium hydride (0.6g, 60% dispersion in oil, 15m mole) in ether (5ml), 
under a gentle stream of nitrogen. After the addition of ketone was 
completed, the suspension was gradually raised to 65 0 and maintained at 
that temperature for an hour. It was then allowed to cool to room temp-
erature and left to stir overnight. 
The resultant brown mixture was taken in benzene (50ml) and dry 
ethanol (4ml) .• More benzene(100ml)was added and the suspension was acidified 
with conc. HCl (4ml). The organic phase was separated, washed with 
saturated aqueous sodium bicarbonate, followed by water (2x20ml) and 
dried over anhydrous magnesium sulphate. Evaporation of benzene afforded 
the crude product (2.58g, 100%Y). 
The crude product was passed down a heated vigreux column 
(200-210o/0.5torr) to remove DEA and other light-ends. The partially 
purified heavy-ends (1.78g, 75%Y) was further purified by column 
o 
chromatography (silica gel, Pet. ether 60-80/ether, 17:3). Final 
o 
purification by preparative TLC (silica gel/Pet. ether 60-80/ether, 7:3) 
afforded pure ethyl 15-benzyloxy-eicos-9,11-dionoate (72) (0.38g, 16%Y). 
-1 IR(film)cm 
1 H-Nr.m (CDCl 3) $ 
MS 
~ 1735, 1606, 732 and 696 
0.89 (t,3H), 1.15-1.90 (m, 25H), 2.15-2.70 (m,6H) 
3 • 4 ° (m, b ro ad, 1 H ), 3 • 50 (s, <,1 H ), 4. 1 2 (q, 2 H ) , 
4.48 (s,2H), 5.45 (s,>1H) and 7.32 (s,5H) 
no [M]t, measured 199.1334 (100%), C11H1903 
Others m/e 178 (82%), 157 (83%), 153 (32%) and 
152 (98%). 
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23.Preparation of ethyl 15-benzyloxy-1O,10- dimethyl eicos-9,11-dionoate (73) 
A solution of ethyl 15-benzyloxy-eicos-9,11-dionoate (808mg,1.7m moles) 
in dry DME (21ml) was added dropwise to prewashed sodium hydride (164mg, 
60% dispersion in oil, 4.3m moles),under a gentle stream of nitrogen. 
Brisk efferverscence followed and the suspension was magnetically stirred 
at room temperature for 10 minutes. A solution of iodomethane (1.39g, 
9. Bm moles) in dry m~F (Bml) was added and stirred fOr a further 30 minutes. 
The reaction mixture \'Jas then gradually brought to reflux point (Ei!.1 00-11 00) 
and maintained for 6 hours. It was then left to cool to room temperature 
and stirred overnight. 
The resultant mixture was evaporated under reduced pressure and 
taken up in ether (150ml) and water (2oml). The organic phase was separated, 
washed with more water (3x2oml) and dried over magnesium sUlphate. 
Evaporation of the ether under reduced pressure,afforded the crude product 
(B42mg, 99%Y). 
Purification of the crude product by preparative TLC (silica gel, 
o 
Pet. ether 6o-Bo/ether, 13: 7) afforded ethyl lS-benzyloxy-l0,1O-dimethyl 
eicos-9,11-dionoate (73) (722mg, 85%). 
-1 IR(film)cm 
1 H-NMR (CDC13 ) b 
MS 
30Bo, 3045, 1736, 1719, 1696, 1462, 1369, 1176, 
1091, 734 and 697. 
0.B8 (t, 3H), 1.13-1.B5 (m, methyl, methylene 
envelope), 2.17-2.54 (m, 6H), 3.21-3.53 (broad m,1H), 
4.13(q, 2H), 4.49 (5, 2H), 7.32 
+ NO[M]" measured 349.2742 (2%), 
(m, 5H). 
+ 
C22H3703'[ M-C9H13 0 2 ] 
Others m/e 242 (7%),199 (18%), 153 (10%),125 (19%), 
105 (74%) and 91 ( 1 00%) 
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2~.Pr~aration of ethyl 15 -benzyloxy-10, 10-dimethyl prost-B (12 )-en 
-9,11-dionoate (74) 
A solution of ethyl 15-benzyloxy-lO,10- dimethyl eicos-9,11-
dionoate (251mg, 0.5m mole) in dry ethanol (5ml) was added dropwise to 
a magnetically stirred solution of sodium ethoxide (prepared from 
Na, 5Bmg, 2.5m mole) in the same solvent (5ml), under a gentle stream of 
nitrogen. The resultant solution was stirred for 5 minutes at room 
temperature. A solution of iodine (254mg, 1m mole) in dry ethanol (6ml) 
was added dropwise (over a period of 2 minutes) and the reaction mixture 
was stirred at room temperature for a further 10 minutes. 
The resultant mixture was evaporated under reduced pressure and 
taken up in ether (120ml) and water (35ml). The organic phase was separated, 
washed with sodium mstabisulphata, water (2x20ml) and dried over anhydrous 
magnesium SUlphate. Evaporation of the ether afforded the crude product 
(273mg ) 
Purification of the crude product by preparative TLC (silica gel, 
o 
Pet. ether 60-BO/ether, 4:1, 3 passes) afforded ethyl 15~benzyloxy-
lO,lO-dimethyl prost-8(12)-en-9,11-dionoate (74) (35mg, 14%Y) as a viscous 
yellow oil. 
) -1 IR{film cm 1738, 1694, 1629, 1463, 1371, 1350, 1302, 1180, 
1094, 735 and 697. 
0.89 et, 3H), 1.03-1.90 (m, methyl, methylene 
envelope), 1.12 (s, 6H), 2.17-2.59 (m, 6H), 3.26 
-3.62 (m broad, 1H), 4.14 (q, 2H), 4.50(weQk),4.5/~ 
(2s, 2H) and 7.25-7.53 (m, 5H) 
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MS [M]t measured 498.3338 (3%), calculated 498.3345 
.J.. 
Others m/e (r~-OEt]' (4%),391 (25%) and 91 (100%) 
UV(EtOH) A 248nm, £ = 5,790 
max 
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25.Preparation of nonn-4 t 6-dione (119) 
A solution of 2-pentanone (17.6g, 0.2 mole) in dry THF (40ml) 
and EtOH (0.5ml) was added dropwise (over a period of one hour) to a 
magnetically stirred slurry of prewashed sodium hydride (20.2g, 50% 
dispersion in oil, 0.42 mole) in ethyl butyrate (46.4g, 0.4 mole) and 
THF (40ml), under a gentle stream of nitrogen. An exothermic reaction 
commenced after 30 minutes. When the addition of ketone was complete, 
the reaction mixture was maintained at 600 for an hour. The thick brown 
suspension was then left to stir overnight at room temperature. 
The crude product was evaporated under reduced pressure and taken 
up in ether (300ml) and water (1ooml). The suspension was stirred in an 
ice-bath and acidified to pH1 by the dropwise addition of conc. "Hel (50ml). 
The organic phase was separated, washed with water (4x50ml) and evaporated 
under reduced pressure to give the crude 1,3-diketone. 
T "1 202,203 h 1 d k he copper comp ex of t e ,3- i etone was directly formed 
by the addition of a hot filtered aqueous solution of copper acetate 
(18.6g, 0.1 mole in 200ml of water) to a stirred solution of the 1,3-diketone 
in MeOH (1ooml). The copper complex precipitated out of solution instantly. 
The suspension was allowed to cool to room temperature and the supernatant 
was decanted. The blue copper complex was redissolved in boiling MeoH 
(50oml) and on cooling to room temperature, greyish blue needles 
(20.26g, 54%Y) mp 159.5-1600 , was obtained. 
To obtain free nono-4,6-dione, the copper complex (7.47g, 0.02mole) 
was taken up in ether (150ml) and shaken with 2N HCI(75ml). The organic 
phase was separated, washed with water (4x20ml) and dried over anhydrous 
magnesium sulphate. On evaporation of the solvent, free nono-4, 6-dione 
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(7.19g > 1 Oo%Y) \"las obtained. Distillation at atmospheric pressure 
afforded pu~ ncna-4, 6-dione (119) (5. 45g, S7%Y), bp 205-2060 , as a clear 
viscous strong smelling oil. 
Copper (11) complex, mp 159.5-160° (lit. 1560 204) 
Elemental analysis Found C = 57.8 
Theory C = 57.81 
H = 8.0 
H = 8.09 
Cu =16.8 
Nona-4,6-dione (119) 
bp 205~206o/1 atm. (lit 
-1 IR(film)cm 
1 H-NMR (CDC13 ) b 
MS 
Cu = 16.99 
bp 85_860 /11 tor}05) 
1707 (w) , 1610 (s), and 945 
0.98 (t,6H), 1.43:...1.94 ( rn, 4H) , 2.30, 2.52 (2t, 4H) 
3.58 (s,< 1H) and 5.51 (s, 1 H). 
[M]t~156 (21%) CgH1602 
Others m/e 113 (100%), 71 (42%) and 43 (42%) 
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26.Preparation of trideca-6, 8-dione (122) 
A solution of 2-heptanone (22.8g, 0.2 mole) in dry THF (4oml) and 
EtoH (0.5ml) was added dropwise (over a period of an hour) to a magnetically 
stirred slurry of prewashed sodium hydride (2o.2g, 50% dispersion in oil, 
0.42 mole) in ethyl hexanoate (57.6g, 0.4 mole) and THF (8oml) under a 
gentle stream of nitrogen. An exothermic reaction commenced after 30 minutes. 
When the addition of the ketone was complete, the reaction mixture was 
, 0 
warmed to 60 and maintained at that temperature for an hour. The thick 
brown suspension was stirred overnight at room temperature. 
The resultant'mixture was evaporated under reduced pressure and 
taken up in ether (300ml). The stirred suspension was cooled in an ice-
.bath and acidified to pH 1 by the dropwise addition of conc. HCl (50ml). 
The organic phase was separated, thoroughly washed with water (4x50ml) 
and evaporated under reduced pressure to afford the viscous 1,3-diketone. 
The 1,3-diketone copper (11) complex was directly obtained by the 
addition of a hot filtered aqueous s61ution of copper acetate (18.6g, 
0.1 mole in 150ml of water )to' a solution of the dike tone and allowed to cool 
to room temperature. The aqueous supernatant was decanted and the copper 
complex \oJas redissolved in boiling r·leOH (900ml). 011 standing to cool, 
. 0 
greyish blue needles of the copper complex (34.6g, 72%Y), mp 120-121 
was obtained. 
To obtain free trideca-6,8-dione, its copper complex (14.32g, 
0.03 mole) was taken up in ether (2ooml) and shaken with 2N HCl (75ml). 
The organic phase was separated, washed with water (4x20ml) and dried over 
anhydrous magnesium sulphate. On evaporation of the ether, free trideca 
-6,8-dione (122) (12.58g, 99%Y) was obtained. Distillation of this product 
afforded pure trideca-6, 8-dione (11. 93g, 94%Y) as a viscous strong smelling 
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colourless oil. 
Copper (11) complex, mp 120_121°, bluish grey needles, (lit.119_1200206 ) 
Elemental analysis Found C::: 64.7 H ::: 9.9 Cu:13.2 
Theory C ::: 64.34 H ::: 9.54 Cu ::: 13.07 
Trideca-6,B-dione (122) 
° . 0 207 bp.124-126 /2.5 torr (l~t. 162-164 /20 torr ) 
IR(filrn)crn-1b" 0.89 (t,6H), 1.13-1.84 (rn, 12H), 2.28, 2.51 (2t,4H), 
3.56 (s,J(1H) and 5.48 (s, 1H) 
r~s [M]t%212 (13'10) , C'3H2,,02 
Others rn/e 141 (100%),99 (78%)·and 71 (33%) 
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27.Dimethylation of nona-4 7 6-dione (119) and trideca-6 7 8-dione (122) 
A solution of the 1, 3-diketone (2m moles) in dry OM E (1 Oml) 
was added dropwise to prewashed sodium hydride (192mg, 50% dispersion in 
oil, 4m moles), under a gentle stream of nitrogen. The suspension was 
magnetically stirred for a period of 15 minutes. A solution of 
iodomethane (71omg, 5m moles) in dry DMF (1oml) was added dropwise (over 
,a period of 30 minutes) to the suspension and stirred for a further 
30 minutes. The reaction mixture was then gradually brought to 1000 in an 
oil bath and maintained at that temperature for 2 hours. The solution 
was left to cool to room temperature and left stirring overnight. 
The resultant suspension was evaporated under reduced pressure and 
taken up in ether (150ml). The organic phase was washed with water 
(4x2oml), dried over anhydrous magnesium sulphate and evaporated under 
reduced pressure. The crude dimethyl 1,3-diketone was obtained as a pate 
yello\-J oil with peppermint odour. This was further purified by 
distillation under reduced pressure. 
5 z5-dimethyl 
bp 105-1100 /8 
IR(film)cm -1 
1 H-N~1R (CDC13 ) 
MS 
nona-4 z6-dione (126)z 88%Y. 
torr 
& 
(lit. bp 129-1300 /18 torr 208) 
1718, 1698, 1368, 1110 and 1 009 
0.90 et, 3H) , 1. 35 (s, 6H) , 1.40-1.85 (m, 4H) 
and 2.41 (t, 4H) 
m/e 114 (90%), 105 (5%), 99 (9%), 86 (31%) 
and 71 (100%). 
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7,7-dimethyltrideca-6,B-dione (127) 83%Y 
o bp 115-120 / 1 torr 
IR( film)cm -1 1721, 1699, 1385, 1368, 1119, 1045 and 999. 
1 H-NMR (CDC1
3
) J 0.89 (t, 6H), 1.03-1.80 (m, methylene envelope), 
1.33 (5, 6H) and 2.33 (t, 4H). 
MS m/e 142 (49%), 99 (100%), 86 (67%), 71 (62%) and 
71 (21%). 
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28Preparation of the dibromo-diketones (131) and (132) from their 
respective 1,3-diketones (126) and (131) 
A solution of the dimethyl 1,3-diketone (3m moles) in dry THF 
(2.5ml) was added in one portion to a magnetically stirred solution of 
triphenylmethylammonium perbromide, (2.26g, 6m moles) in dry THF (2.5ml). 
The orange solution was stirred overnight at room temperature. 
(Precipitation of the ammonium salt generally occurs after 15-60 minutes). 
The resultant suspension was evaporated under reduced pressure and 
taken up in ether (150ml)/water (20ml). The organic phase was washed 
with more water (4x2oml), dried over anhydrous magnesium sUlphate and 
evaporated under reduced pressure (do not overheat above 500 ). The crude 
dibromo-diketone was obtained as a thick,pale yellow,lachrymatory oil. 
This was further purified by column chromatography (silica gel; Pet. ether 
o 
6o-8o/ether, 3:1) to afford pure dibromo-diketone. 
3,7-dibromo-5,5-dimethyl nona-4,6-dione (131) 
-1 IR(film)cm 1728, 1699, 1383, 1320, 1110, 1030 and 900. 
1 H-NMR (CDCI3) b 1.00 (t, 3H) , 1. 03 (t, 3H), 1.56, 1.61, 1. 69 
2.03 (m, 4H) , 4.50 (t, 1 H) and 4.54 (t, 1 HI. 
MS [M-HEr] +, 262 ( 16%) , 260 (16%) 
Others m/e 151 (31%) , 149 (31%) , 123 (30%), 
113 (49%), 95 (61%), 57 (59%) and 41 (100%) 
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(3s, 6H), 
121 (31%), 
5,9-dibromo-7,7-dirnethyltrideca-6,B-dione (132) 
-1 IR(filrn)crn 
1H-NMR(CDC13) S 
MS 
172B, 1699, 1371, 1110 and 1047 
0.92 (t, 6H), 1.06-1.52 (rn, 8H), 1.56, 1.6i, 1.69 
(3s, 6H), 1.79-2.25 (rn, 4H), 4.54(t, 1H) and 4.57 
(t,1H). 
[M-HEr] + 318 (18%), 316 (18%) 
Others rn/e 247 (6%), 249 (6%), 177 (7%), 179 (7%), 
141 (51%),123 (80%),97 (52%),85 (68%), 70 (43%) 
and 69 (100%). 
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29.Preparation ofdiiodo-diketones (137) and (138) from their respective 
dibromo-diketones (129) and (130) 
A soJ.u t_._~n_n n_¥. ~n_dl.·um ~n~;~o21o (~Rn_~ ~ ~m mole) _ _ __ ........... oJ \-.. ..... ....,111'::1' ~.'-II .a. in dry acetone 
(6ml) was added in one portion to a magnetically stirred solution of the 
dibromo-diketone (1.5m mole) in the same solvent (6ml). Immediate 
precipitation of sodium bromide occurred and the reaction mixture was 
stirred at room temperature for 30 minutes. 
·The resultant mixture was evaporated under reduced pressure, taken 
up in ether (150ml) and washed with sodium metabisulphite,followed by 
water (4x2oml). The organic phase was separated, dried over anhydrous 
magnesium sulphate and evaporated under reduced pressure (do not heat) 
to afford the diiodo-diketone as a viscous yellow liquid. 
3,7-diiodo-5,5-dimethvl nona-4,6-dione (137) (91%Y) 
-1 IR( film)cm 
1 H-NMR (CDC13 ) ~ 
MS 
1719 and 1688 
0.98,1.01 (2t, 6H), 1.67, 1.73, 1.80 (3s, 6H), 
1.73-2.20 (quintet, 4H), 4.65 and 4.70 (2t, 2H) 
[M-I]+ m/e 309 (5%) 
5.9-diiodo-7,7-dimethyltrideca-6.8-dione (138) (100%Y) 
IR(film)cm-1 
1H-NMR(CDC13) 
MS 
TLC 
1720 and 1690 (contaminant peak at 1620). 
0.93 (t, 6H), 1.09-1.60 (m, 8H), 1.67, 1.72, 1.80 
(3s, 6H), 1.74-2.14 (m, 4H), 4.71 and 4.76 (2t, 2H). 
[M-I]+ m/e 365 (52%) 
Silica gel, Pet. ether 6o-8o/ether (3:1) 
In each case, the diiodo-diketone appeared as two bands 
which ran very close to one another. They were 
presumed to be the (+,-) and (mesa) isomers. 
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30.Preparation of 4,5-diethyl-2,2-dimethyl-cvclopent-4 en-1,3-dione (143) 
A magnetically stirred solution of 3,7-dibromo-5,5-dimethyl nona 
-4,6-dione (131) (6B4mg, 2m moles) in dry triethylamine (Bml) and 
acetonitrile (12ml) was maintained at near reflux temperature (oil bath 
at 65_700 ) for 16 hours, with the exclusion of moisture. 
The resultant dark brown suspension was evaporated under reduced 
pressure and taken up in ether (150ml). The suspension was washed 
with 2N HCI(2x10ml) and water (4x20ml). The organic phase was separated, 
dried over anhydrous magnesium sUlphate and evaporated under reduced 
pressure to afford a crude dark brown oil (344mg, 96%Y). 
The crude product was separate~ into two major components by 
". preparative TLC (silica gel, Pet. ether 60-80/ether, 4:1). The higher 
Rf band afforded the 4,5-diethyl-2,2-dimethyl-cyclopent-4-en-1,3-dione 
(143) as a yellow oil (114mg, 32%Y). The lower Rf band afforded an 
unknown cyclic hemiketal as a viscous colourless oil (97mg, 28% w/w of 
crude product). 
4,5-diethyl-2,2-dimethyl-cyclopent-4-en-1 ,3-dione (143) 
-1 IR (film) cm 
1 H-NMR (CDC13 ) b 
MS 
1741,1693, 1630, 1381, 1351,1302, 1178 and 1078. 
1.14, 1.14 (s, t, 12H) and 2.52 (q, 4H). 
[M]Tmeasured 180.1141 (4%), calculated 180.1150 , Cll H1602 
[M + Ht measured 181.1223 (24%),calculated 181.1128,C11 H17 0 2 
Others m/e 112 (24%), 85 (33%), 71 (27%), 70 (49%) 
and 69 (100%) 
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Unknown cyclic hemiketal (144) 
IR(film)cm-1 
MS 
3450, 1764, 1726, 1383, 1098 and 1045 
0.93-1.28 (m, 12H), 1.58-2.12 (m, 4H), 2.62-3.07 
(m, 2H), 3.90-4.52 (m, 2H, one exchangeable proton). 
Highest ion measured 198.1254 (3%), C
11 
H
1S
0
3 
co1.198.1256 
and strong ion at 157.0863 (51%), CSH130 3 col. 157 .. 0864 
Others m/e 115 (46%), 112 (25%), 87 (69%), 
71 (24%), 70 (62%), 69 (100%) and 57 (3S%). 
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31.Preparation of 4,5-di-~-butyl-2,2-dimethyl-cyclopent-4-en-1 ,3-dione (147) 
A magnetically stirred solution of 5,9-dibromo-7,7-dimethyl trideca 
-6,8-dione (690mg, 1.73m moles) in dry triethylamine (8ml) and acetonitrile 
o (12ml) was maintained at 70-75 , under a gentle stream of nitrogen, for 
a period of 19 hours. 
The resultant dark brown suspension was evaporated under reduced 
pressure and taken up in ether (150ml). The suspension was washed with 
2N Het (2x10ml) ,followed by a thorough wash with water (4x20ml). The 
organic phase was separated, dried over anhydrous magnesium sUlphate and 
evaporated under reduced pressure to afford the crude product (456mg, > 100%Y) 
as a dark brown oil. 
The crude product was purified into two major components 'by 
o 
preparative TLC (silica gel, Pet. ether 60-80/ether,3:1.). The higher Rf 
band afforded 4, 5-di-~-butyl-2, 2-dimethyl-cyclopent-4-en-1 ,3-dione (147) 
(228mg, 56%Y) as a clear yellow oil. The lower Hf band afforded an unknown 
cyclic hemiketal (148) as a colourless viscous oil (44mg, 10% w/w of crude). 
4,5-di-n-butyl-2,2-dimethyl-cyclopent-4-en-1,3-dione (147) 
-1 IR(film)cm 
1H-NMR(CDCI3)& 
MS 
1740, 1693, 1625, 1380, 1352, 1302, 1172, 1089 
and 1010. 
0.94 (t, 6H), 1.12 (s, 6H), 1.21-1.72 (m, 8H) and 
2.47 (t, 4H). 
lM]tmeasured 236.1776 (9%),calcu[ated 236.1776 ,C15H2~02 
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Lower Rf unknown (148) 
-1 IR(film)cm 
1 H-NMR (CDC1
3
) S 
MS 
3430, 1763, 1722, 1384, 1259, 1138, 1113 and 1054. 
0.94, 1.01 (t + 5, 9H), 1.18 (5, 3H), 1.26-2.00 (m, 
methylene envelope), 2.62-2.94 (rn, 2H), 3.49-4.05 
(broad 5, 1H, D20 exchangeable) and 4.05-4.45 (m, 1H) 
. Ions measured at 
320.1145 (2°10) ,calculated 13 81 320.1130 (C14 C1H260 2 Br1) 
319.1116( 9°10) ,calculated 319.1095 (C 15H26 0281Br1 ) 
. 318.1111 (3°/0), calculated 318.1149 ( C 113c1 H26 0279Br,) 
. 79 317.1139(1O°Io),calculated 317.1114 (C 1S H26 02 Br,) 
Others m /e 254(11 %),237(16% ),185(97°/0),97 (77.°/o),85( 100°/0) 
188 
32Formation of methyl ketal (152a) from the unknown cyclic hemiketal (14B) 
A solution of the unknown cyclic hemiketal (14B) (50mg) in 
anhydrous MeOH (2ml) and acetyl chloride (2 drops) was magnetically 
stirred at room temperature, under a gentle stream of nitrogen, for a 
period of 16 hours and subsequently maintained at 400 for 8 hours. 
The resultant solution was evaporated under reduced pressure anq 
dried by azeotropic removal of added dry benzene (2x5ml) , to afford the 
crude p·roduct (52mg, 10O%Y) as a viscous colourless oil. 
The crude product was purified by preparative TLC (silica gel, 
0 
Pet. ether 6o-Bo/ether, 3: 1) to afford the methyl cyclic ketal (152a) 
(27mg, 53%Y) and unreacted cyclic hemiketal (148) (13mg) (Yield of 
methyl ketal (152a) based on reacted cyclic hemiketal is 69%). 
( . \ -1 lR film)cm 
NMR (CDCI3 ) , 
MS 
1766, 1725, 1383, 1365, 1116 and 937. 
0.76-1.10 (m, 9H), 1.19 Cs, 3H), 1.10-2.10 (m, 
methylene envelope), 2.67 (t, 2H), 3.21 Cs, 3H) and 
3.66-4.43 (m, 1H). 
m/e 253 (7%), 199 (92%), 97 (82%), 85 (98%), 
70 (98%) and 57 (100%). 
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33.Acetylation of the unknown cyclic hemiketal (148) 
A solution of the unknown hemiketal (149mg) in dry acetic anhydride 
(224mg), triothylamine (10ml) and a few crystals of 4-dimethylamino-
. d' , 8 9 t . 11 t . d t t t f BB h d pyrl lna . was magna lca y s lrre a room empera ure or ours, un er 
a nitrogen blanket. 
The resultant solution was evaporated under reduced pressure and 
taken up in ether (150ml). The organic phase was washed with 2N Hel (2ml) , 
water (4x20ml) and dried over anhydrous magnesium sulphate. Removal of the 
ether under reduced pressure,afforded the crude cyclic ketal acetate 
(180mg) as a pale yellow oil. 
The crude product was purified by preparative TLC (silica gel, 
o 
Pet. ether 60-80/ether 4:1) to give a mixture of acetates (115m~). On TLC 
these acetates appeared as two very close bands. This partially purified 
mixture of acetates was further separated by careful preparative TLC 
o _ 
(silica gel, Pet. ether 60-80, 2 passes followed by Pet. ether 60-80/ether 
4:1, single pass) to afford a high Rf band as a semi-crystalline solid 
(45mg) and a low Rf band as a viscous colourless oil (53mg). 
Higher Rf. acetate (156) 
-1 IR(film}cm 
1 H-NMR (CDCl3 ) b 
r~s 
1740, 1720, 1382, 1373, 1255, 1182 and 926 
0.93 (t, 6H), 1.35, 1.37 (28, 6H), 1.20-1.95 (m, 
methylene envelope), 2.06 (s, 3H), 4.16 and 4.20 
(2d,1H). 
m/e 253 (8%), 242 (32%), 158 (21%), 140 (100%), 
125 (15%); 96 (26%), 85 (53%) and 70 /100%) 
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Lower Rf acetate (155a) 
-1 IR(film)cm 
1 H-N~lR (CDCl~) 6 
j 
MS 
1760, 1729, 1384, 1371, 1239, 1109 and 932 
0.94 (t, 6H), 1.00 (s, 3H), 1.23 (s, 3H), 1.30-1.90 
(m, methylene envelope), 2.04 (s, 3H), 2.39, 2.60 
(2t, 1H), 3.13, 3.33 (2t, 1H) and 4.12 (t, 1H) 
.m/e 269 (5%), 253 (7%),227 (10%),185 (98%), 
167 (11%), 115 (14%), 97 (29%), 87 (12%),85 (85%), 
70 (22%), 57 (33%) and 43 (100%) 
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34.Cyclisation of the diiodo-diketones (137) and (138) in triethylamine! 
acetonitrile 
A magnetically stirred solution of the diiodo-diketone (0.5m mole) 
in dry triethylamine (4ml) and acetonitrile (6ml) was maintained at 650 
for a period of 16 hours, with the exclusion of moisture. 
The resultant suspension was evaporated under reduced pressure and 
taken up in ether (150ml)/water (2oml). The organic phase was separated, 
washed with 2N HCl(5ml),followed by water (3x2oml) and dried over 
anhydrous magnesium sulphate. On evaporation of the solvent, a dark 
brown crude product was obtained. 
The amount of the dimethyl cyclopentene-1,3-dione (144) and (147) 
in their respective crude products was estimated by GLC and UV determinations. 
Purification of the crude product in each case, afforded a higher 
Rf. band containing the dimethyl cyclopentene-1,3-dione and a lower Rf. 
band containing an unknown cyclic hemiketal. 
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35.CyclisRtion of the diiodo-diketones (137) and (138) in sodium ethoxide/ 
= 
ethanol. 
A solution of the diiodo-diketone (o.5m mole) in anhydrous ethanol 
(5ml) was added dropwise (addition period of about a minute) to a magnetically 
stirred solution of sodium ethoxide (1m.mole) in ethanol (5ml) at room 
temperature, under a gentle stream of nitrogen. The yellowish solution 
was stirred for a further 45 minutes. 
The resultant solution was evaporated under reduced pressure and 
taken up in ether (150ml)/water (1oml). The organic phase was separated, 
washed with more water (3x2oml) and dried over anhydrous magnesium sulphate. 
Removal of the solvent under reduced pressure afforded the crude product. 
The amount of the dimethylcyclopentene-1,3-dione (144) and (147) in 
their respective crude products was estimated by GLC and UV determinations. 
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APPENDIX 
13 The C-NMR spectra of a selected number of compounds prepared 
in this project are presented here. A correlation diagram of 13C_NMR 
chemical shifts relative to tetramethylsilane (TMS) of these compounds 
are shown in figure 1. Details of the 13C_NMR spectra of these compounds 
are entered below. 
13 C-NMR data (CDC13 , in ppm relative to TMS) 
Assignments are based on the numbering system shown in figure 1. 
(i) 4,5-diethyl-2,2-dimethyl cyclopent-4-en,1,3-dione (143) 
207.25 (C-4, C-6), 156.90 (C-3,C-7), 45.38 (C-5), 19.94 (C-10,C-11), 
17.19 (C-2, C-8) and 12.69 (C-1, C-9). 
(ii) 4,5-di-n-butyl-2,2-dimethyl cyclopent-4-en-1,3-dione (147) 
207~51 (C-6, C-8), 156.20 (C-5, C-9), 45.46 (C-7), 30.30 (C-4,C-10), 
23.80 (C-3, C-11), 22.96 (C-2, C-12), 20.03 (C-14, C-15) and 
13.79 (C-1, C-13). 
(iii) Methy110,10-dimethyl prost-8(12)-en-9,11-dionoate (25) 
N.B.: 1 
207.34 (C-9, C-11), 156.27 (C-8, C-12), 51.39 (C-23), 45.54 (C-10), 
34.00 (C-2), 31.81 (C-18), 29.79 (C-7, C-13), 29.48 (C-4), 
29.17 (a ),27.99 (a ), 24.80 (C-3), 2402 ( a ), 22.61 (C-19), 
20.04 (C-21, C-22) and 1404 (C-20). 
H-NMR spectrum of the same sample confirmed the presence of the 
carbomethcixy group, 13 However, the C-NMR spectrum only showed the 
-COO£H3 carbon (51.39 ppm), the acyl carbon (-£00CH3, expected at 
~ 174.1) was not detected. 
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(iv) N-phenyl 10,10-dimethyl prost-8(12)-en-9,11-dionamide (47) 
207.71,207.38 (C-9, C-11), 171.16 (C-1) , 156.46, 155.94 (C-12,[-8), 
138.00, 129.02, 124.27, 119.85 (aromatic ring carbons), 45.52(C-10), 
37.65 (C-2), 31.87 (C-18), 30.11 ( a ),29.72 ( a ), 29.46 ( a ), 
29.26 ( a ), 29.13 ( a ), 28.81 ( a ), 28.22 ( a ), 27.96 ( a ), 
25.49 ( a ), 25.36 ( a ), 23.93 ( a ), 22.70 ( a ), 20.03 (C-21,C-22) 
and 14.11 (C-20). 
N.B.: ~ore peaks appeared in the spectrum than can be accounted for by 
the number of carbons posse~sed by (47).' The presence of impurities is 
expected as the UV data of (47) shOlrled it to be impure. 
(v) 5,5-dimethyl nona-4,6-dione (126) 
209.52 (C-4, C-6), 62.31 (C-5), 40.30 (C-3, C-7), 21.31(C-10,C-11), 
17.27 (a) and 13.65 (a ) 
(vi) 7,7-dimethyl trideca-6,B-dione (127) 
209.42 (C-6, C-B), 62.48 (C-7), 38.34 (C-5, C-9), 31.51 (C-3,C-11), 
23.61 (C-4, C-10), 22.61 (C-2, C-12), 21.35 (C-14, C-15) and 
13.92 (C-1,'C-13) 
(vii) Ethyl 10,10-dimethyl eicos-9,11-dionoate (17) 
209.53 (C-9, C-11), 173.45 (C-1), 62.40 (C-10), 60.06 (C-23), 
38.30 (C-8, C-12), 34:27 (C-2), 31.93 (C-18), 29.47 ( a ), 
29.30 ( a ), 29.12 ( a ), 29.01 a), 24.91 (C-3), 23.74 (C-7), 
22.69 (C-19), 21.29 (C-21, C-22), 14.27 (C-24), and 14.09 (C-20) 
(viii) Ethyl 10,10-dimethyl-15-benzylo~y eicos-9,11-dionoate (74) 
209.53 (C-9, C-11),173.56 (C-1), 138.94, 128.24, 127.66, 127.31 
(aromatic ring carbons), 78.65 (C-15), 70.70 (0-£H2Ph), 
62.22 (C-10), 60.00 (C-23), 38.30 (C-8, C-12), 34.20 (C-2), 
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33.62 ( a ), 33.10 ( a ), 32.05 (C-18), 28.95 ( a ), 
24.91 (C-3) , 23.68 (C-7) , 22.63 (C-19), 21.29 (C-21, C-22) , 
19.65 ( a ), 14.21 (C-24) and 14.09 (C-20). 
(ix) Nona-4,6-dione (119) 
(204.06) , 194.33 (C-4, 214 C-6), 99.28 (C-5) , (57.18), (45.74), 
40.45 (C-3, C-7) , 19.29 (C-2, C-8), ( 19.02) , (17.05) , 
13.78 (C-1 , C-9). 
(x) Trideca-6,8-dione (122) 
(203.96),194.44 (C-6, C-8), 99.04 (C-7), (57.19), (43.77), 
38.49 (C-5, C-9), (31.46),·25.57 (C-4, C-10), (23.30), 
22.60 (C-2, C-12) and 13.95 (C-1, C-13). 
(xi) Ethyl eicos-9,11-dionoate ( 3 
194.32 (C-9, C-11), 173.45 (C-1) , 99.00 (C-10), 60.06 (C-23), 
38.42 (C-8, C-12), 34.33 (C-2),' 31.99 (C-18), 29~36 ( a ), 
29.12 ( a ), 25.79 ( a ), 24.97 (C-3), 22.75 (C-19), 14.33(C-24) 
and 14.15 (C-20) 
(xii) Eicos-9,11-dionoic acid (4) 
(204.50),194.44 (C-9, C-11), 179.82 (C-1), 99.00 (C-10), (57.02), 
(43.74), 38.36 (C-8, C-12), 34.03 (C-2), 31.93 (C-18), 29.36 ( a), 
29.01 ( a ), 25.67 ( a ), 24.62 (C-3), (23.39), (23.27),22.69 
(C-19) and 14.09 (C-20) 
(xiii) Ethyl 15-benzyloxy-eicos-9,11-dionoate (74) 
194.38, 194.03 (C-9, C-11), 173.68 (C-1) , 139.00, 128.24, 127.66, 
127.37 (aromatic ring carbons), 99.00 (C-10), 78.59 (C-15), 
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" . '. 
38.36 (C-8, C-12), 34.27 (C-2), 33.68 ( a ), 33.33 ( a ), 
31.99 (C-18), 28.95 ( a ), 25.61 ( a ), 24.91 ( a ), (23.27), 
22.63 (C-19), 21.52 ( a ), 14.21 (0-CH~H3) and 14.03 (C-20) 
(xiv) 6-berrzyloxy -undeca-2-one (67) 
208.53 (C-2), 139.06, 128.24, 127.72, 127.37 (aromatic ring carbons) 
78.65 (C-6), 70.76 (O-£H/h), 43.62 (C-3), 33.68 ( a ), 33.22 (a) 
32.05 (C-9), 29.71 (a), 24.97 (a), 22.63 (C-10), 19.71 (a) 
and 14.03 (C-11) 
(xv) Diethyl azelate (1) 
173.68 (C-1), 60.12 (0-CH 2CH 3 ), 34.33 (C-2, C-8), 28.95 (C-4,5, 
and 6), 24.91 (C-3, C-7) and 14.27 (0-CH2-£H 3 ) 
N.B.: (a), assignment ambiguous or undetermined.Weak signals are shown 
in brackets. 
The 13C_NMR assignments made above were based on a careful comparison 
13 39 . 40 42 between known C-NMR data of natural PG ' , PG analogues and 
other relevent model compounds, 86, 119, 120, 135 
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APPENDIX FIGURE 1. 
CORRELATION DIAGRAM OF nC NMR CHE11ICAL SHIFTS RELATIVE TO 
TMS OF SOME PROSTANOIDS AND RELATED COI-1POUNDS. 
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